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2ABSTRACT
The importance of brain structure is indisputable. It forms the framework on 
which functional parameters can be mapped and referenced. The classical region of 
interest based morphometric methods that have hitherto formed the mainstay of 
structural neuroimaging have a number of drawbacks not least because they are 
spatially constrained and operator dependent. In light of substantial advances in 
magnetic resonance imaging techniques and concomitant computational post 
processing innovations, new insights into brain structure are now possible. A new 
generation of whole brain imaging techniques can now inform about brain structure in 
a more holistic way with enhanced precision. Computational neuroanatomy is a new 
method employing the versatile framework of statistic parametric mapping and 
volumetric high-resolution magnetic resonance images of the brain. It consists of a 
triad of interactive techniques: voxel-based morphometry (VBM) which provides 
voxel-wise inferences about regional grey and white matter, deformation-based 
morphometry (DBM) which characterises global brain shape differences and tensor- 
based morphometry (TBM) which characterises local shape differences with high 
precision.
This thesis examines the application and usefulness of voxel-based 
morphometry with particular reference to its practicality, reproducibility, validity and 
sensitivity to characterise brain structure. VBM is first applied to a large normative 
database to characterise physiological variations in normal brain structure in order to 
create a canonical framework against which pathology can be measured. VBM is then 
rigorously compared with classical morphometries in patients with two distinct forms 
of dementia and in patients with mesial temporal sclerosis in order to establish validity 
md sensitivity. VBM is then applied to a variety of disease groups where classical 
morphometries have failed to reveal consistent brain structural phenotypes in order to 
jeveal morphological changes in functionally implicated regions. Finally VBM is used 
is a tool to allow genotype-phenotype mapping. The strengths and weaknesses of this 
lew technique are discussed with reference to its applicability and usefulness for 
leurologists and neuroradiologists
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CHAPTER 1 
INTRODUCTION
The importance of brain structure
One of the fundamental goals of neuroscience is to understand the complex 
functions of the human brain in health and its adaptations to disease. To this end, 
increasing importance has been placed on brain structure not only to establish links 
between structure and function, but also to allow brain function to be mapped precisely 
into a neuroanatomical framework. Brain structure can be expressed at a macroscopic 
scale (e.g., global or regional grey matter, regional asymmetries), at a mesoscopic scale 
(e.g., cortical thickness) or at a microscopic scale (e.g., cytoarchitectonics). Large 
multicentre databases are now integrating several components of structural information 
such as cytoarchitectonics, myeloarchitectonics, neurochemical receptor distribution 
and diffusion properties of white matter tracts with functional imaging data from PET, 
fMRI, EEG and MEG, and genetic profiles in order to create a more holistic map of 
the human brain. It is now increasingly important to have a standardised accurate 
anatomical framework to enable multiple sources of information to be pooled and 
compared between laboratories.
There has been recent renewed interest in brain macroscopic and mesoscopic 
structural imaging in light of substantial advances in computational power and 
analytical expertise that permit objective analyses of high resolution three-dimensional 
MRI scans. The great challenge for structural imaging is to accommodate the full 
spatial and temporal complexity of macroscopic brain anatomy during normal 
development and its adaptations to physiological senescence. It is only after the 
dynamic physiological asymmetries and heterogeneities of normal cerebral anatomy 
are realised, that perturbations of disease can be properly appreciated. This requires 
sophisticated registration and analysis of MRI scans. The relationship between brain 
structure and function is complex; abnormalities in structure are not necessarily
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associated with functional deficits, and the spatial extent of a structural lesion does not 
necessarily determine the degree of functional deficit. Despite this, the importance of 
anatomy is indisputable and it remains the infrastructure upon which brain function is 
mapped.
Macroscopic cerebral anatomy
Crude descriptions of cerebral anatomy originate from ancient Egyptian times, 
but at that time the cerebrum was passed off as a functionless organ. It was not until 
the early nineteenth century that the important functions of the cerebral cortex were 
recognised. By the late nineteenth- and early twentieth-century pioneering work by 
anatomists allowed the first detailed labelling of brain surface structures and formed 
the foundations of modem neuroanatomy. With the introduction of modem scanning 
techniques, detailed labelling of deeper brain structures began - and today 
comprehensive and detailed brain atlases map the brain in its entirety with great 
precision in three dimensions.
Brain size and gross morphology
The human brain lies within the cranial cavity attached to the spinal cord at the 
cervico-medullary junction. The brain and spinal cord are surrounded by fibrous 
membranes, the meninges, which comprise three layers: a dense outer dura mater, an 
intermediate arachnoid membrane and a thin inner pia mater. Cerebrospinal fluid 
circulates in the subarachnoid space around the brain and spinal cord in free continuity 
with the ventricles. The basic divisions of the brain are into two cerebral hemispheres, 
the brainstem and cerebellum. The right and left cerebral hemispheres are separated by 
the falx cerebri that lies within the interhemispheric fissure. A broad commissure of 
white matter fibres, the corpus callosum, connects the hemispheres. Each hemisphere 
comprises an outer mantle of grey matter (the cerebral cortex) and underlying white 
matter that extends down to the ventricular system. Embedded deep within the white 
matter are additional grey matter structures, the grey matter nuclei (e.g. accumbens, 
basalis, caudate, lentiform, thalamic, hypothalamic, subthalamic, parafascicular, red 
and septal). The grey matter contains the cell bodies of neurons whereas the white 
matter consists of bundles of myelinated axons emerging from cell bodies. The cortical 
surfaces are markedly convoluted into a complex system of gyri and sulci.
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The hemispheres are generally divided into six lobes: frontal, temporal, 
parietal, occipital, insula and limbic. The frontal lobe is the only lobe that can be 
clearly separated from the other lobes on the lateral surface. It is bounded posteriorly 
by the central sulcus and inferiorly by the Sylvian fissure, and is divided into four 
frontal gyri: precentral, superior, middle and inferior. Some of the boundaries of the 
temporal, parietal and occipital lobes are less distinct and are conventionally defined 
on arbitrary criteria that have no anatomical, histological or functional basis. The 
parietal lobe is clearly separated from the frontal lobe by the central sulcus, but its 
boundary with the temporal lobe is based on an arbitrary convention: a horizontal line 
extending posteriorly from the point that the Sylvian fissure becomes vertical. The 
division between the occipital, temporal and parietal lobes is usually based on a 
theoretical straight line running from the parieto-occipital fissure (visible on the medial 
surface of the brain) to the temporo-occipital incisure. The parietal lobe is divided into 
the postcentral and the superior and inferior parietal gyri. The temporal lobe is divided 
into superior, middle and inferior temporal gyri. The occipital lobe anatomy is so 
complex and variable that most classic anatomy textbooks avoid detailed descriptions. 
In general it is divided into superior, middle and inferior occipital gyri. The insula is 
situated in the bottom of the lateral fossa and can only be seen once the lateral 
operculum has been removed. It is shaped as a small inverted triangle and is separated 
from the lateral operculum by the circular insular sulcus. The insula is divided into 
anterior and posterior portions by the central insular sulcus. The limbic lobe is a 
complex structure consisting of large convolutions of the medial hemisphere and is 
separated from surrounding structures by the limbic fissure. The limbic lobe may be 
divided into limbic and intralimbic gyri. The limbic gyrus comprises the subcallosal 
gyrus, cingulate gyrus, isthmus and parahippocampal gyrus. The intra-limbic gyrus 
comprises the pre-hippocampal rudiment, the indusium griseum and the hippocampus.
Sulcal and gyral anatomy
It is beyond the scope of this text to provide a comprehensive account of each 
and every sulcus and gyrus, particularly considering the wide variations in sulcal 
anatomy not just between different brains, but also between hemispheres of the same 
brain. This section will document the most consistent and major surface anatomical 
landmarks that are used as reference points by most brain imagers. Variability of 
structures and inconsistencies of nomenclature will also be highlighted. Anatomical
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descriptions and nomenclature are in general based on Henri M. Duvemoy’s 
comprehensive and excellent brain atlas (Duvemoy 1999).
The Sylvian fissure, also termed the lateral fissure forms a deep depression on 
the lateral fossa whose banks constitute the lateral operculum. It is divided into basal 
and lateral parts, and the lateral part is further subdivided into anterior, middle and 
posterior segments. Its start marks the division between the frontal and temporal lobes 
and it bifurcates posteriorly into a small downward curving segment and a larger 
vertical portion called the terminal ascending segment.
The central sulcus, also termed fissure of Rolando, separates the frontal and 
parietal lobes, and more importantly delineates the boundary between the primary 
motor and sensory cortices. It is usually clearly identifiable on MRI and serves as an 
important reference point for the identification of other sulci. (That said, occasionally 
even the most experienced anatomists have problems identifying the central sulcus).
On superior axial slices the central sulcus displays a typical notch and does not connect 
with sulci orientated in a different direction (such as the superior frontal and 
intraparietal sulci). At the level of the vertex the precentral, central and postcentral 
sulci form a typical triad of parallel lines. On para- sagittal sections the central sulcus 
forms a notch just anterior to the end of the callosomarginal sulcus. On lateral sagittal 
slices, the central sulcus is the third sulcus after the ascending branch of the Sylvian 
fissure.
Frontal lobe sulci: The superior and inferior frontal and precentral sulci divide 
the frontal lobe into precentral, superior, middle and inferior frontal gyri. The 
horizontally orientated superior and inferior frontal sulci branch into ascending and 
descending rami at their caudal ends. These rami form the inferior and superior 
precentral sulci, which may remain separate or merge to form a single precentral 
sulcus lying anterior and parallel to the central sulcus. The superior frontal sulcus 
frequently intersects the precentral sulcus (usually the inferior segment) and is easily 
identifiable on axial MR slices, helping to differentiate the precentral sulcus from the 
central sulcus. The lateral surface of the superior frontal gyrus (FI) is often divided by 
an additional longitudinal sulcus that may be discontinuous. The middle frontal gyrus 
(F2) is often divided into superior and inferior parts by a middle frontal sulcus that 
sometimes merges with the frontomarginal sulcus. The inferior frontal gyrus (F3) may 
merge with the orbital lobe inferiorly or be separated from it by a lateral orbital sulcus. 
The ascending and horizontal rami of the Sylvian fissure divide the inferior frontal
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gyrus into three parts: the pars orbitalis inferiorly, the pars triangularis centrally and 
the pars opercularis posteriorly. An additional sulcus diagonalis may arise from the 
inferior frontal sulcus to divide the pars triangularis and a vertical groove, the sulcus 
diagonalis may be seen on the pars opercularis. Confusion may arise over terms such 
as dorsolateral prefrontal cortex (generally considered to be the superior and middle 
frontal gyri excluding the posterior portions) and ventrolateral prefrontal cortex 
(generally considered to be the middle and anterior parts of the inferior frontal gyrus). 
The frontal pole is a transitional area between the lateral, medial and orbital surfaces of 
the frontal lobe. Most of the medial surface of the frontal lobe comprises the superior 
frontal gyrus (FI), which is bounded posteriorly by the small paracentral sulcus.
Caudal to this is the paracentral lobule, which bridges the frontal and parietal lobes.
The medial surface of the frontal lobe is separated from the limbic lobe by the 
cingulate sulcus. In the subcallosal region one or two supraorbital sulci separate the 
medial surface of the frontal lobe from the gyrus rectus, which forms part of the 
inferior surface of the frontal lobe (also termed the orbital lobe)
Parietal lobe sulci: The parcellation of the parietal lobe is very variable. On 
the lateral surface only one sulcus is clearly visible, the intraparietal sulcus, which 
divides the parietal lobe into the postcentral and superior and inferior parietal gyri. The 
intraparietal sulcus usually comprises three segments: an anterior segment that 
ascends, an intermediate segment that lies horizontally and a posterior segment that 
descends. The anterior segment, also termed the inferior postcentral sulcus, runs 
parallel to the central sulcus. There may also be a separate superior postcentral sulcus. 
The posterior segment descends until it reaches the theoretical boundary between the 
parietal and occipital lobes then becomes the intra-occipital sulcus. The postcentral 
gyrus is often narrower than the precentral gyrus. The subcentral gyrus (ventrally) and 
the paracentral lobule (dorsally) form a superficial link between the pre- and 
postcentral gyri. The superior parietal gyrus (PI) is clearly identifiable, limited 
anteriorly by the postcentral sulcus and inferiorly by the intraparietal sulcus. At the 
level of the parieto-occipital fissure PI is linked to the superior occipital gyrus by a 
transitional area called the parieto-occipitalis and there may be bridging lobules 
connecting the superior and inferior parietal gyri. The inferior parietal gyrus (P2) is 
highly variable and complex. It is divided by a descending ramus of the intraparietal 
sulcus into two parts: the supramarginal gyrus and the angular gyrus. The 
supramarginal gyrus is an arched lobule surrounding the end of the Sylvian fissure.
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The angular gyrus is a narrow lobule surrounding the ascending posterior segment of 
the superior temporal sulcus. To complicated matters the left superior temporal sulcus 
often has a double parallel termination, and in this scenario there is no consensus on 
the anterior and posterior limits of the angular gyrus, with some authors ascribing part 
of the angular gyrus to the parietal lobe and others ascribing it to the occipital lobe.
The confusion is further confounded by the cytoarchitectonics of this region 
(Brodmann’s area 39), which cannot be clearly separated from the occipital and 
temporal regions. The medial surface of the parietal lobe comprises the precuneus, 
which is part of the superior parietal gyrus (PI). The marginal segment of the cingulate 
sulcus separates the anterior border of the precuneus from the paracentral lobule. 
Posteriorly the parieto-occipital fissure separates the precuneus from the occipital lobe. 
The subparietal sulcus partially separates the precuneus from the cingulate gyrus.
Temporal lobe sulci: The superior and inferior temporal sulci divide the 
temporal lobe into superior, middle and inferior temporal gyri. The superior temporal 
sulcus runs parallel to the Sylvian fissure and is easy to identify. It is usually divided 
into an anterior and posterior segment. The anterior segment is sometimes termed the 
anterior temporal sulcus as it reaches the temporal pole. The posterior segment is 
variable. It may be a single sulcus or, as is most often the case, it branches into an 
ascending posterior segment (sulcus angularis) and a horizontal segment. The inferior 
temporal sulcus is not only highly variable, but it is difficult to define along its course, 
particularly posteriorly, where it may be termed the anterior occipital sulcus. As a 
result the delineation between the posterior limits of the middle and inferior temporal 
gyri and the adjacent inferior occipital gyrus is unclear. The medial temporal lobe 
comprises the amygdala, the complex folded allocortex of the hippocampal formation 
(subicular cortices, hippocampus and dentate gyrus) and the surface allocortical and 
peri-allocortical layers of the parahippocampal gyrus (T5) that cover them. Confusion 
in nomenclature arises because many of the “medial temporal” structures are formally 
part of the limbic lobe (see below for details). The inferior surface of the temporal lobe 
consists of three gyri: the inferior temporal gyrus (T3), the fusiform gyrus (T4) and the 
parahippocampal gyrus (T5) separated by the lateral occipitotemporal and collateral 
(medial occipitotemporal) sulci respectively. The fusiform gyrus does not extend to the 
temporal pole and is bounded rostrally by the anterior transverse collateral sulcus and 
caudally by the posterior transverse collateral sulcus.
Occipital lobe sulci: laterally, the occipital lobe is separated from the other
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lobes by a theoretical line running from the parieto-occipital fissure to the temporo- 
occipital incisure. Although parcellation of the occipital lobe is by no means 
consistent, Duvemoy (Duvemoy 1999) describes superior and inferior occipital sulci 
on the lateral surface forming superior (01), middle (02) and inferior (03) occipital 
gyri. The superior occipital sulcus (or intra-occipital sulcus) is usually the continuation 
of the intraparietal sulcus. The inferior occipital sulcus is variable and usually difficult 
to identify. A transverse occipital sulcus is also described. On the medial surface the 
occipital lobe is clearly separated from the parietal lobe by the parieto-occipital fissure. 
On the inferior surface, there are no clear boundaries between the occipital and 
temporal lobes. The fourth occipital gyrus (04) and its paired temporal homologue 
(T4) together form the fusiform (lateral occipitotemporal) gyrus. The lingual gyrus 
(05) and the parahippocampal gyrus (T5) together form the medial occipitotemporal 
gyrus. The cuneus (06) is the only well defined occipital gyrus bordered by the 
parieto-occipital fissure and the calcarine sulcus. Occasionally a bridging lobule links 
the cuneus to the lingual gyrus. On the occipital pole, the calcarine sulcus branches off 
into the retro-calcarine sulcus, which demarcates a small lobule, called the gyrus 
descendens of Ecker, which marks the caudal boundary of the striate cortex. The striate 
cortex is situated in the gyrus of Ecker, superior and inferior banks of the calcarine 
sulcus proper and extending rostrally along the inferior bank of the anterior calcarine 
sulcus without reaching its end.
Limbic lobe sulci: The limbic fissure demarcates the limbic lobe, but problems 
arise because this fissure is complex and difficult to define. It is formed by a 
succession of different and discontinuous sulci (subcallosal, cingulate, subparietal, 
anterior calcarine, collateral and rhinal), which constitute the limbic fissure only for 
part of their course. The limbic gyrus is made up of several parts: the subcallosal 
gyrus, cingulate gyrus, isthmus and parahippocampal gyrus. The subcallosal gyrus is 
bordered by the anterior para-olfactory (subcallosal) sulcus and the posterior para- 
olfactory sulcus, which separates it from the paraterminal gyrus. There are 
inconsistencies with terminology here. The subcallosal gyrus is sometimes termed the 
area adolfactoria, in which case the paraterminal gyrus is called subcallosal gyrus. The 
cingulate gyrus courses around the corpus callosum from which it is separated by the 
pericallosal sulcus. A narrow bridge of cortex, the isthmus, connects the cingulate 
gyrus to the parahippocampal gyrus beneath the splenium of the corpus callosum. The 
parahippocampal gyrus, confusingly termed T5, and the lingual gyrus (05) together
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form the medial occipitotemporal gyrus. The parahippocampal gyrus is usually divided 
into two parts. A larger anterior segment called the piriform lobe, which consists of the 
anterior part of the uncus and the entorhinal cortex. The narrower posterior segment 
has a flat superior surface, the subiculum, which is separated from the hippocampus by 
the hippocampal sulcus. The uncus is divided into anterior and posterior portions. The 
anterior portion is part of the piriform lobe. Two protrusions are conspicuous in this 
region: the semilunar gyrus (part of the amygdala) and the ambient gyrus. The ambient 
gyrus is often misidentified as uncus because it bulges medially in a similar fashion, 
but the ambient gyrus actually arises from medial entorhinal cortex and is always a few 
millimetres anterior to uncus and in the same plane as the posterior portion of the 
amygdala. The posterior portion of the uncus belongs to the intralimbic gyrus and 
comprises the uncinate gyrus, the band of Giacomini and the uncal apex. The 
entorhinal cortex (Brodmann’s area 28) is the largest cortical field of the 
parahippocampal gyrus and forms the lower part of the piriform lobe. This structure is 
difficult to differentiate from surrounding anatomy; the sulcus semilunaris separates it 
from the amygdala, but posteriorly it merges with the lingual part of the occipital lobe 
near the anterior tip of the calcarine fissure and medially it merges with the subicular 
part of the hippocampal formation. Its borders are thus usually defined by arbitrary 
criteria (see chapter 4). The perirhinal cortex also causes confusion and is often 
ignored in anatomy texts. It forms the lateral border of the parahippocampal gyrus and 
corresponds to Brodmann’s area 35 which constitutes the medial bank of the collateral 
sulcus intervening between the entorhinal cortex and the inferior temporal cortex 
(Brodmann’s area 36). Its exact configuration depends on the positioning and depths of 
the rhinal and collateral sulci.
Macroscopic anatomical variability
Sulcal variability
Features such as neocortical expansion and complex gyrification help to 
differentiate the human brain from the brains of lesser primates. As unique as the 
human brain is relative to other species, there are considerable interindividual 
variations in neuroanatomy including global size and shape differences as well as 
regionally specific differences in gyral and sulcal geometry. The spatial variations in
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sulcal and gyral geometry relate in part to the timing of sulcal formation during brain 
development. The more consistent sulci are generally those that develop early such as
tlithe primary and secondary sulci, while those developing later (after the 28 week of 
gestation) show greater complexity and variation. The early sulci include the 
interhemispheric fissure (8th week), Sylvian fissure (14th week), parieto-occipital 
sulcus, central sulcus and calcarine fissure (16th week). The precentral, postcentral, 
intraparietal, middle temporal and superior frontal sulci develop between the 24th and 
28th weeks and finally in the third trimester, the tertiary sulci and gyri (such as the 
inferior temporal, inferior parietal, angular and supramarginal gyri) develop. This 
complex variability between individuals and across different regions presents a huge 
challenge for anyone attempting to create an anatomical reference frame. A fixed brain 
atlas cannot truly represent the individual brain and direct averaging of digital brain 
maps is only valid if homologous regions are accurately mapped. For this reason, 
sophisticated computational morphometric models are integral to modem brain 
mapping.
Cerebral asymmetries
An important and specific form of cerebral variability is asymmetry. 
Morphological left-right asymmetry appears to be the rule rather than the exception in 
biological systems (Geschwind and Galaburda 1985a; Geschwind and Galaburda 
1985b; Geschwind and Galaburda 1985c; Kimura 1973). Even single-celled organisms 
are commonly asymmetric, and greater organisational complexity may be reflected in 
greater functional specialisation and thus in more elaborate asymmetry of function and 
structure. Certainly human beings are structurally asymmetric; from the size of their 
feet, sex organs and hands to the placement of visceral organs and facial features 
(Kimura, 1973; Levy, 1978; Purves et al., 1994) and they exhibit lateralised behaviour 
as early as 10 weeks gestation (Hepper et al., 1998).
Structural asymmetries in the human brain have been sought and studied for 
over a century (Geschwind and Galaburda 1985a) (Geschwind and Galaburda 1985b) 
(Geschwind and Galaburda 1985c) and observations of macroscopic structural 
asymmetries in areas known to be functionally asymmetric have proliferated in the last 
two decades. The main and most consistent observations include the right frontal and 
left occipital petalia; marked indentations of the inner table of the skull resulting from 
the greater protrusion of the adjacent cerebral lobes (Chiu and Damasio 1980; Gundara
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and Zivanovic 1968; LeMay 1986). This term is now used in reference to the lobar 
asymmetries themselves. One of the earliest reported brain asymmetries is also one of 
the most consistent: the trajectory of the Sylvian fissure is angled upwards (dorsally) 
more steeply in the right hemisphere (Cunningham 1892; Geschwind and Galaburda 
1985a; Loftus et al 1993; Ratcliff et al 1980; Thompson et al 1998; Thompson et al 
2001a; Westbury et al 1999). This trajectory asymmetry is very probably related to 
another well-known posterior Sylvian asymmetry - one probably more easily 
detectable by voxel-based morphometry (VBM) - the leftward volume asymmetry of 
the planum temporale (Geschwind and Levitsky 1968; Steinmetz et al 1989; Wada et 
al 1975; Watkins et al 2001) and of cytoarchitectonic area Tpt, characteristically 
found in this region (Galaburda et al 1978).
Other macrostructural asymmetries can be found on the superior temporal 
plane: the first gyrus of Heschl, containing primary auditory cortex, appears to be 
larger on the left side (Penhune et al 1996; Rademacher et al 1993). This difference 
has been ascribed to a larger volume of white matter rather than grey matter (Penhune 
et al 1996). Finally recent studies corroborate and extend older reports of a larger 
Broca’s area (areas 44 and 45 of Brodmann) in the left hemisphere (Foundas et al 
1998b; Annett 1970; Annett 1976; Falzi et al 1982; Foundas et al 1995; Foundas et 
al 1996; Geschwind and Galaburda 1985a). Chapter 4 examines human brain 
asymmetries on a voxel-wise scale and documents the effects of sex and handedness.
Relationship between macroanatomy and microanatomy
The microanatomy of the brain has to a large extent already been mapped in 
detail. In 1909 in the famous book Vergleichende Lokalisationslehre der 
Grosshirnrinde in ihren Prinzipien dargestellt auf Grund des Zellenbaues, Korbinian 
Brodmann provided detailed mapping of architectonic fields (Brodmann 1909). The 
basis of Brodmann's cortical localisation is its subdivision into 'areas' with similar 
cellular and laminar structure. He compared localisation in the human cortex with that 
in a number of other mammals, including primates, rodents and marsupials. In man, he 
distinguished 47 areas, each carrying an individual number, and some being further 
subdivided. To this day Brodmann’s work forms the basis for localisation of function 
in the cerebral cortex, with most neuroanatomical texts referring to Brodmann's areas
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(Brodmann 1909). In early times, specific cognitive functions were assumed to be 
directly predicated by specific cytoarchitectural fields. But since the advent of 
functional imaging, it is now clear that there is not an exact correspondence between 
cytoarchitectonic anatomy and function, for example in areas 17,18 and 19 of the 
human occipital cortex, the myelo- and cytoarchitecture do not correspond with the 
putative boundaries of functional visual areas (Clarke and Miklossy 1990). It is thus 
more appropriate to parcellate the microstructure of the human cerebral cortex using 
multiple criteria based on quantitative measurements of microstructural variables, such 
as neuron densities, neurotransmitter receptor densities and enzyme densities (Roland 
and Zilles 1998). Although architectonic fields often show a characteristic relationship 
to macroscopic landmarks such as gyri and sulci, there are several areas such as 
Brodmann’s areas 9 and 46 in preffontal cortex where cytoarchitectonic fields and 
macroscopic landmarks do not correlate (Rajkowska and Goldman-Rakic 1995b; 
Rajkowska and Goldman-Rakic 1995a). The "primary" cytoarchitectonic neocortical 
fields, Brodmann’s areas 17,41, 3b, and 4 bear a characteristic relationship to a set of 
bounding anatomic landmarks, in particular gyri, fissures, and sulci that can be readily 
defined by MRI. In general there are two types of variability. In the first case, 
variability is not predictable from visible landmarks as exemplified by the 
extracalcarine distributions of area 17 or the extent of area 4 on the paracentral lobule. 
In the second case, Variability is predictable from visible landmarks as exemplified in 
the marked interindividual or iiiterhemispheric variation in overall size or shape of a 
field. Because of the prominence of this second class of variability, direct reference to 
landmarks that frame these fields may be more reliable for functional mapping than 
reference to a fixed or standard template.
Brain atlases
Brain atlases have existed for many decades and their purpose is to provide an 
anatomical reference frame. Many of the early atlases were collections of micrographs 
or schematic drawings of brain sections derived from one or a few post mortem 
specimens depicting information such as microscopic architecture (Brodmann 1909) or 
neurochemical distribution (Mansour et al. 1995). In the early 1970s, Jean Talairach 
(Talairach and Toumoux 1988) combined a system of teleradiography with
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ventriculography to describe brain anatomy in a statistical way within a proportional 
grid localisation system. His system is based on the premise that despite marked 
variability in brain sizes, the relationship of structures in the telencephalon to the 
anterior and posterior commissures is stable. Structures close to the AC or PC exhibit 
smaller variations in stereotactic space than those at the periphery of the brain. This 
methodology was originally designed as a navigational tool for functional 
neurosurgery, but it rapidly became an international standard for localising functional 
imaging data and one of the most used brain atlases that has subsequently been 
digitised. The atlas maps the brain of a sixty year old woman within a stereotactic 
coordinate system and includes the cartography of Brodmann (Brodmann 1909). One 
of the problems with this atlas is that it does not accurately reflect the in vivo anatomy 
of most of the subjects used in activation studies (usually young males). A further 
confound is the variable separation between atlas plates and the sometimes imprecise 
mapping of Brodmann areas: "The brain presented here was not subjected to 
histological studies and the transfer of the cartography of Brodmann usually pictured 
in two dimensional projections sometimes possesses uncertainties". To address these 
limitations the Montreal Neurological Institute (MNI) (Evans et al. 1993) produced a 
more representative brain template based on a large series of normal MRI brain scans. 
Initially they manually defined various landmarks on 241 normal brain MRIs, scaled 
each image to match the landmarks on the Talairach atlas using affine transformations 
(translations, rotations, zooms) and finally created a mean image. They then used an 
automated linear algorithm to match 305 normal MRI scans (all right handed, 239 M, 
66 F, age 23.4 +/- 4.1) to the mean scaled 241-brain image. From this they generated a 
mean template: the MNI 305. They have subsequently generated the ICBM 152 
template which is based on 152 normal MRI scans that have been affinely matched to 
the MNI 305 (age range 18-44, mean 24 (+/- 4.9), 56% male. This digitalised template 
is now the standard for the International Consortium for Brain Mapping 
(ICBM)(Mazziotta et al 2001) and the widely used Statistic Parametric Mapping 
(SPM) package (Friston et al. 1995). However, with the introduction of the MNI 
templates, some confusion has arisen over reporting localisations in the Talairach 
coordinate system. The linear transformations have not matched the MNI templates 
precisely to the Talairach brain and as a result the MNI brain is slightly larger than the 
Talairach brain. Furthermore, mismatches are most pronounced (up to 10mm) at the 
periphery of the brain and least pronounced centrally. For this reason there are now
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approaches for translating MNI coordinates to Talairach space.
In light of the complex interindividual variability in cortical structure, a fixed 
brain atlas cannot allow a precise representation of each and every brain. This is 
because sulci and gyri will not be precisely matched. With improvements in 
registration techniques, deformable MRI atlases can now be created to more accurately 
match individual MRI image sets. Two options exist: the incoming MRI can be warped 
to the atlas, or the atlas can be warped to the incoming MRI. In the former, the 
subject’s anatomy is transformed into the anatomical framework of the atlas, removing 
subject specific shape differences. For example regionally specific effects can be 
compared having removed confounding factors such as global size and shape 
differences. In the latter, the information from the atlas is transferred onto the subject’s 
anatomy, whilst preserving subject specific characteristics. For example, 
cytoarchitectonic architecture can be mapped onto a specific subject’s brain.
These deformable brain atlases thus allow more accurate matching of brain 
scans, but they do not encode information on interindividual variations in cortical 
architecture. Complex mathematical strategies are needed to quantify the magnitude 
and directional biases of neuroanatomical variability. Such atlases now exist, and are 
referred to as digital probabilistic atlases. They encode precise statistical information 
on local structural variations. For example, gyral and sulcal variations can be 
quantified to determine whether they lie outside the normal range, which may be a sign 
of disease (Thompson et al 1996a; Thompson et al 1996c; Thompson et al 2000). 
Pioneering work by Thompson and colleagues has allowed the generation of 
population-based probabilistic brain atlases in a number of important diseases 
including Alzheimer’s disease and schizophrenia (Thompson et al 1998; Thompson et 
al 2001a; Thompson et al 2001b).
Evolution of morphometry techniques
Although the quest for understanding the structure and function of the human 
brain started centuries ago, most of the earlier descriptions were qualitative. 
Quantitative assessments of anatomy and function are preferable, but are more 
challenging to obtain. The highly complex organisation of human cerebral cortex, 
including the dynamic changes with time and marked interindividual variability in
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regional anatomy need to be catered for. In addition, brain function is likely to be more 
closely related to a combination of structural features such as cytoarchitecture, 
neurotransmitter receptor and enzyme densities and myeloarchitecture than simply 
macroscopic structure. Thus crude anatomical descriptions on a macroscopic level are 
generally of limited value, and more sophisticated objective morphometric methods are 
required. Quantitative differences in macroscopic brain structure have been assessed 
by a variety of techniques over the last 3 decades. As early as 1905 indirect 
measurements of brain volume were made post mortem by instilling water into the 
cranial cavity and measuring the brain/ intracranial cavity volume ratio (Reichardt 
1905). Direct post mortem analyses of brain structure, whilst sensitive to microscopic 
and macroscopic structural differences are subject to a number of practical 
shortcomings. Firstly post mortem material is not readily available. Secondly these 
studies are time consuming, since much of the tissue preparation is performed 
manually. Further confounding effects such as the interval between death and fixation 
of brain tissue, the timing of measurements (Last and Tompsett 1953; Messert et al 
1972) and the inclusion or exclusion of brain stem structures and meninges (which can 
be difficult to control), can vary across studies, making comparisons difficult. The 
introduction of modem in vivo imaging techniques including cranial ultrasound, 
computed tomography (CT) and more recently magnetic resonance imaging (MRI) 
have provided the opportunity for direct, non-invasive, in vivo measurements of 
intracranial structure. MRI is now the established imaging technique of choice for 
accurate assessment of brain structure. Three-dimensional (volumetric) high-resolution 
structural MRI scans are the current standard requirement for modem brain 
morphometry. Another important requirement for modem brain morphometry is the 
use of spatial normalisation to bring brain images from different individuals and/or 
different modalities into a common anatomical reference space. The simplest methods 
apply rigid body registration (linear registration) of brain images. Linear registrations 
allow extrinsic differences between images to be matched. For example, rotations, 
translations, zooms and shears can be adequately catered for. The original Talairach 
linear registration transforms brain volumes to fit the so-called Talairach box 
(Talairach and Toumoux 1988). The drawback of linear registrations is that they 
cannot accommodate intrinsic shape differences and they are therefore used primarily 
for registering images from the same subject. For example, registration of serial 
images from a single subject can provide information about changes in global cerebral
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volume over time (Freeborough et al 1996). The simple linear transformations have 
generally been superseded by less constrained non-linear transformations that allow 
more accurate matching of brain structure. These non-linear registrations can be used 
within subject over time to provide information about local shape differences with time 
(e.g. Freeborough and Fox, 1998).
To make meaningful regional comparisons between brains from groups of 
subjects, confounding factors such as extrinsic differences (e.g. head position and 
orientation) and intrinsic differences (e.g. brain size and shape) need to be catered for. 
To achieve this, more complex models are required to register multiple images into a 
common anatomical framework enabling region by region comparisons in cross 
sectional or longitudinal studies followed by robust statistical analyses..
A wide variety of warping algorithms have been specifically developed for 
registering multiple volumetric brain MRIs, and there is a rapidly expanding literature 
on various non-linear registration methods. In general, they can be broadly classified 
as intensity-based or label-based. Intensity-based approaches employ mathematical 
and/or statistical criteria to match some voxel-similarity measure in MR images, where 
both are considered as continuous unlabelled processes. Hie matching criterion is 
usually based upon minimising the sum of squared differences or maximising the 
correlation between images. Examples include elastic methods (Shen and Davatzikos 
2003; Davatzikos 1997a), fluid methods (Fox et al. 1996a; Freeborough and Fox 1998) 
spline-based methods (Bookstein 1997; Johnson and Christensen 2002; Lamm et al 
2001) and Bayesian (probabilistic) frameworks, e.g. statistic parametric mapping 
(SPM)(Friston et al 1995). Label-based approaches identify homologous features 
(labels) in the source and reference images and then find the transformations that 
provide a best match. Label-based approaches are classified according to the 
anatomical features that drive them. The homologous features include points 
(Bookstein 1997; Davis et al 1997; Neelin et al 1993) (e.g. anterior and posterior 
commissure), curves (Subsol et al 1997; Ge et al 1994) (e.g. sulci) or surfaces 
(Thompson et al. 1996b; Thonpson et al 1998) (e.g. three dimensional cortical surface 
maps). Point landmarks usually need to be identified manually and there are relatively 
few readily identifiable points within the brain. Curves and surfaces are preferable 
because they are more readily identifiable and in many instances can be extracted 
automatically (or at least semi-automatically). Cortical sulci and grey/white matter 
surfaces can then be accurately matched using elastic or fluid warping algorithms (e.g.
31
Davatzikos and Resnick 1998; Davatzikos et al 2001b; Thompson et al 1996a; 
Thompson et al. 1996c).
In theory, non-linear warps that precisely match the complex gyral patterns of 
one brain to another need to embody a potentially enormous number of parameters, in 
other words, they need to be very high dimensional. In practice, much of the spatial 
variability between individual brains can be captured with just a small number of 
parameters (Ashbumer and Friston 1999). If the aim is to match global brain size and 
shape, whilst preserving regional differences, then warps consisting of a linear 
combination of smooth basis functions are adequate. The rationale for adopting a low­
dimensional approach is that it allows rapid and easy modelling of global brain 
features without matching individual gyri and sulci precisely. If the aim is to 
accurately characterise sulcal and gyral differences then high dimensional approaches 
are more suitable.
Once brains have been mapped into the same anatomical framework, structural 
differences can be characterised. Morphometry methods can be broadly classified into 
region of interest (ROI)-based or whole brain techniques. In simple terms, ROI 
methods require expert anatomists to label homologous structures based upon prior 
hypotheses and inferences are restricted to a particular structure. Whole brain 
approaches interrogate each and every portion of the brain and do not require prior 
hypotheses. To date, a variety of ROI-based volumetric methods have evolved from 
simple two-dimensional (2D) or three-dimensional (3D) measurements of specified 
brain structures on relatively thick slice 2D CT or MRI scans, to more sophisticated 
volumetric measurements of chosen regions on high resolution 3D MRI scans that 
have been co registered and segmented into tissue compartments (Caviness et al 1996; 
Chan et al 2001; Cook 1994; DeLeo et al 1985; Filipek et al 1994; Jack, Jr. et al 
1988; Jack, Jr. et al 1989; Jack, Jr. 1991; Jackson et al 1990; Jemigan et al 1990; Lee 
et al 1998; Murphy et al 1996; Schulz et al 2002; Schwartz et al 1985). 3D-fractal 
analysis of the grey/white interface (Free et al 1996) has offered additional 
information about the surface complexity of the cerebral cortex. These techniques have 
all been interactive and operator dependent to a greater or lesser extent and subject to 
bias. The bias is introduced by the small number of regions and metrics used in 
classical morphometries that are insensitive to changes elsewhere in the brain. In 
addition, ROI measurement errors are likely to be greater for smaller structures with 
complex architectures, particularly if anatomical borders are defined by arbitrary
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criteria, for example the entorhinal cortex. Furthermore, a number of morphometric 
features (e.g. thinning of the cortical ribbon) may be difficult to quantify by inspection 
and thus could be missed by ROI-based techniques. Despite these limitations, ROI- 
based methods have been regarded as the best available “gold standard” and are still 
widely used in research studies and clinical practice. A number of unbiased whole 
brain techniques are emerging due to the development of sophisticated image 
processing tools. These whole brain approaches, of which there are many hybrids offer 
a number of advantages not least because they are semi or fully automated, and thus 
reproducible and applicable to large groups for cross sectional and longitudinal studies.
There is a wide range of whole brain approaches and in simple terms they can 
be generally categorised according to the types of spatial normalisation used. For 
example, information about global brain volume difference can be provided with 
analysis of serial linear registrations (Fox et al., 1996). Information about regional grey 
(or white) matter volume or concentration differences can be provided by voxel-wise 
assessment of spatially normalised (linear and non-linear) segmented images. Low 
dimensional spatial warps that remove global brain confounds whilst allowing regional 
differences to be assessed statistically at a voxel-wise level underpin the philosophy of 
voxel-based morphometiy (VBM)(Ashbumer and Friston 2000). A similar approach 
using higher dimensional warps and interactive sulcal matching is embodied in the 
Regional Analysis of Volumes Examined in Normalized Space (RAVENS) approach 
(Goldszal et al. 1998; Davatzikos et al. 2001a). Information about global brain shape 
differences can be provided by analysis of low-dimensional spatial warps e.g. 
deformation-based morphometry (DBM)(Ashbumer and Friston 2000; Good et al. 
2001a). At the other end of the spectrum, warps that allow precise matching of sulci 
and gyri need to be very unconstrained or high dimensional. This approach is 
necessarily time and computer intensive. The differences between brains will then be 
embodied in the warps themselves, which can be assessed statistically. This 
philosophy underpins methods such as tensor-based morphometry (TBM)(Ashbumer 
and Friston 2000; Ashbumer and Friston 2001; Good et al. 2001a) and precise cortical 
mapping techniques allowing the generation of probabilistic brain cortical atlases 
(Thompson et al. 1996c; Thompson et al. 1998).
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Computational neuroanatomy: VBM, DBM, TBM
Computational neuroanatomy is the application of mathematical and statistical 
techniques to the characterisation of structural information in high-resolution MRI 
scans. It is emerging as an exciting new automated methodology to characterise shape 
and neuroanatomical configuration of structural MRI brain scans on a macroscopic and 
mesoscopic scale. The term was originally coined to describe the application of 
statistic parametric mapping (SPM) to structure rather than function, and for the 
purpose of this thesis I will adopt this definition, acknowlegeing that other analytical 
packages could potentially be used instead of SPM. Voxel-wise analysis of functional 
imaging data with SPM is well established in the neuroimaging community. This 
technique is also ideally suited to the interrogation of structural data: instead of 
determining whether voxels are significantly activated or not, SPM can also determine 
whether voxels of grey matter (or white matter or CSF) are significantly increased or 
decreased. An additional advantage is that the same general analytical framework 
encompasses both structural and functional data, facilitating comparisons between 
them. Computational neuroanatomy comprises a triad of techniques: Voxel-based 
morphometry (VBM) interrogates high-resolution structural MRI brain scans that have 
been warped into a common anatomical framework providing voxel-wise information 
about grey (or white) matter volume and density. Deformation-based morphometry 
(DBM) interrogates the low-dimensional warps created during spatial normalisation to 
inform about global differences in brain shape. Tensor-based morphometry (TBM) 
interrogates high-dimensional warps in order to characterise local shape differences. 
The basic methodologies of these techniques have already been described in some 
detail (Ashbumer et al 1998; Ashbumer and Friston 2000; Ashbumer and Friston 
2001) and VBM and to a lesser extent DBM have been employed in preliminary 
neuroimaging studies (May et al 1999a; Mummery et al 2000; Woermann et al 
1999b; Wright et a l 1995a), however their practical implementation and clinical 
usefulness remain to be established. In this thesis I examine the implementation and 
clinical usefulness of VBM for neurologists and neuroradiologists.
Clinical neuroimaging: current status
The main purposes of imaging in clinical neurology are firstly to identify (or
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exclude) global or regional structural abnormalities in a given subject relative to 
normal subjects. Secondly to monitor an abnormality in a given patient over time to 
assess the evolution of a disease or its response to therapy and thirdly to characterise 
the brain structural phenotypes of various diseases across groups of patients at single 
time points and over time. Neuroradiological appraisal of images should be quick and 
practical and ideally objective. Currently, clinical neuroradiological appraisal is 
subjective and qualitative, relying upon the experience and expertise of an individual 
neuroradiologist. Given that the spectrum of normal anatomy is wide and complex, it 
is not uncommon for subtle pathology to be misdiagnosed as normal, or indeed for 
normal structural variability to be misinterpreted as pathology. Furthermore, inter-rater 
and intra-rater variability needs to be acknowledged. There are different problems 
when a radiologist assesses serial scans in order to determine disease evolution or 
treatment effects. The scans are often technically different, particularly with respect to 
slice position and angulation, contrast and magnification making assessment of subtle 
lesional differences unreliable. Clearly, characterising disease brain structural 
phenotypes across groups of different subjects needs to cater for interindividual 
differences. For these reasons, objective morphometric methods are used increasingly 
in the research domain, and it is surprising that they are not used more as an ancillary 
clinical tool by neuroradiologists. The main reason is probably because many 
morphometric methods are complex (in computational terms), time intensive and 
operator dependent. If a relatively simple and quick automated method could be shown 
to produce clinically plausible, reliable results it might well be adopted by clinicians. 
There are a number of areas where automated registration and voxel-wise assessment 
of images could be clinically useful. For example, diagnosing a specific disease in an 
individual could be aided by supplementing the standard post processing that occurs 
following image acquisition with automated registration to a population and disease 
specific template. Voxel-wise statistical analysis using VBM could then demonstrate 
whether the scan deviated significantly from a normal age and sex matched population.
Assessing structural change over time
Neuroimaging at a single time point provides a static representation of brain 
structure, but this is generally inadequate for assessing dynamic processes such as
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ageing and degenerative disease. There are two main options to model structural 
changes over time. The first option, as in most imaging studies, is a cross sectional 
study design, i.e. studying a group of subjects of different ages at one time point. Cross 
sectional studies are practical to implement and can accommodate wide age spectrums 
and large study groups, but have inherent drawbacks. Firstly, dynamic effects are not 
actually measured, but are inferred from measured differences between age cohorts. 
Secondly, systematic differences between age cohorts such as differences in body size 
(and corresponding brain size) can potentially reflect spuriously as age-related effects, 
unless accounted for. For example, body size has increased over the past century; so 
younger cohorts will have spuriously larger brains for age than elderly cohorts.
Thirdly, subtle changes over time may be masked by the large inter-individual 
variability in normal cortical anatomy. In order to properly model dynamic change, a 
longitudinal study is required where a group of individuals is followed over time. For 
practical reasons such studies are generally limited to very short time windows and 
small study groups. Evaluating serial images of the same patient over time allows the 
detection of subtle pathology and automated registration of serial MRI has already 
proved to be a useful tool in dementia research and clinical practice (Fox et al 1999; 
Fox et al. 2000)
Neuroimaging in disease
In disease, structural imaging can characterise the macroscopic 
neuroanatomical sequelae of underlying pathological processes in some detail. 
Neuroimaging is now a useful tool in the diagnostic work up of neurological disease 
and has an established role as a surrogate marker for disease progression in clinical 
trials for chronic progressive diseases such as multiple sclerosis and Alzheimer’s 
disease. In vivo assessment of microanatomy is not yet possible, but by employing a 
multimodal imaging approach, functional parameters such as regional cerebral 
perfusion and diffusion properties, neurochemical receptor distributions, regional 
glucose metabolism, local tissue biochemistry and the response of brain regions to 
specific tasks can be refined with accurate structural localisation to inform about the 
underlying pathophysiology.
Of particular interest is the extent to which the human brain is plastic and 
whether determinants of plasticity (on a structural or functional level) may provide
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hope for future therapies. For example, it may be possible to better characterise 
structural and functional predictors of recovery in cerebral infarcts to allow early and 
effective therapeutic measures. Even now, early subtle structural perturbations in the 
brains of individuals genetically at risk for dementia can be identified with 
neuroimaging before the onset of symptoms. In theory, with major advancements in 
the human genome project and molecular mapping of diseases coupled with refined 
neuroimaging, at risk populations can be identified and offered new disease modifying 
treatments before substantial pathology occurs.
In this thesis, I have used VBM to characterise the pathological perturbations in 
brain structure in a number of relatively common neurological (and psychiatric) 
diseases. Firstly, I have chosen diseases that have previously been examined with 
neuroimaging and histopathology in order to establish the face and construct validity 
of VBM. Secondly, I have tried to choose diseases that affect the brain in different 
locations, to further test the usefulness of VBM. These include diffuse cortical 
processes (Alzheimer’s disease), regional cortical processes (Frontotemporal lobar 
degeneration of the semantic type), deep grey matter processes (mesial temporal 
sclerosis, Huntington’s disease, Turner syndrome), putative brainstem processes 
(migraine, familial ataxic migraine) and cerebellar processes (familial ataxic migraine). 
I have also included diseases where the literature on structural imaging is highly 
variable and contradictory (schizophrenia) or diseases where structural change has 
hitherto been occult (primary autonomic failure).
A particular new area of interest is the extent to which genetic make up 
(genotype) predicates external manifestations of structure or function (phenotype). 
Many diseases are very heterogeneous by nature (owing to a number of genetic, 
environmental and idiopathic causes). As a result, the clinical and structural brain 
phenotypes are highly variable and unpredictable. If more homogenous groups of 
patients can be selected, the chance of characterising a consistent brain phenotype can 
be improved. With major advances in molecular mapping and genotyping it is now 
possible to select patient groups (pedigrees) with a specific genotype. These groups are 
then ideal candidates for brain phenotype characterisation. By using a sensitive 
unbiased whole brain technique such as VBM with the versatility provided by the 
statistical framework of the general linear model, it is now possible to map structural 
brain phenotypes to their genotypes and to employ a gene deletion mapping strategy to 
identify specific genetic loci that influence the structure of specific brain regions. This
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is particularly important since it provides insight into the normal development and 
pathological alteration of specific brain regions (e.g. the amygdala, see Chapter 10). 
Furthermore, by characterising brain structural phenotypes in genotype positive pre- 
symptomatic patients VBM can be used as a surrogate marker for disease progression 
in clinical trials of disease modifying agents (e.g. dementia, Huntington’s disease)
Summary
The importance of brain structure is indisputable. It forms the basis on which 
functional parameters can be mapped and referenced. What is less sure is the optimal 
method for characterising brain structure in health and disease. Certainly the classical 
region of interest approaches that have hitherto formed the mainstay of neuroimaging 
are flawed and do not inform about brain structure in a holistic, reproducible way. 
Modem whole brain morphometric techniques allow brain structure to be mapped into 
a standardised anatomical framework giving information about entire brain structure 
on a voxel-wise basis. These methods are in a constant process of evolution, and while 
automated methods may never quite match the most expert neuroanatomist for the 
appraisal of a single complex structure, they do offer an unbiased reproducible 
appraisal of brain structure which has distinct advantages over region of interest 
methods performed by a wide spectrum of variously skilled and less skilled operators 
leading to a vast but inconsistent literature. The purpose of this thesis is to evaluate the 
usefulness of voxel-based morphometry in health and disease, and to highlight the 
advantages and potential pitfalls of the methodology in its current state of evolution.
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CHAPTER 2 
METHODS
Introduction
The experiments reported in this thesis are predicated on two main 
methodologies. Firstly, magnetic resonance imaging of the brain and secondly 
computational processing and statistical analysis of high resolution volumetric brain 
magnetic resonance images. This chapter will address each of these methodologies, 
focusing especially on refinements enabling optimised appraisal of human brain 
structure. The concept of computational neuroanatomy will be introduced and the 
methodology of voxel-based morphometry will be detailed.
Structural Magnetic resonance imaging (MRI)
Basic principals o f  M RI
The basic principles of nuclear magnetic resonance were discovered by Bloch 
and Purcell in 1945 (NMR)(Bloch et al. 2003; Purcell et al 1945) earning them the 
Nobel prize in 1952, but it took more than three decades before magnetic resonance 
(MR) images of the of the human brain were possible (Holland et al 1980a; Holland et 
al 1980b). Since that time there have been substantial advances in MR brain imaging, 
particularly in the last decade, not only to characterise brain structure with great 
precision in three dimensions, but also to provide information about an array of brain 
functional parameters such as blood flow (MR angiography (MRA) and venography 
(MRV)), cerebral perfusion (MR perfusion), biochemical properties of brain tissue 
(MR spectroscopy) and brain activation (functional MRI). In parallel with MR 
sequence refinements there have been major advances in computer power and speed 
accompanied by rapid expansion of a large body of skilled manpower. It is this 
combination of MR scientific development coupled with computational expertise that
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has been the driving force behind the recent acceleration of brain imaging 
advancement. Another key factor in brain imaging development has been the 
multidisciplinary approach where ideas from physicists, computer scientists, 
psychologists, psychiatrists, neurologists and neuroradiologists are pooled to allow 
greater insights into the human brain.
Source o f  the MR signal
MRI depends on the gyromagnetic properties of certain nuclei. Nuclei with an 
odd number of protons and/or neutrons possess magnetic moment and behave like 
small magnets inducing local magnetic fields along their spin axis. In living organisms 
the most abundant source of protons is hydrogen within water molecules, and 
structural neuroimaging with MRI is based on the nuclear magnetism of these 
hydrogen protons. Other naturally occurring magnetic nuclei of biological interest 
include3 phosphorus, 23sodium and 13carbon. In the presence of an external magnetic 
field, the processing protons will align themselves to the magnetic field, like a compass 
aligning to the earth’s magnetic field. The MRI scanner used in these experiments 
produces a 2 Tesla magnetic field which is 40 000 times stronger than the earth’s 
magnetic field. Usually the alignment of hydrogen protons is not perfect and the axis 
of alignment will itself spin or process around the direction of the external magnetic 
field, akin to a spinning top processing around the earth’s gravitational field. The 
processional frequency (Larmor frequency), coo, is proportional to the strength of the 
magnetic field, Bo, and a gyromagnetic constant specific to each type of nucleus, y:
©o = yBo
For a 2- Tesla magnetic field strength the Larmor frequency (a>o) of hydrogen protons is 
approximately 85 MHz.
Net magnetisation
The spinning hydrogen protons may exist in two states depending on the 
orientation of magnetic moment with respect to the applied field; a low- (ground) 
energy state (spin axis parallel to the magnetic field) or a high-energy state (spin axis 
anti-parallel). The quantum of energy required for protons to move between these two 
energy states depends on the field strength. For a 2 Tesla field strength, the thermal 
energy at room temperature is enough to flip the spins of hydrogen protons. At
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equilibrium, a greater proportion exist in the lower energy state according to the 
Boltzmann relation:
Parallel/anti-parallel=exp (yhBo/KT)
where h is Planck’s constant, K is Boltzmann’s constant and T the absolute 
temperature. The sum of all spins will give a net magnetisation that comprises a 
component along the applied magnetic field (longitudinal magnetisation) and a 
component transverse to the applied field (transverse magnetisation). By convention, 
the net magnetisation is based on a co-ordinate system with the applied magnetic field 
along the z-axis and the transverse magnetisation along the xy plane. The net 
magnetisation in the resting phase is termed the equilibrium net magnetisation where 
more spins are in the low energy state than the high-energy state. By applying an 
oscillating radio-frequency pulse (Bl) perpendicular to the longitudinal magnetisation, 
spins can be excited from the low to the high-energy state and in doing so alter the net 
magnetisation. The most efficient energy transfer occurs when the applied frequency 
matches the Larmor frequency, ©o. The net magnetisation will precess around Bi with 
a different Larmor frequency, cDi. Varying the strength and duration of the 
radiofrequency pulse that is usually applied in millisecond bursts modulates the 
angular deviation of the net magnetisation in the xy plane. It is this transverse 
component that produces a detectable NMR signal.
77 and T2 relaxation
After excitation, the net magnetisation gradually returns to precess around the 
original magnetic field, Bo. As the protons return to equilibrium, with a greater 
proportion in the lower energy state, energy is released to neighbouring molecules 
(spin-lattice relaxation) or neighbouring spinning nuclei (spin-spin relaxation).
Spin-lattice or T1 relaxation is governed by the ‘T l’ time constant. The 
longitudinal magnetisation, Ml, recovers towards the equilibrium state, Mo, over time 
t, as:
Ml = Mo(l-e
The transfer of energy to surrounding molecules determines the Tl constant and 
depends on the nature of the environment. Small mobile free water molecules resonate 
too rapidly for efficient energy transfer, while large protein molecules resonate too
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slowly. Mid-sized fat molecules however resonate at frequencies close to the Larmor 
frequency and absorb the energy most efficiently. If a series of radiofrequency pulses 
is applied after a short time interval, relaxation will be incomplete for protons in water, 
but nearer completion for protons in fat. The repetition time, TR, can be adjusted to 
highlight differences in Tl-dependent relaxation properties of various tissues. Tl 
differences between tissues can be highlighted with inversion recovery sequences.
Here the net magnetisation is inverted by a 180° radiofrequency pulse followed by a 
second pulse after a short delay (known as inversion time, Tl). The combination of Tl 
and TR can be modulated to maximise the sensitivity of proton Tl relaxation to the 
differential molecular composition of various brain tissues, such as grey and white 
matter and cerebrospinal fluid. Thus Tl-weighted imaging optimises the contrast 
between brain tissues (in particular grey and white matter) allowing the accurate 
appraisal of brain structure. Tissues with a short Tl such as fat and to a lesser extent 
white matter give a high signal and appear bright on MR images whereas tissues with 
a long Tl such as CSF and to a lesser extent grey matter appear dark.
The transfer of energy to neighbouring nuclei (spin-spin relaxation) results in 
an exponential decay of the transverse net magnetisation, Mt, determined by the T2 
time constant, where:
Mt = Mo.e '|tT21
As energy is passed from one spin to another, the phase of precession of neighbouring 
nuclei becomes desynchronised. If the local magnetic field is not homogeneous (given 
the complex nature of human tissue), then the Larmor frequencies of protons in a 
region will vary and they will lose coherence rapidly, which reduces the net transverse 
magnetisation, Mt. The effective T2 tiihe constant, denoted T2*, is shorter than T2 
proper for any given tissue type. Spin-echo (SE) pulse sequences utilise a 90° pulse 
followed after time x by a 180° pulse and a further time x. The echo time (TE) = 2x. 
These sequences produce images with contrast predominantly dependent on 
differences in T2. On T2-weighted SE sequences tissues with long T2 such as water 
appear bright. These sequences are also sensitive to many acute and sub acute 
pathological processes but provide relatively poor contrast between grey and white 
matter.
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Whole brain imaging
For structural brain imaging, it is necessary to measure and localize the MR 
signal from every part of the brain. This is achieved by a combination of three 
processes.
Firstly, slice selection. Regions of the brain are excited slice by slice and the 
position and width of these slices can be modulated. If a gradient is introduced along 
Bo, then each slice of the brain will have a distinct Larmor frequency. If the excitatory 
radiofrequency (RF) pulse has a narrow spectrum of frequencies, only a 
correspondingly narrow slice of brain will be excited. For the structural imaging 
studies here, slices were contiguous and 1mm or 1.5mm in thickness.
Secondly, frequency encoding. A weak magnetic gradient is applied 
transversely across Bo, thus perpendicular to the slice select gradient, so that spins are 
frequency encoded according to their spatial position in the x direction. By sampling 
the magnetic resonance signal at different frequencies, signal from different sides of 
the brain may be distinguished.
Thirdly, phase encoding. The MR signal contains phase information as well as 
frequency information. When the transverse gradient is applied, it may be varied in one 
direction and fixed in the other. A transient change in the transverse gradient along one 
axis will introduce phase differences in the spin along that axis. Individual phase 
encoding steps must be performed for each frequency encoded column
These three processes produce a grid of varying phase and frequency of 
radiofrequency signal following excitation. Fast Fourier Transform of this spectrum is 
used to reconstruct the signal for each part of the grid. A small volume of tissue with 
its unique phase and Larmor frequency after slice-specific excitation is known as a 
voxel. The signal intensity for all voxels is written in a standard radiographic format 
(ANALYZE) for subsequent viewing and analysis.
High resolution imaging
There are three main requirements for good structural brain imaging. First there 
should be high spatial resolution (1mm isotropic voxel size is preferred) to allow 
discrimination of small anatomic structures. Second, there should be high contrast 
between grey and white matter and cerebrospinal fluid to improve conspicuity of small 
structures and to facilitate segmentation of images. Third the scan time should be short 
(10-12 minutes) to facilitate quick and practical imaging in elderly or debilitated
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subjects and allow extra time for further structural or functional sequences.
Since computational neuroanatomy involves a number of fully automated pre­
processing steps to partition the brain into grey and white matter in stereotaxic space, 
the quality of the structural MRI is of major importance. Accordingly, the standard 
volumetric structural sequence (magnetization-prepared rapid gradient-echo imaging 
(MP-RAGE)) for our 2Tesla Siemens system was optimised to provide improved 
spatial resolution and Tl contrast facilitating excellent grey/white matter segmentation. 
The standard MP-RAGE sequence (Mugler, IITand Brookeman 1990) comprises an 
inversion pulse, a delay (Tl), followed by a single segment 3-D gradient echo (GRE), a 
further delay (TD) and a repetition of this process for the next segment. Usually each 
segment includes all partition-encoding gradients so the number of echoes acquired per 
segment equals the number of partitions, while the strength of the 2D-phase encoding 
gradient is different for each segment. The drawback of this sequence is a loss of 
contrast during segment acquisition due to relaxation effects, particularly when many 
partitions are selected. The contrast in GRE images depends on the order of the phase 
encoding (PE) because the image intensity is predominantly determined by the amount 
of longitudinal magnetisation available when the central k-space lines are acquired 
(Holsinger and Riederer 1990). When linear phase encoding is used, half of the 
segment acquisition time has already passed when the k-space lines are acquired, so 
notable relaxation has already occurred. Image contrast tends to be poor, particularly 
for a high number of phase encoding steps (Holsinger and Riederer 1990). It is 
possible to substantially increase contrast by ordering PE differently, such as centric 
PE, where the central k-space lines are acquired first. There is a drawback to this 
strategy; the relaxation during segment acquisition alters the magnetisation causing 
distortion of the point spread function (PSF) and blurring in one direction. A further 
drawback of centric PE is its vulnerability to RF inhomogeneity that occurs 
particularly at the periphery of the RF head coil. The optimised MR sequence for 
structural imaging developed in our laboratory (Deichmann et al 2000a) (Deichmann 
et al. 2002b) uses centric PE to provide high tissue contrast and 100% improvement in 
contrast-to-noise. The deleterious effects on PSF are corrected by means of an 
appropriate k-space filter and RF coil inhomogeneities are corrected by the use of 
shaped excitation pulses. The new sequence provides high contrast-to-noise images of 
the whole brain with 1mm isotropic voxels and an acquisition time of 12 minutes. 
Importantly the new sequence allows markedly improved automatic segmentation of
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images into grey and white matter.
'MR image quality
The MR signal may be affected by many physical and physiological 
parameters. Artefacts arise from two main sources: the MR scanner (hardware and 
software) or the subject being scanned. Strict quality control of the MR scanner and 
local environment is essential to maintain a stable and homogeneous Bo magnetic 
field. Instability and/or inhomogeneity of the Bo magnetic field will result in variations 
in local Larmor frequencies, and misattribution of measured signal for a given 
coordinate. This may produce distortions of the reconstructed brain image. The 
homogeneity of the RF head coil falls off towards the edges. This causes Bi 
inhomogeneities and signal loss in peripheral parts of the image unless specific 
compensation pulses are applied (as in the high resolution sequence used for our 
studies (Deichmann et al 2000a; Deichmann et al 2002b). For all of my experiments 
careful attention was paid to ensure that subjects’ heads were positioned centrally 
within the head coil.
Gross head movement during scanning causes major problems for MRI and 
usually produces a markedly distorted image due to misattribution of signal for a 
coordinate that has moved. Some physiological movements such as blood vessel 
pulsations, or minor head movement during breathing and swallowing cannot be 
prevented, but these do not usually produce notable distortions. Before scanning each 
subject, I explained the importance of avoiding head motion and I made sure that they 
were relaxed and comfortable before starting the sequence. I also used foam pads to fix 
subjects heads centrally within the head coil. Most subjects tolerate a 12 minute 
structural scan well, but ill patients, especially those with dementia or movement 
disorders, and claustrophobic subjects have problems lying still for the duration of a 
scan. Usually after careful explanation and reassurance the scan can be repeated 
successfully.
SPM basic principles:
The statistic parametric mapping (SPM) framework and associated theory was 
originally developed for the routine statistical analysis of functional neuroimaging data 
(Friston et al 1995). This software was made available to the emerging functional
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imaging community in 1991, to promote collaboration and a common analysis scheme 
across brain imaging laboratories. This versatile framework incorporates the general 
linear model and the theory of Gaussian fields to analyse functional neuroimaging 
data. The value of each voxel in a functional statistical parametric map is a statistic 
that expresses evidence against the null hypothesis of no experimentally induced 
change at that voxel. There are 3 main steps in the formation of such maps (Friston 
1997).
Spatial transformations
Images are initially realigned to remove movement-related variance, followed 
by spatial normalisation of images into standard stereotaxic space, using a combination 
of affine and non-linear transformations (Ashbumer et al. 1997; Ashbumer and Friston 
1999; Ashbumer et al 2000). A smoothing step compensates for interindividual gyral 
variations.
Construction o f  an SPM
The experimental design and the model used to test for specific 
neurophysiological effects or neuroanatomical changes are embodied in a 
mathematical structure termed the design matrix. The design matrix partitions the scan 
data into effects of interest, confounds of no interest and an error term. This 
partitioning is based on the general linear model which in essence relates what one 
observes to what one expected to see, by expressing the observations as a linear 
combination of expected components and some residual error. The estimated 
contributions are known as parameter estimates. Regionally specific effects in the 
brain are framed in terms of differences amongst these parameter estimates and are 
specified using linear contrasts. The significance of each contrast is assessed with a 
statistic whose distribution has Student’s t distribution under the null hypothesis. For 
each contrast a t statistic is computed for each voxel to form a SPM{t}.
Statistical inferences
Classical inference about parameters, or contrasts of the model parameters is 
made using conventional parametric statistics to provide P values pertaining to the 
maxima, spatial extent of voxel-clusters or number of clusters. These P values are used 
to reject the null hypothesis. The P values have to be adjusted to protect against
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family-wise false-positives over the search volume (correction for multiple non- 
independent multiple comparisons) using distributional approximations from the 
theory of Gaussian fields (Friston et al 1996; Friston 1997; Worsley et al 1996). This 
is similar to the role of a Bonferroni correction for independent data.
Application o f SPM to structure
With advancements in segmentation techniques from simple binary methods to 
more sophisticated segmentation methods encoding the probability of each voxel 
belonging to a particular tissue group, voxel-wise statistical analyses of brain structure 
are now possible. The SPM framework can be extended to the analysis of brain 
structure by considering local increases or decreases in the amount of grey (or white 
matter or CSF) instead of the presence or absence of functional activations. This 
framework forms the basis of computational neuroanatomy which comprises three 
interrelated techniques introduced in the first chapter, each of which informs about 
different aspects of brain structure: voxel-based morphometry (VBM), deformation- 
based morphometry (DBM) and tensor-based morphometry (TBM).
Voxel-based morphometry (VBM)
VBM was first introduced in 1995 (Wright et al 1995a) as a technique to 
characterise regional cerebral grey and white matter density correlates of syndrome 
scores (distinct psychotic symptoms) in a group of 15 schizophrenic patients. At its 
simplest VBM involves the voxel-wise comparison of regional concentrations of grey 
(or white) matter between groups of subjects. The software is freely available 
(www.fil.ion.ucl.ac.uk/spm) and the procedure is fully automated and relatively 
straightforward. High-resolution 3D structural MR images are spatially normalised 
into the same stereotaxic space, segmented into grey and white matter and CSF 
compartments and smoothed with an isotropic Gaussian kernel. Voxel-wise parametric 
statistical tests are then performed on the smoothed grey matter segments employing 
the framework of the General Linear model.
Evolution in the pre-processing of structural data for VBM
In this section I will describe the evolution of the VBM methodology from its 
inception in 1995 to the current method. There are two major factors: Firstly SPM has
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evolved since SPM94 which was the first major revision of the SPM software and the 
basis of the Wright et al., experiment (Wright et al 1995a). SPM94 was written 
primarily by 1995 and has undergone further revisions: SPM 96, SPM99 and most 
recently SPM2 (2002). Secondly the VBM methodology has been refined and 
augmented (optimised technique). I will describe first the standard method of VBM. I 
then highlight the need for an optimised method and finally detail the various steps of 
the optimised method for grey and white matter.
Before pre-processing, all the structural images are checked for incidental 
pathology (lipoma of the corpus callosum) or anatomical variants (for example mega 
cistema magna), technical quality and artefacts and the centre point is placed on the 
anterior commissure. Originally the technique used SPM95 pre-processing steps that 
involved segmentation, smoothing and spatial normalisation (affine only) to a 
symmetrical template in stereotaxic Talairach space. Following specific refinements to 
the segmentation and spatial normalisation pre-processing steps within SPM 
(Ashbumer and Friston 1997), VBM was released as part of the freely available SPM 
96 package (Wellcome Department of Imaging Neuroscience, ION, UCL, London). 
The sequence of the pre-processing steps was altered so that spatial normalisation 
preceded segmentation, the reason being that the segmentation of spatially normalised 
images is preferable since the procedure partitions the normalised images into grey and 
white matter (and CSF) segments based upon a priori knowledge from prior 
probability images which are themselves in stereotaxic space.
Standard VBM protocol
In simple terms, pre-processing for the sirhple VBM protocol involves:
1. Spatial normalisation of subject whole brain volumetric MR brain images to a 
whole brain template in stereotaxic space (e.g. the SPM Tl template)
2. Segmentation of normalised whole brain images into grey matter, white matter 
and CSF compartments
3. Smoothing with an isotropic Gaussian kernel
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A design matrix is then created within the framework of the general linear model and 
statistical maps of grey matter (or white matter) concentration differences are generated 
(see Fig. 2.1).
Template
The standard SPM whole brain template is the ICBM 152 template (Montreal 
Neurological Institute) that is derived from 152 young normal subjects (mean age 24 
(4.9), 59% male) and approximates the Talairach space.
Spatial normalisation
Structural MRI scans (in native space) are transformed to the same stereotaxic 
space by registering each of the images to the same template image, using the residual 
sum of squared differences as the matching criterion. Spatial normalisation consists of 
a combination of linear and relatively low dimensional non-linear transformations. The 
first step in spatial normalisation involves estimating the optimum twelve-parameter 
affine transformation to match images (Ashbumer and Friston 1997). A Bayesian 
framework is used, whereby the maximum a posteriori (MAP) estimate of the spatial 
transformation is made using prior kiiowledge of the ndrmal variability in brain size.
The second step accounts for global non-linear shape differences, which are 
modelled by a linear combination of smooth spatial basis functions (three dimensional 
discrete cosine transform basis functions) (Ashbumer and Friston 1997; Ashbumer and 
Friston 1999). The matching involves simultaneously minimising the membrane 
energies of the deformation fields and the residual squared differences between the 
image and template. The goal of these non-linear warps is to discount global brain 
shape differences (i.e., displacement of grey matter from its normal location), but not 
to match each gyms and sulcus exactly. VBM thus allows the characterisation of 
regional differences at a local scale having discounted global shape differences. If the 
spatial normalisation were perfect (infinitely high dimensional warps), the normalised 
images would be identical and all the differences would be encoded in the deformation 
fields. TBM could then be used to characterise the deformation field differences with 
high precision. This idea is appealing; particularly for characterising subtle gyral and
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sulcal differences, but at present the high dimensional warps are too computer 
intensive and time consuming, and thus impractical for large study groups.
A masking procedure is used to weight the normalisation to brain rather than 
non-brain tissue. The spatially normalised images are resliced with a final voxel size of 
approximately 1.5 x 1.5 x 1.5mm3 ( l x l x l  mm3 if high-resolution 1mm isotropic 
voxel structural scans are used (Deichmann et al 2000).
Segmentation
Scans are segmented into grey matter, white matter, CSF and other non-brain 
partitions. SPM segmentation employs a mixture model cluster analysis to identify 
voxel intensities matching particular tissue types (grey matter, white matter and CSF) 
combined with an a priori knowledge of the spatial distribution of these tissues in 
normal subjects, derived from prior probability maps.
Smoothing
The normalised, segmented images are smoothed with an isotropic Gaussian 
kernel. After smoothing, the intensity in each voxel is a locally weighted average from 
a region of surrounding voxels, the size of the region being defined by the size of the 
smoothing kernel (Ashbumer and Friston 2000). Smoothing helps to compensate for 
the inexact nature of the relatively low dimensional non-linear spatial normalisation. 
Smoothing also conditions the data to conform more closely to the Gaussian field 
model underlying the statistical procedures used for making inferences about 
regionally specific effects. Prior to smoothing, the segmented images tend to have a 
highly non-normal density function with voxels having values close to the extremes of 
0 and 1. This is because the voxel values correspond to a probability of a voxel being 
grey or white matter. The distribution of errors about any group mean also tends 
towards a similar non normal distribution. However it is generally assumed that errors 
are rendered normally distributed by spatial smoothing (according to the Central Limit 
Theorem). The size of the smoothing kernel should be a function of registration 
accuracy balanced with localisation accuracy and normality of the data. In practice 
smoothing kernels of 10- 12mm are the best balance between compensating for 
registration inaccuracies, rendering the data more normally distributed and optimising 
the spatial resolution of the inferences. For most study designs, and in particular group 
comparisons, inferences are quite robust to violations of normality and remain valid
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even with no smoothing (Salmond et al. 2002). I would however caution against the 
exclusion of smoothing, because the low dimensional non-linear warps do not provide 
precise gyral mapping. High-resolution differences in anatomy would generally be 
finessed with high dimensional warps and tensor based morphometry. Unbalanced 
designs, for example comparing a single subject to a normative group, are susceptible 
to violations of normality, and smoothing kernels in the order of 12mm are essential to 
avoid false positive results. (See Fig. 2.1).
Statistical analysis
The smoothed data are analysed using MATLAB 5 (MathWorks, Natick, 
Mass., USA) and SPM99 (Wellcome Dept, of Cognitive Neurology, ION, London) 
employing the framework of the General Linear Model. Global and regionally specific 
differences in grey (or white) matter or CSF between groups can be assessed 
statistically using 2 contrasts, namely testing for increases or decreases in grey (or 
white) matter or CSF (two tailed test). Normalisation for global differences in voxel 
intensity across scans is made by inclusion of the global mean grey matter (or white 
matter or CSF) voxel value as a confounding covariate in an analysis of covariance 
(ANCOVA) whilst preserving regional differences in grey (or white or CSF) matter. 
This provides information about regionally specific changes in a tissue over and above 
global tissue changes. Corrections for the size of the search volume (multiple 
comparison correction) are made using techniques based on Gaussian field theory to 
permit valid inference (Friston et al 1996; Worsley et al. 1996)
Figure 2.1: Schem a o f the standard VBM  protocol
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Motivation for Optimisation
Inspection of segmented images from the simple pre-processing procedure 
described above often shows several small areas of mis-segmented non-grey matter 
voxels. For example, on segmented grey matter images, voxels from the dural venous 
sinuses, scalp fat, petrous apices and diploic space are often mis-classified as grey 
matter (Fig. 2. 2). This has implications if there are systematic differences in skull size 
and shape or scalp thickness among study groups, especially if the groups are large, as 
in this study. For example, in a standard VBM analysis of sex effects on grey matter 
(see chapter 4), large clusters of significant voxels that are not ascribable to grey 
matter change can be seen along the course of the venous sinuses and outside the brain 
margins. This error is removed by the introduction of additional pre-processing steps 
to exclude non-brain voxels prior to normalisation and subsequent segmentation. New 
features of the optimised method include (1) a fully automatic brain extraction 
technique, (2) study-specific grey/white matter templates and (3) a modulation step to 
incorporate volume changes induced during normalisation into the analysis. This 
modulation procedure allows me to assess both regionally specific changes in 
grey/white matter volume and concentration (i.e. density).
Optimised structural volumetric image with high spatial and contrast resolution:
The structural MRI sequence has been optimised to produce volumetric scans 
with a high spatial resolution providing 1mm isotropic voxels and enhanced grey/white 
matter contrast to allow optimal segmentation (Deichmann et al 2000; Deichmann et 
al 2002).
Creation of a separate grey and white matter and CSF customised templates
An ideal brain template should consist of the average of a large number of MRI 
scans that have been registered to within the accuracy of the spatial normalisation 
technique. The best-matched templates are created from the study group itself so that 
the template is customised to the local scanner and subject population. This is relevant 
when studying disease groups, since diseased brains may differ substantially from a 
template based upon young normal subjects (e.g. the default SPM template). 
Customised population specific templates allow the spatial normalisation for diseased 
brains to be balanced to control brains, thus avoiding a systematic group difference in
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spatial normalisation. Separate grey and white matter templates are created from the 
study group thereby providing templates that are customised to the MR scanner and to 
the demographics of the study population. Practically, I spatially normalise (affine 
registration and non-linear warps) all the study MRI scans to the SPM whole brain 
template, segment into grey and white matter and CSF compartments and smooth with 
an 8mm isotropic Gaussian kernel. Averaging the smoothed segments produces the 
grey and white matter and CSF templates.
Segmentation and extraction of a brain image
This is a fully automated procedure to remove scalp tissue, skull and dural 
venous sinus voxels. This procedure initially involves segmentation of the original 
structural MR images (in native space) into grey and white matter images, followed by 
a series of fully automated morphological operations for removing unconnected non­
brain voxels from the segmented images (erosion followed by conditional dilation). 
The resulting images are extracted grey and white matter partitions in native space.
Normalisation of grey and white matter images
The extracted grey and white matter segments are pre-processed separately. 
The grey matter images are spatially normalised (affine and non-linear) to the 
customised grey matter template and the extracted white matter segments are spatially 
normalised to the customised white matter template. This method prevents any 
contribution of non-brain voxels and affords optimal spatial normalisation of 
grey/white matter. The 12 parameter affine registration has been made more robust by 
the inclusion of regularisation (a mathematical procedure for increasing stability by 
preventing overfitting of the data). The penalty for unlikely warps is now based on the 
matrix log of the affine transformation matrix (after removing rotation and translation 
components) being multivariate and normal. The non-linear warps have also been 
further refined with improved computation of derivatives of objective functions and 
the inclusion of regularisation. The bending energy of the warps is used to regularise 
the procedure, rather than the membrane energy, resulting in more realistic looking 
distortions (Ashbumer and Friston 1999). There is however a caveat: the initial 
segmentation (implicit in the brain extraction step) is performed on affine-normalised 
images (in native space), but the probability maps which are used as Bayesian priors 
for segmentation, are in stereotaxic space. Segmentation of fully-normalised images is
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therefore preferable. In order to facilitate an optimal segmentation, the optimised 
normalisation parameters (this is performed separately for grey and white matter) are 
re-applied to the original, whole brain structural images (in native space). Effectively 
this protocol employs a recursive version of segmentation, extraction and 
normalisation operators (see Fig. 2.7).
Figure 2.2: Error in the standard VBM protocol
Glass brain images of a grey matter VBM comparison of healthy males and females 
using the simple VBM method. The black arrows point to clusters of significant 
differences along the course of the dural venous sinuses. These erroneous differences 
are removed by the optimised VBM method.
SPM{T }
SPM results: t'4?2 jdCulysvzfl ji io r jp i
Height threshold T = 4.54 
Extent thresholdk = 0 voxels
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Optimised VBM protocol
Segmentation and extraction of normalised whole brain images
The optimally normalised whole brain structural images, which are now in 
stereotaxic space, are then segmented into grey and white matter, CSF and non-CSF 
partitions and subject to a second extraction of normalised segmented grey/white 
matter images. The segmentation step now includes an image intensity non-uniformity 
correction step which models intensity non-uniformity caused by different positions of 
cranial structures within the MRI head coil by a linear combination of smooth basis 
functions (Ashbumer and Friston 2000). Figure 2.3 shows the improvements in 
segmentation from SPM 96 to SPM 99. The customised grey and white matter and 
CSF templates used for spatial normalisation can also be used as the prior probability 
maps for segmentation. Theoretically, prior probability maps from young normal 
subjects (the default SPM priors) are not optimal for diseased brains. In practice, visual 
inspection of segmented images shows little difference using customised disease 
specific priors and the default SPM priors in groups of patients with Alzheimer’s 
disease and semantic dementia (see Chapter 5) (Good et al 2002), however statistical 
parametric maps show a significant main effect of the choice of priors with improved 
registration of brainstem and cingulate voxels and higher T statistics using customised 
priors (see Chapter 5).
The brain extraction step is repeated at this stage because some non-brain 
voxels from scalp, skull or venous sinuses in the optimally normalised whole brain 
images could still remain outside the brain margins on segmented grey/white matter 
images (Fig. 2.4).
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Figure 2.3: Evolution of the spatial normalisation and segmentation within SPM
The top row depicts the native structural image and normalised (ns) images using SPM 
96, SPM 99 and SPM2 respectively. The bottom three rows depict differences in the 
normalised grey matter segments. Note particularly the improvement in the temporal 
lobe of normalised grey matter segments between SPM 96 and SPM 99 (red arrows)
Original ns SPM96 ns SPM99 ns SPM2
SPM96 ns segl SPM99ns segl SPM2ns segl
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Figure 2.4: The effect of brain extraction
Grey matter segment before 
brain extraction. The arrows 
show typical regions of 
misclassified non-brain voxels.
Grey matter segment after 
brain extraction with removal 
of non brain voxels.
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Modulation
As a result of non-linear spatial normalisation the volumes of certain brain 
regions may grow, whereas others may shrink. In order to preserve the absolute 
amount of a particular tissue (grey or white matter) within a voxel, a further processing 
step is incorporated. This involves modulating voxel values by the Jacobian 
determinants derived from the spatial normalisation step (see Fig. 2.5) (Ashbumer and 
Friston 2000; Ashbumer and Friston 2001).
Figure 2.5: Modulation step
Cartoon to illustrate the effect of modulation, (v) represents the absolute amount of grey 
matter in a voxel before normalisation. During spatial normalisation the voxel may 
grow or shrink (volume change denoted by x) to match the corresponding voxel in the 
template while the concentration of grey matter is preserved. The modulation step 
corrects for this so that absolute volume of grey matter is preserved within the 
normalised voxel (the concentration will correspondingly be altered as demonstrated by 
the preserved size but altered colour of the voxel cartoon). A reslicing step follows to 
preserve isotropic voxels in the matrix.
m odulation
v ► V* X ► v* x/x
normalisation
UNMODULATED MODULATED
Voxel volume 
change
Voxel
concentration
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This augmented VBM can thus be considered a combination of VBM and 
TBM, where TBM employs testing of the Jacobian determinants themselves. In order 
to simplify this concept, it is helpful to compare VBM with an analysis using regions 
of interest. Each voxel in a smoothed grey matter image is the count of the grey matter 
voxels within the limits of a region defined by the smoothing kernel. After spatial 
normalisation, the voxels within the region defined by the smoothing kernel can be 
thought of as being projected onto the original anatomy, but in doing so their shapes 
and sizes will be distorted. Without modulation, the proportion of grey matter within 
each region of interest would be measured. Modulation effectively converts values of 
grey and white matter concentration into grey matter mass (i.e. rendering the 
inferences about the absolute amounts (volume) of grey matter in a voxel as opposed 
to the relative amounts (concentration)) (Ashbumer and Friston 2000; Ashbumer and 
Friston 2001; Davatzikos et al., 2001). Analyses of modulated and unmodulated data 
are complementary and not exclusive. A practical illustration of the differences 
between the two can be seen in male: female comparisons (see Fig. 2.6). It is well 
known that males have larger brains than females, but more interesting is the detection 
of regionally specific differences (over and above global differences). VBM detects 
regions of increased grey matter volume in the anteromesial temporal lobes, but no 
regions of significantly increased concentration in males. In females, VBM detects 
diffusely increased grey matter concentration throughout the cortical mantle as well as 
regions of increased grey matter volume in the posterolateral temporal lobes (Good et 
al. 2001c). Another example where the two techniques show different and 
complementary results is gross cerebral atrophy such as in Alzheimers disease or 
semantic dementia. For studies of normal subjects of similar age groups (where the 
deformation maps from spatial normalisation are very similar) the modulated and 
unmodulated data show similar effects.
Smoothing
The normalised, modulated/unmodulated grey and white matter segments are 
smoothed using a 12mm FWHM isotropic Gaussian kernel (as in the standard 
method). The various steps of the optimised method are summarised in Fig. 2.7.
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Figure 2.6: Practical effect of the modulation step
Sex differences in grey matter volume (modulated data) and concentration 
(unmodulated data), p<0.05 corrected.
(a) Grey matter volume (modulated) 
males -  females females - males
(b) Grey matter concentration (unmodulated) 
males -  females females - males
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Statistical analysis
The unmodulated and modulated smoothed data are analysed separately using 
MATLAB 5 (MathWorks, Natick, Mass., USA) and SPM99 (Wellcome Dept, of 
Cognitive neurology, ION, London) employing the framework of the General Linear 
Model as in the standard method. Grey and white matter and CSF analyses are 
performed separately in order to provide a more complete characterisation of brain 
structure than grey matter analyses in isolation. This has relevance when making 
inferences about brainstem and deep grey matter structure since voxel classification 
into grey and white matter in these regions is less reliable because of intrinsic contrast 
properties. Global modelling proceeds according to the method described for the 
standard VBM protocol: the global mean grey voxel value is included as a 
confounding covariate for grey matter analyses and the global white voxel value is 
included as a confounding covariate for white matter analyses. This provides 
information about regionally specific changes within a tissue compartment, over and 
above global changes within that compartment. This is important if, for example, the 
detection of regionally specific differences between males and females is sought, given 
that there are marked global differences in brain volumes. In certain instances, such as 
in analyses of patients with dementia, it may be more appropriate to model total 
intracranial volume (TIV) as a confounding covariate, so that differences in head size 
are separately accounted for and the influence of this variable on the result is removed, 
while global grey matter changes are preserved (which is generally what ROI 
approaches measure). This only applies for modulated analyses that have incorporated 
a correction for volume changes during spatial normalisation. For unmodulated 
analyses, TIV would not need to be included, since the global differences have already 
been removed. In most cases, global and regional inferences are complementary. 
Corrections for the size of search volume (multiple comparison correction) are made to 
the p values using techniques based on Gaussian field theory (Friston et al 1996; 
Worsley et al. 1996). In general a whole brain correction is applied, however this is 
stringent when one considers classical region of interest (ROI) based morphometric 
methods, which are limited to only a few metrics. Where prior hypotheses about 
putative regional structural change exist, sensitivity can be increased by using small 
volume corrections (SVC).
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Validation of the optimised technique
Details on the evaluation of the VBM segmentation technique, including 
evaluation of the non-uniformity correction and stability with respect to mis­
registration with a priori images can be obtained in Ashbumer and Friston (2000). 
Evaluation of the assumptions about normal distribution of the data is also detailed in 
this reference. In order to determine scan-rescan differences in tissue classification, I 
scanned 10 healthy subjects twice on the same day. Each subject left the scanner room 
between scans, and the time interval between scans was approximately 15 minutes. For 
the standard VBM method, the coefficient of variation (100 x standard deviation of the 
differences/overall mean) for grey and white matter volumes, CSF volume and TIV 
were 0.45, 0.75,1.07 and 0.16 respectively. For the optimised VBM method, the 
coefficients of variation for grey matter volume, white matter volumes, CSF volume 
and TIV were 0.41, 0.59,1.07 and 0.17 respectively. These values show that tissue 
classification is highly reproducible using both standard and optimised VBM methods. 
Furthermore, a VBM statistical analysis using a paired t-test design matrix yielded no 
significant regional differences between first and second scans, even with reduced 
corrected thresholds of 0.5. The standard VBM technique has been validated with 
independent region of interest measurements (Maguire et al 2000; Vargha-Khadem et 
al 1998) and as detailed in Chapter 5 ,1 validate the optimised VBM technique with an 
independent automated segmentation technique and region of interest measurements in 
groups of elderly healthy subjects and patients with Alzheimer’s disease and semantic 
dementia (Good et al 2002).
Since no gold standard exists against which in vivo measurements can be 
compared, and furthermore since variations in MRI protocols, normalisation and 
segmentation techniques can be expected to produce inconsistent data, reproducibility 
of a given technique is more important. In this regard the tissue classification 
technique used in VBM yields highly reproducible results.
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Figure 2.7: Schema showing the steps implicit in the optimised protocol
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Deformation based morphometry (DBM)
Whereas VBM analyses the spatially normalised brain segments on a voxel- 
wise basis, DBM analyses differences in the deformation fields used to normalise 
brains into standard space. The deformation fields are defined by the affine and non­
linear components of the spatial normalisation. The affine components relate to head 
position and size, which are not themselves interesting and can be modelled as 
confounds, whereas the non-linear components relate to head shape. Inferences about 
these global shape differences can be made using multivariate statistics.
Tensor Based Morphometry (TBM)
TBM characterises regional shape differences by interrogating the Jacobian 
matrices of the deformation fields. The Jacobian matrices encode information about 
local shearing, stretching and rotation of voxels when an image is spatially normalised 
to a template. Inferences about local shape differences can be made using multivariate 
statistics. A simpler form of TBM involves analysis of the Jacobian determinants with 
univariate statistics to provide information about local volume changes. As previously 
mentioned, the more accurate the spatial normalisation is, the more information is 
encoded in the deformation fields and the more appropriate TBM is for testing the 
differences. One can imagine a continuum with simple VBM being performed on 
images with relatively low-resolution spatial normalisation at one end of the spectrum 
and TBM being performed on the Jacobian determinants of high-resolution 
deformation fields at the other end of the spectrum. The augmented VBM (i.e. 
incorporating the modulation step) could be regarded as a combination of VBM and 
TBM, becoming more important with faster and more precise spatial normalisation 
techniques.
Summary
This chapter has firstly detailed the basic principles of MR imaging whilst 
expanding upon techniques to optimise structural brain images. Secondly, this chapter 
describes the application of SPM to structural analysis, introducing the concept of 
computational neuroanatomy. Special emphasis has been placed on the methodology 
implicit in voxel-based morphometry and in particular on optimisations I have 
introduced to the technique.
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CHAPTER 3 
NORMATIVE DATA 
AGEING
Guide to Reader
An understanding of normal brain structure, and in particular, normal 
variability, is fundamental to the appreciation of patterns of pathologically induced 
structural change. The acquisition and characterisation of a large bank of normative 
data also provides a canonical framework against which future studies of disease can 
be compared. Chapter 3 addresses the physiological effects of ageing on brain structure 
and Chapter 4 characterises normal human brain asymmetries and the effects of gender 
and handedness on brain morphology
Summary
In this experiment VBM is used to characterise the global and regional effects 
of physiological ageing on brain structure in a large cross-sectional study of healthy 
subjects. Global grey matter declines linearly with age, with a significantly steeper 
decline in males compared to females. Local areas of accelerated grey matter loss are 
observed in the insula, superior parietal gyri, central sulci and cingulate sulci 
bilaterally. Areas exhibiting relatively little age effect (relative preservation) include 
the amygdala, hippocampi and entorhinal cortex bilaterally. Global white matter does 
not decline with age, but local areas of accelerated loss and relative preservation are 
seen. There is no evidence of an interaction of age with sex for regionally specific 
effects. The global results confirm previous autopsy and imaging data, while VBM 
introduces new data on the regional effects of ageing.
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Introduction
There is compelling evidence from post mortem and in vivo studies that the 
brain shrinks with age, but accurate quantification of the specific patterns of age- 
related atrophy has proved elusive. It remains unclear whether there are predictable 
common patterns of ageing or whether individual human brains respond to the ageing 
process idiosyncratically. Post mortem analysis of mammalian brains suggest that 
there may be a gradient of ageing from the association areas to the primary sensory 
regions, with the former showing the most prominent correlations between age and 
atrophy (Flood and Coleman 1988). In ageing humans, autopsy studies consistently 
reveal age-related decreases in brain weight and brain volume (e.g. Dekaban 1978; 
Hubbard and Anderson 1981) with evidence of neuronal loss within the cerebral 
cortex, brainstem and basal ganglia (Brody 1992; Vijayashankar and Brody 1979; 
Bugiani et al 1978). Despite the large autopsy literature, detailed characterisation of 
regionally specific age related changes is relatively scanty. This is predominantly due 
to the practical constraints of analysing vast numbers of pathological specimens. 
Furthermore, if brain weight is related to body height, the progressive increase in 
height over the past century may limit the applicability of conclusions from the 
significant fraction of post-mortem studies that were conducted in the last century 
(Miller and Corsellis 1977).
A number of in vivo imaging studies have attempted to quantify age-related 
change in Whole brain volume, grey rtiatter, white matter and CSF compartments using 
CT, 2D MRI and more recently high resolution MRI morphometry. Apart from the 
more obvious limitations of small cohort studies and earlier imaging techniques (e.g. 
Schwartz et al 1985), as well as variability in reporting absolute or fractional volumes, 
the majority of these studies have been based on manual or semi-automated region of 
interest guided measurements (Filipek et al 1994; Luft et al 1999; Pfefferbaum et al 
1990; Pfefferbaum et al 1994; Raz et al 1992; Raz et al 1997; Raz et al 1998; Xu et 
al 2000a) which may be inherently biased. This bias is introduced by the small 
number of regions and metrics used in classical morphometries that are insensitive to 
changes elsewhere in the brain. Despite such constraints, CT and MRI consistently 
confirm global increases in CSF and global grey matter loss without significant global 
loss of white matter (e.g. Jemigan et al 1991c).
With the improved resolution of structural MRI scans and emergence of a
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number of unbiased whole brain morphometric techniques more accurate 
characterisation of the structural correlates of ageing is now possible. Relatively 
simple rigid body registration within subjects, shows minor global brain volume loss 
in aged normal subjects and accelerated loss in a small group of patients with 
Alzheimer’s disease over a one year interval (e.g. Fox et al 1996a). More 
sophisticated and less constrained non linear within subject registration confirms little 
change in a small group of elderly controls over a year using a fluid model 
(Freeborough and Fox 1998). Automated segmentation techniques have allowed the 
quantification of global effects of age on tissue compartments, but provide no 
information with regional specificity within these compartments (Guttmann et al 
1998a). More recently, researchers have used a combination of semi automated 
registration and segmentation techniques followed by region of interest measurements 
to characterise ageing changes in a few predefined brain regions. One group document 
disproportionate volume loss in the frontal lobes and hippocampus with white matter 
loss occurring later and ultimately more marked than grey matter loss (e.g. Jemigan et 
al 1991a). Another group (Resnick et al 2000) show disproportionately large age 
effects in the parietal lobes and sex differences most marked in the frontal and 
temporal lobes. They also reveal increases in ventricular volume over a one-year 
period but no detectable change in global or regional brain volumes.
The great variety of morphometry methodologies combined with the 
heterogeneity of study groups are probably the most relevant factors accounting for the 
conflicting literature on linear and non-linear patterns of tissue change, the effect of 
sex and the heterogeneic response of various compartments of the brain to ageing.
Despite the rapidly developing literature on various forms of unbiased whole 
brain methods allowing reproducible voxel-wise characterisation of brain structure 
(e.g. Ashbumer et al 1998; Ashbumer and Friston 2000; Christensen et al 1997; 
Davatzikos 1996; Davatzikos 1997b; Davatzikos et al. 2001b; Guimond et al 2000; 
Thompson et al 1996a; Thompson et al 1996b; Thompson and Toga 1997), at the 
time of this research such methods had not yet been applied to large subject groups to 
characterise ageing effects. For this reason the following study applies VBM to a large 
group of normal adults (n= 465) in order to characterise and quantify age-related 
change in the human brain on a voxel-by-voxel basis. This facilitates not only the 
global assessment of separate brain compartments, namely grey and white matter and 
CSF, but more importantly regionally specific changes within these compartments.
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Methods
Subjects
Approval for the study was obtained from the Local Research Ethics 
Committee of The National Hospital for Neurology and Neurosurgery (UCLH, NHS 
Trust) and the Institute of Neurology (UCL). The study group was selected from a 
population of 1761 normal volunteers who responded to advertisements and were 
scanned at the Wellcome Department of Cognitive Neurology between February 1998 
and December 1999. All subjects with any neurological, medical, psychiatric 
condition or migraine were excluded. Inclusion criteria included: 1) Normal MRI brain 
as determined by an experienced neuroradiologist (myself). Any MRI scans with 
structural abnormalities, prominent normal variants (e.g. mega cistema magna, cavum 
septum pellucidum) or technical artefacts were excluded. 2) No history of alcohol 
intake of more than 30 units/week or intake of more than 10 units within 48 hours prior 
to scanning (A unit of alcohol is equal to 10ml of pure alcohol and is roughly 
equivalent to a glass of wine (125ml) or a single measure of spirits (25ml). 3) No 
history of severe head trauma requiring medical attention. 4) No history of cognitive 
difficulties, 5) No history of treated hypertension. 465 subjects met all the inclusion 
criteria. They comprised 29 left- handed females (aged 18-75, median 31), 171 right- 
handed females (aged 18-79, median 28), 38 left- handed males (aged 20-59, median 
33) and 227 right- handed males (aged 17-67, median 26).
Structural MRI scanning protocol
Magnetic resonance imaging was performed on a 2 Tesla Siemens 
MAGNETOM Vision scanner. A 3D structural MRI was acquired on each subject 
using a T-l weighted MPRAGE sequence (TR/TE/TI/NEX: 9.7/4/ 600/1, flip angle 
12°, matrix size 256 x 192, FOV 256 x 192, yielding 120 sagittal slices and a slice 
thickness of 1.5mm with in plane resolution of 1mm x 1mm).
Data analysis
Voxel based morphometry was performed using the optimised method, which 
is fully detailed in Chapter 2. Details pertinent to this study will be emphasised here.
Global effects of age were examined by multiple regression of summed voxel 
values of grey matter, white matter, CSF and total intracranial volume (TIV) in a
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model including linear and quadratic expansions of age for both males and females. 
Significance levels for F statistics were set at p<0.05.
Regionally specific differences in grey (and white) matter and CSF between 
groups were assessed statistically using a two-tailed contrast, namely testing for an 
increased or decreased probability of a voxel being grey (or white) matter. I tested for 
volumetric changes in grey or white matter by incorporating the modulation of 
segmented data. Concentration changes were assessed using the segmented images 
directly (unmodulated data). Normalisation for global differences in voxel intensity 
across scans was effected by inclusion of the global mean voxel value (grey matter 
globals for the grey matter analysis and white matter globals for the white matter 
analysis) as a confounding covariate in an analysis of covariance (ANCOVA) whilst 
preserving regional differences in grey (and white) matter. Orthogonalised first, second 
and third order polynomial expansions of age were entered into the design matrix to 
determine the linear and non-linear effects of age. I assessed the goodness of fit of 
first, second and third order polynomial expansions using F maps or SPM{F} (Buchel 
et al. 1996; Friston 1997). Significance levels for the F statistics were set at p<0.05, 
corrected for multiple comparisons. Significance levels for one-sided T statistics were 
set at p<0.025, corrected.
Results
Grey matter
Global effects of age
There was a decline of global grey matter volume with age (Figure. 3.1a), 
overall R squared = 0.489. This involved cortical and deep grey matter structures and 
cerebellum diffusely, and a similar pattern was observed when TIV was included as a 
confounding covariate. The linear coefficient (bl) was significant for both males, bl = 
-0.0039, F (1,458) = 58.7, p<0.0001, and females, bl = -0.0026, F (1,458) = 31.7, 
p<0.0001. Both quadratic coefficients failed to reach significance (F<1.06, p>0.30). 
The rate of decline was greater in males than females, a trend that approached 
significance, F (1,458) = 3.54, p<0.06. The mean grey matter volume was 
significantly greater in males (0.829 litres) than females (0.747 litres), F 
(1,458)=239.85, p<0.0001. There was no effect of handedness on global grey matter
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volume, F (1,458) <1. When absolute volumes were expressed as a fraction of TIV, a 
similar significant pattern of linear decline was noted for males (p<0.001) and females 
(p<0.001), although the increased decline in males was less marked, F (1,457) = 0.8, p 
= 0.17) The mean fractional volume of grey matter was significantly greater for males 
than females (p<0.001), although this was less pronounced than the absolute volume 
difference (Fig. 3.1b). The grey-white absolute volume ratio was 1.89 for females and 
1.89 for males. The grey-white fractional volume ratio was 1.82 for females and 1.82 
for males.
Regional effects of age
Local areas of relative accelerated loss of grey matter volume (modulated data) 
(i.e. regional loss more than the global loss) were observed bilaterally in the superior 
parietal gyri, pre- and post- central gyri, insula/frontal operculum, right cerebellum 
(posterior lobe) and anterior cingulate (Fig. 3.2). Areas of relative accelerated loss of 
grey matter concentration (unmodulated data) were observed in the left middle frontal 
gyrus (F2), transverse temporal (Heschl’s) gyri bilaterally and left planum temporale 
(Fig. 3.3). Areas of relative preservation (i.e. less than the global loss) of grey matter 
volume were noted symmetrically in the lateral thalami, amygdala, hippocampi and 
entorhinal cortex (Fig. 3.4). Areas of relative preservation of grey matter concentration 
were seen more diffusely in the thalami (Fig. 3.5). Table 3.1 demonstrates the 
stereotaxic co-ordinates corrected p and Z scores for grey matter analyses. These local 
effects tended to be linear, with no improved fit to the data with inclusion of a second 
and/or third order polynomial term. There were no significant two or three way 
interactions with age, sex or handedness.
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Figure 3.1: Global grey matter changes with age
465 normal subjects: males are depicted in blue and females in red. Absolute grey 
matter volume (a) and grey matter volume normalised to TIV (b). Note the linear 
pattern of grey matter loss with age with a significantly steeper decline in males.
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Figure 3.2: Grey matter volume (modulated): negative correlation with age
Regions of accelerated loss of grey matter volume from 465 healthy subjects 
superimposed on the normalised structural image. The colour bar represents the T score. 
Significant voxels (p>0.025, corrected) are shown in the anterior cingulate, bilateral 
pre- and post- central gyri and bilateral angular gyri (anterior insular and cerebellar 
voxels not shown).
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Figure 3.3: Grey matter concentration (unmodulated): negative correlation with
age.
Regions of accelerated loss of grey matter concentration from 465 healthy subjects 
superimposed on the whole brain template derived from all subjects. The colour bar 
represents the T score. Significant voxels (p<0.025, corrected) are shown bilaterally in 
Heschl’s gyri and the left planum temporale
Figure 3.4: Grey matter volume (modulated): positive correlation with age.
Regions of relative preservation of grey matter volume in the mesial temporal lobes and 
lateral thalami (p<0.025, corrected) projected on the group template)
8 r —
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Figure 3.5: Grey matter concentration (unmodulated): positive correlation with
age
Regions of relative preservation of grey matter concentration in the thalami bilaterally 
(p<0.025, corrected) projected on the group template
White matter
Global effects of age
There was no significant decline in white matter volume with age (Fig. 3.6a), 
overall R squared = 0.326. The linear coefficients were not significant (F<1.05, 
p>0.30), though the quadratic coefficient approached significance for females, b2 = 
0.0004, F (1,468) = 3.65, p<0.06 (but not males, F<1). The mean white matter volume 
was significantly greater in males (0.454 litres) than females (0.395 litres), F (1,458) = 
218, p<0.0001, but no other sex differences approached significance (F<1.27). There 
was no effect of handedness on global white matter volume F (1,458) <1. When white 
matter volume was expressed as a fraction of TIV, the quadratic coefficient was 
significant for females (p<0.01), but not for males (Fig. 3.6b)
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Regional effects of age
There were local areas of relatively accelerated loss of white matter volume 
bilaterally in frontal white matter, optic radiations (Fig.3.7) and posterior limbs of 
internal capsule, bordering on the ventrolateral thalamus. Local areas of accelerated 
decline of white matter concentration were seen bilaterally in posterior limbs of 
internal capsule, bordering on the lateral thalamus (Fig. 3.8). Inspection of white 
matter segmented images (from the optimised pre-processing method) shows some 
lateral thalamus voxels classified as white matter (see discussion). There were local 
areas of relative preservation of white matter volume bilaterally in the posterior frontal 
lobes (Fig.3.9), cerebellum and right temporal lobe. Relative preservation of white 
matter concentration was noted bilaterally in the internal capsules, frontal and posterior 
temporal/occipital white matter (Fig. 3.10). Table 3.2 demonstrates the stereotaxic co­
ordinates of local maxima, corrected p and Z scores for the white matter analyses.
These local effects of age also tended to be linear, with no improved fit to the 
data with inclusion of second and/or third order terms, apart from two small foci of 
accelerated non-linear decline in white matter concentration at the anterior aspect of 
both internal capsules. There were no significant two or three way interactions with 
age and sex and handedness.
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Figure 3.7: White m atter volume (modulated): negative correlation with age
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Figure 3.8: White matter concentration (unmodulated): negative correlation with
age
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Figure 3.9: White matter volume (modulated): positive correlation with age
Figure 3.10:White matter concentration (unmodulated): positive correlation with
age
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CSF
Global effects of age
There was a global increase in CSF volume with age (Fig. 3.11a), overall R 
squared = 0.377. This involved the entire CSF compartment including the ventricles 
and surface sulci. A similar pattern was observed when TIV was included as a 
confounding covariate. The linear coefficient was significant for both males, 
bl=0.0019, F(l,458)=39.1, p<0.0001, and females, bl = 0.0018, F(l,458) = 40.2, 
p<0.0001. The quadratic coefficient was significant for females, b2 = 0.0003, F(l,458) 
= 5.53, p<0.05, but not males, F<1. The mean CSF volume did not differ significantly 
between males (0.397 litres) and females (0.401 litres), F(l,458) = 1.91, p = 0.22, and 
no other sex differences approached significance, F<1.9, p>0.16. There was no 
significant effect of handedness on CSF volume F(l,458) <1. When CSF was 
expressed as a fraction of TIV, the linear coefficients were significant for males 
(p<0.001) and females (p<0.001), and the quadratic coefficient was significant only for 
females (p = 0.006). There was also a significant difference in mean fractional volume 
of CSF, female fractional volume being greater than male (p<0.001)(Fig. 3.1 lb).
There was a slight but significant linear decline of TIV with age for males (p = 
0.008) but not for females (p = 0,282). Both quadratic coefficients failed to reach 
significance. The rate of decline was greater in males than females, a trend that 
approached significance, F (1,457) = 1.9, p = 0.08. The mean TIV was significantly 
greater for males than females (pO.OOl)
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Figure 3.11: Global CSF volume change with age
(a)
0.6
g 0.5
<D
E
3
>  0.4
UL</)o
0.3
5020 30 40 60 70 80
Age (Yrs)
(b)
0.35
>
t:0)
E
3  0.3
o 
>
Li.(0
°  0.25
0.2
20 30 40 50 60 70 80
Age (Yrs)
81
Regional effects of age
Relatively little enlargement of the CSF space with age (negative correlation 
with age) was seen in the pontine cistern, including its caudal extent around the 
medulla (Fig. 3.12). Areas of accelerated enlargement of the CSF space (positive 
correlation with age) were seen symmetrically in the chiasmatic and supracerebellar 
cisterns, cistema magna, third ventricle and the Sylvian and interhemispheric fissures 
(Fig. 3.13). Regional effects of age tended to be linear with no improved fit of the data 
with inclusion of a second and/or third order polynomial expansion of age.
Figure 3.12: CSF volume (modulated): negative correlation with age
Relatively little or no increase in CSF with increasing age projected onto the mean 
normalised CSF image. The colour bar represents the T score. Significant voxels 
(P<0.025, corrected) are seen in the pontine cistern.
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Figure 3.13: CSF volume (modulated): positive correlation with age
Accelerated enlargement of the CSF space with increasing age superimposed on the 
mean normalised CSF image. The colour bar represents the T score. Significant voxels 
(P<0.025, corrected) are seen in the Sylvian and interhemispheric fissures; chiasmatic 
and supracerebellar cisterns; cistema magna and third ventricle.
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Discussion
Subject selection
This is a cross-sectional study in which structural age differences observed at a 
given time are used to make inferences about the ageing process. This approach has 
inherent limitations since there is potential for confounding age and cohort effects and 
in particular for secular bias, which can only be resolved by a longitudinal study. 
(Haug 1984) points out that an increase in height due to secular acceleration is in the
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order of approximately 1mm per year, and as body weight increases, so does brain 
weight. There has been a trend in the literature to report brain volumes as percentages 
of body height or total intracranial volume. I have therefore provided data on absolute 
and fractional (as a fraction of TIV) brain volumes. It is worth noting that there are 
subtle differences between the two as demonstrated in the global ageing graphs, which 
further explains inconsistencies in the literature on ageing. The major drawback of a 
longitudinal study is the time it would take to acquire data from youth to senescence. It 
would also be practically impossible to maintain identical scanning parameters; 
thereby introducing systematic differences unassociated with ageing per se. 
Longitudinal studies thus tend to look at small time windows in the ageing process.
Another difficult issue is the question of what constitutes a “normal” ageing 
population? I recruited volunteers responding to advertisements distributed around the 
university and local community, and the vast majority of volunteers were of European 
extraction. Most young and middle aged subjects were students or professionals with 
higher degrees and the majority of elderly volunteers were motivated, high functioning 
individuals, many attending educational programs and thus probably not representative 
of the population at large. All volunteers with controlled hypertension were excluded, 
but since blood pressure rises with increasing age, “normal” elderly subjects may have 
been excluded and this is reflected in the relatively small numbers of subjects in the 
seventh to ninth decades. Formal cognitive tests were not performed on any subject, 
but subjects with any history of cognitive decline were excluded and all subjects 
completed a questionnaire as part of the recruitment process. If anything, this elderly 
population errs on the side of high cognitive functioning. Certainly further studies need 
to look longitudinally at a smaller cohort of elderly subjects with comprehensive 
cognitive testing, functional and structural imaging.
Silent brain lesions
Deep white matter lesions are seen on magnetic resonance imaging in 
approximately one-third of asymptomatic elderly subjects (Fein et al. 1990) and the 
significance of these remains unclear. Some reports have suggested an association 
between silent white matter lesions and coronary artery stenosis, hypertension and 
cognitive performance. A CT and MRI based study using relatively crude region of 
interest measurements reported an association between silent white matter lesions and 
brain atrophy (Yamano et al 1997). The bulk of evidence suggests however, that they
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are merely frequent incidental findings in the elderly, with no link to significant central 
nervous system pathological processes. A recent MRI study on the sex effects of age- 
related changes in brain structure (Xu et al 2000a) specifically excluded all subjects 
with silent brain lesions, citing the CT study mentioned above. In this study, healthy 
subjects whose MRIs showed a few small hyperintense white matter foci were 
specifically not excluded, because these are probably a normal findings, and exclusion 
of such subjects would misrepresent the normal ageing population.
Global effects o f  age: Grey matter, white matter and CSF
Many neuropathological studies show that normal ageing is characterised by a 
substantial and extensive loss of neurons in the cerebral cortex, although this is 
controversial, with recent stereological investigations indicating little neuronal loss 
with normal ageing (e.g. Gomez-Isla et al 1996; Peters et al 1998). Some reports 
suggest that alterations in cerebral white matter and subcortical neuronal loss may be 
the predominant effect of age (Guttmann et al 1998a). My data concur with those 
neuropathological and previous CT and MRI morphometry studies that suggest ageing 
predominantly and substantially affects the grey matter (Jemigan et al 1991a; Lim et 
al 1992; Pfefferbaum et al 1990; Pfefferbaum et al 1994; Schwartz et al 1985; 
Hazlett et al 1998). In particular, my data suggest a linear decline in grey matter in 
concordance with Pfefferbaum et al (1994) and this pattern of decline is observed for 
absolute and fractional grey matter volumes. Others have suggested accelerated ageing 
in the later decades of life (Jemigan et al 2001) and since my data included relatively 
few subjects over 65 years and furthermore my elderly subjects could be considered 
“super normal”, a potential late non-linear trend may have been missed.
The majority of structural MRI data indicate that although significant 
microstmctural changes are seen in cerebral white matter (Raz et al 1997; Wahlund et 
al 1990; Wahlund et al 1996), significant total white matter volume loss is not found 
(Jemigan et al 1991a; Pfefferbaum et al 1986; Pfefferbaum et al 1990; Pfefferbaum 
et al 1994; Raz et al 1997; Raz et al 1998). My data are consistent with this finding. 
This phenomenon may be due to concomitant factors with opposing influence: the loss 
of myelin associated with ageing (Ansari and Loch 1975) may reduce white matter 
bulk, whereas the simultaneous expansion of the capillary network and swelling of 
perivascular spaces (Meier-Ruge et al 1992; Ishiwata et al 1998) may enlarge white 
matter bulk. In accordance with previous CT and MRI literature, my data show an
85
increase in the CSF compartment with age, best described by a linear function. A small 
but significant decline of TIV with age is noted in males and a smaller insignificant 
trend in females, which most probably reflects the secular trend of increasing head size 
over the last century. The mean absolute grey -  white matter volume ratio was 1.89, 
and the mean fractional grey-white volume ratio was 1.82. Grey-white matter ratios 
vary widely in the literature, for example post mortem and in vivo studies, using a 
variety of methodologies, report ratios in a wide range from approximately 3 -1 .1 , 
dependent on age (e.g. Caviness et al 1996; Guttmann et al 1998a; Pfefferbaum et al 
1994; Resnick et al 2000).
Regional effects o f  age
These data support the theory of a heterogeneic response of various 
compartments of the brain to ageing. Accelerated loss of grey matter volume is noted 
symmetrically in parietal lobes (angular gyri), pre- and post- central gyri, insula and 
anterior cingulate cortex. Accelerated loss of grey matter concentration in noted in the 
left middle frontal gyrus, left planum temporale and transverse temporal gyri 
bilaterally. There is relative preservation of grey matter volume symmetrically in the 
amygdala, hippocampi, entorhinal cortices and lateral thalami, with relative 
preservation of grey matter concentration more diffusely in the thalami. This is in 
accordance with previous work showing a predominant age effect in the parietal lobes 
(Resnick et al 2000) and prefrontal grey matter (Raz et al 1997); a smaller effect in 
fusiform, inferior temporal and superior parietal cortices and minimal change in the 
hippocampal formation (Raz et al 1997). The lack of a substantial age-related 
structural change in the amygdala/hippocampal regions demonstrated by my data and 
work by (Raz et al 1997) also corresponds with recent evidence (unpublished data) of 
preserved regional cerebral blood flow in the mesial temporal lobes with age. Animal 
and human pathological studies have demonstrated age-related changes in the 
hippocampus (Kemper 1993; Landfield 1988; Desgranges et al 1998; Insausti et al. 
1998) as have previous structural imaging studies (Jemigan et al 2001) and recent 
work using MR spectroscopy (Schuff et al 1999). A possible explanation for this 
discrepancy could be the sampling methods used to assess the hippocampus: ROI 
techniques used in these previous studies may be observer dependent and subject to 
error due to the complex and variable shape of the hippocampus. It should be noted 
that VBM examines age-related changes in local tissue composition, deliberately
86
adjusting for macroscopic and shape differences that classical ROI-based 
morphometric approaches characterise. It is also worth emphasising that my data are 
reporting regionally specific changes within the grey matter compartment over and 
above global grey matter change, whereas most other studies report changes without 
covarying out global grey matter volume changes. A recent ROI and voxel-wise 
morphometry paper in young adults reported that the volume of the amygdala appeared 
to be independent of age and gender, whereas the hippocampi showed shrinkage with 
age in men but not in women (Pruessner et al, 2001). The statistical model used in this 
paper did not model the global amount of grey matter and the age range is substantially 
different, so it cannot be directly compared with my method.
Sex differences
The whole brain volume and grey and white matter partitions were larger in 
males compared to females in accordance with previous literature (Coffey et al. 1998; 
Gur et al. 1991; Murphy et al. 1996; Raz et al. 1997).
There was an interaction of sex with age-related global grey matter decline, 
with a steeper age-related decline in males, in accordance with previous reports 
(Coffey et al. 1998; Cowell et al. 1994; Gur et al. 1991; Murphy et al. 1996; Oguro et 
al. 1998; Xu et al. 2000a; Guttmann et al. 1998b), although this effect was not 
significant when global grey matter was expressed as a fraction of TIV. There was no 
interaction of sex with regional grey matter volume or concentration, contrary to a 
report from (Murphy et al. 1996) who showed greater age related loss in frontal and 
temporal lobes in males, and greater loss in hippocampus and parietal lobes in females. 
There was no significant interaction of sex with age for CSF or white matter change 
either globally or regionally. Some previous studies have found greater increases in 
CSF spaces in males compared with females (e.g. Coffey et al. 1998; Gur et al. 1991), 
although this has not been reproduced by others (Guttmann et al. 1998a).
Many previous reports have suggested regional sex differences in age-related 
decline, for example, Raz et al. (1997), demonstrated a steeper trend of ageing in the 
inferior temporal cortex in males. Xu et al. (2000a) showed significantly more atrophy 
in posterior right frontal lobe, right temporal lobe, left basal ganglia, parietal lobe and 
cerebellum in males, using semi-automated region of interest MR techniques in 331 
subjects, but without partitioning the brain into grey and white matter compartments. 
Salat et al. (1997) showed sex differences in the corpus callosum with ageing, but no
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atrophy of the pons or cerebellum. Gunning-Dixon et al (1998) showed differential 
shrinkage of the globus pallidus in males. Murphy et al (1996) reported sex 
differences in the ageing pattern of whole brain, frontal, temporal and parietal lobes 
and hippocampus. It is difficult to compare such results with my data, particularly 
since the majority of studies are confounded to a greater or lesser degree by 
methodological factors such as normalising for brain size, region of interest 
measurements, variable quality of structural images and the use of manual 
segmentation techniques.
Methodological issues
In order for VBM to be valid a number of assumptions need to hold. All raw 
original structural images need to be acquired on the same scanner with identical 
imaging parameters since different acquisitions can result in intensity and geometric 
variations. If such variations are systematic they can emerge erroneously as group 
differences. In this study all subjects were scanned on the same scanner using identical 
imaging parameters and the scanner was subject to strict quality control. The templates 
were created from a subset of the group, which matched the mean age, age-range and 
sex of the group in order to avoid bias during the spatial normalisation step. The non­
linear spatial transformations used in this study were used to match global brain shape 
differences whilst preserving regionally specific effects of interest. Since this approach 
does not provide precise sulcal and gyral matching (see Chapter 2) a smoothing kernel 
is used to accommodate imperfect registration of variable structures. By applying the 
modulation step information from the deformation fields is incorporated and allows 
inferences about grey (and white) matter volume. While my approach cannot provide 
exact matches between small cortical or deep grey matter structures (which would 
require time consuming high dimensional warps), it provides additional information in 
a practical way for large subject cohorts.
The segmentation step needs to correctly identify grey and white matter and 
CSF partitions. In areas where grey/white matter differentiation is poor, for example in 
the brainstem and thalamus, voxels may be incorrectly classified, even when an 
optimal pre-processing method is used. This effect is demonstrated in the significant 
lateral thalamic differences detected on both the grey and white matter analyses. These 
age-related differences are real and significant but their cause cannot be attributed 
directly to grey or white matter changes, rather to the way the changes impact on the
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classification of grey or white matter. This problem can be diminished by optimising 
the MR structural imaging sequence to provide better grey/white matter contrast and 
segmentation (Deichmann et al 2000; Deichmann et al 2002). Additional 
improvements can be made to the segmentation procedure by the creation of 
customised prior probability maps appropriate to the subject group of interest. This has 
particular relevance when studying patient populations whose brain structure differs 
greatly from young normal subjects. Elderly subjects with a few small white matter 
hyperintensities were deliberately included. In addition perivascular spaces enlarge 
with age and there may be subtle diffuse MRI T1 signal changes in the white matter of 
elderly subjects. These could potentially result in misclassification of CSF or grey 
matter, leading to a potential overestimation of CSF and grey matter and an 
underestimation of white matter. Since no age related global white matter atrophy was 
observed, one can conclude that perivascular spaces and small white matter lesions 
were predominantly classified as white matter. The inclusion or exclusion of the 
modulation step facilitates the assessment of absolute amount or concentration of a 
region of tissue. The latter does not however provide information about 
cytoarchitecture, neuronal packing density or cell morphometry; hence the term 
concentration is preferred to density.
The statistics I used to identify structural differences assume that the residuals 
after fitting the model are normally distributed and this is one of the reasons for using 
smoothing. If the data are not well behaved such as in unbalanced study designs 
(single subject versus group comparisons) or in diseased populations it may be 
appropriate to perform nonparametric statistical analyses (Ashbumer & Friston, 2000, 
Holmes et al., 1996). The voxel-based extent statistic available within SPM, should not 
be used with VBM. This statistic is based upbn the number of connected voxels in a 
cluster defined by a pre-specified threshold. In order to be valid, this test requires the 
smoothness of the residuals to be spatially invariant, but this is not the case with 
neuroanatomy which has a highly non-stationary nature and thus leads to inexact p 
values (Ashbumer & Friston, 2000; Worsley et al, 1999).
There is a great deal of endogenous variability within and between brain 
regions, and in a recent paper the authors report that 80% of the total variance in gyral 
volume arises from individual and specific gyri, whilst only 10% of the total variance 
reflects uniform scaling to total neocortical volume (Kennedy et al 1998). In addition 
there may be contributions from artifactual sources such as imperfections in the spatial
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normalisation that themselves show regional specificity. These considerations have 
implications for the sensitivity of any morphometric technique to detect changes in 
regions of high variance. The VBM technique I have developed and used may be 
relatively insensitive to subtle age effects in regions of high variance whilst more 
sensitive to change in regions of low variance. However SPM employs a regionally 
specific estimate of variance that obviates some of these sources of error. Regional 
variance may well explain inconsistencies of the literature with regard to regionally 
specific age changes especially in small brain structures. The hippocampus, for 
example, is a relatively small structure with a complex architecture that often 
demonstrates a degree of variability between subjects on visual inspection. VBM has 
demonstrated subtle changes within the hippocampus in a group of taxi-drivers that 
corroborated independent and accurate ROI measurements (Maguire et al, 2000), 
suggesting that the technique can register and segment small structures with some 
degree of accuracy. There is more potential for error in patients, for example those 
with Alzheimer’s disease, or indeed in normal elderly subjects, since the grey/white 
matter contrast is reduced and segmentation may be less accurate. As high dimensional 
warping techniques advance to the stage where they can provide accurate mapping of 
small gyri in large subject groups in a time efficient and practical way, then some of 
these sources of ambiguity will be more satisfactorily resolved.
Conclusion
My data provide evidence of specific patterns in the structural brain correlates 
of ageing, not only globally between grey and white matter compartments, but also 
locally within regions of the brain. The use of large numbers of subjects in this study 
permitted the examination of relatively subtle age-related effects, but also highlighted 
the need for a rigorous and optimal VBM method to avoid errors of interpretation 
caused by misclassification of non-brain voxels. Significantly the data have been 
obtained with a fully automated method that eschews observer bias and have been 
collected in life, eliminating post mortem and agonal changes. They also demonstrate 
that VBM is a suitable tool for detecting subtle structural brain changes in normal 
subjects.
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CHAPTER 4
NORMATIVE DATA
BRAIN ASYMMETRIES AND EFFECTS OF SEX AND
HANDEDNESS
Summary
In this experiment, VBM is used to characterise physiological brain 
asymmetries and the effects of sex and handedness on brain structure in a large group 
of normal subjects. VBM confirms the well-established lobar asymmetries whilst 
offering new insights into more subtle regional asymmetries, including an interaction 
of sex with asymmetry of Heschl’s gyrus. VBM confirms the well known global 
differences in brain volume between the sexes whilst expanding upon regional sex 
differences in grey and white matter. Despite a prior expectation of an effect of 
handedness on brain structure, particularly in the central sulcus region, VBM does not 
detect any structural difference associated with left and right-handedness.
Introduction
The main and most consistently reported human brain asymmetries include the 
right frontal and left occipital lobar protuberances causing marked indentations of the 
inner table of the skull (the so called petalia) (Chiu and Damasio 1980; Gundara and 
Zivanovic 1968; LeMay 1986). Asymmetry of the Sylvian fissure is one of the earliest 
and most reproducible reported brain asymmetries. The trajectory of the Sylvian 
fissures is angled upwards (dorsally) more steeply in the right hemisphere 
(Cunningham 1892; cited in Geschwind and Levitsky 1968; Geschwind and Galaburda 
1985a; Loftus et al 1993; Ratcliff et al. 1980; Thompson et al 1996a; Thompson et 
al 1998; Westbury et al 1999; Hochberg and Le May 1975). This trajectory 
asymmetry reflects another well-known posterior Sylvian asymmetry -  namely 
asymmetry of the planum temporale that is more pronounced on the left side 
(Geschwind and Levitsky 1968; Geschwind and Galaburda 1985a; Steinmetz et al
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1989; Steinmetz 1996; Wada et al 1975). This is associated with microscopic 
asymmetry of cytoarchitectonic area Tpt that is characteristically found in this region 
(Galaburda et al 1978). Additional macroscopic asymmetry has been reported in 
Heschl’s gyrus which houses primary auditory cortex and appears to be larger on the 
left side (Penhune et al 1996; Rademacher et al 1993; Rademacher et al 2001). This 
difference has been ascribed to a larger volume of white matter than grey matter 
(Penhune et al 1996). Several older and more recent studies confirm asymmetry of 
Broca’s area (Brodmann areas 44 and 45) being larger in the left hemisphere (Amunts 
et al 1996; Annett 1970; Falzi et al 1982; Foundas et al 1995; Foundas et al 1996; 
Foundas et al 1998a; Geschwind and Galaburda 1985a; Penhune et al 1996). It is less 
clear from the literature what effect handedness and sex have on many of these 
asymmetries. One might for example expect functional lateralisation such as 
handedness and language to impact upon the structure of sensorimotor cortex and 
language regions respectively.
Certainly there are well-established sex differences in global brain size with 
males having approximately ten percent larger total brain volumes (Peters et al 1996), 
but many post mortem and in vivo reports of regional sex differences conflict. Reports 
of regional sex effects include a larger left planum temporale (PT)/anterior Sylvian 
fissure in males (e.g. Kulynych et al 1994); but see Foundas et al (1999); 
cytoarchitectural dimorphism of the PT cortex, with significantly higher percentages of 
grey matter in females (Gur et al 1999; Gur et al 2002; Schlaepfer et al 1995), which 
may possibly be explained by higher neiironal densities and neuronal number estimates 
in females (Witelson et al 1995). Females have also been reported to have a larger 
anterior commissure (Allen and Gorski 1991; Allen and Gorski 1992) and a more 
bulbous posterior corpus callosum (Bishop and Wahlsten 1997; Habib et al 1991; 
Steinmetz et al 1992; Witelson 1985), although this latter finding has been refuted by 
others (Byne et al 1988; Constant and Ruther 1996). Larger caudates have been 
observed in females (Giedd et al 1996), although conversely there are also reports of 
smaller caudates in females (Filipek et al 1994). Other reports of sexual dimorphism 
include leftward asymmetry of the inferior parietal lobule in males (Frederikse et al 
1999; Frederikse et al 2000); a larger volume of one of the interstitial nuclei of the 
anterior hypothalamus in males (Byne et al 1988) and larger globus pallidus and 
putamen volumes in males (Giedd et al 1996). These conflicting reports in the 
literature of sex differences for regional structure not only reflect the different
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measurement techniques but could also in part relate to inconsistent ways of de­
trending differences in global brain volume from the data. There is a potential for 
global brain sex differences to masquerade as regional differences if substructure 
metrics depend nonlinearly on brain volume. For example, in an attempt to factor out 
effects of gross variations in brain size many earlier postmortem and neuroimaging 
studies expressed regional volumes as a ratio to global volume or weight. But such 
measures may be highly correlated with global measures. More recently linear 
statistical models such as analyses of covariance (ANCOVA) or multiple correlation 
analyses have been used to model global differences, but even these may be flawed 
since they do not model nonlinear correlations (Thompson et al 2001a).
Handedness, as a habitual lifelong manual behaviour, may plausibly have 
structural correlates in the sensorimotor system. Melsbach et al (1996) showed 
morphological asymmetries of motor neurons innervating upper extremities. More 
recently Amunts et al (1996; 1997; 2000), reported deeper left central sulci in right- 
handed males and vice versa in left-handed males. This macro structural asymmetry 
was associated with concordant leftward microstructural asymmetry of neuropil 
volume in Brodmann’s area 4, suggesting that hand preference is associated with 
increased connectivity and an increased intra-sulcal surface of the precentral gyrus in 
the dominant hemisphere. White et al (1994,1997) examined the central sulcus of 42 
post mortem brains in detail, and found a slight, but insignificant trend towards a 
longer left central sulcus and larger Brodmann areas 3 and 4 on the left side. Several 
studies have shown structural and functional asymmetries correlating with handedness. 
For example, Steinmetz (1996) reported decreased leftward asymmetry of the PT in 
left-handers (see also Geschwind and Galaburda 1985a). Others, however, have 
demonstrated that this finding may well be an artefact of the increased likelihood of 
atypical functional organisation in left-handers (Foundas et al 1995; Moffat et al 
1998; Ratcliff et al 1980). These researchers have found that, whereas subjects with 
left-hemisphere speech representation show a strong leftward asymmetry in the PT 
(regardless of handedness), subjects with right hemisphere speech representation do 
not show a consistent PT asymmetry. Moffat et al (1998) also showed that left-handed 
subjects with left-hemisphere speech functions had a larger corpus callosum than either 
left-handed subjects with right-hemisphere speech representation or right-handed 
subjects. In addition, there have been reports of a handedness effect on frontal and 
occipital lobe asymmetry (Bear et al 1986; Kertesz et al 1990; Weinberger et al
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1982; Zilles et al 1996).
In this study, VBM delivers a voxel-wise overview of regional physiological 
morphological effects in a large group of normal subjects to characterise and quantify 
human brain asymmetry and the effects of sex and handedness on macroscopic and 
mesoscopic brain structure.
Methods
Approval for the study was obtained from the Local Research Ethics 
Committee of the National Hospital for Neurology and Neurosurgery (UCLH, NHS 
Trust) and the Institute of Neurology (UCL). The study group was selected from a 
population of 1761 normal volunteers who responded to advertisements and were 
scanned at the Wellcome Department of Cognitive Neurology from February 1998- 
December 1999. All subjects with incomplete questionnaires, any neurological, 
medical, psychiatric condition or migraine were excluded. Inclusion criteria included: 
1) Normal MRI brain as determined by an experienced neuroradiologist (myself). Any 
MRI scans with structural abnormalities, prominent normal variants (e.g. mega cistema 
magna, cavum septum pellucidum) or technical artefacts were excluded. 2) No history 
of alcohol intake of more than 30 units/week or intake of more than 10 units within 48 
hours prior to scanning. 3) No history of severe head trauma requiring medical 
attention. 4) No history of cognitive difficulties. Handedness was assessed by a simple 
questionnaire documenting which hand subjects wrote with, which foot they kicked 
with and whether or not they had been encouraged to change handedness as a young 
child. I only included subjects with a clear-cut hand preference, and no history of 
coercion to change handedness as a young child. In all, 465 subjects met the inclusion 
criteria. They comprised 29 left-handed females (aged 18-75, mean 38; 5 right­
footed), 171 right-handed females (aged 18-79, mean 33; 3 left-footed, 4 equal-footed), 
38 left- handed males (aged 20-59, mean 36; 9 right-footed) and 227 right- handed 
males (aged 17-67, mean 30,10 left-footed, 3 equal- footed).
Structural M RI scanning protocol
Magnetic resonance imaging was performed on a 2 Tesla Siemens 
MAGNETOM Vision scanner. A 3D structural MRI was acquired on each subject 
using a T-l weighted MPRAGE sequence (TR/TE/TI/NEX 9.7/4/ 600/1, flip angle
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12°, matrix size 256 x 192, FOV 256 x 192, yielding 108 sagittal slices, slice 
thickness of 1.5mm and in plane resolution of 1mm x 1mm.
Data analysis
Data were analysed using the optimised VBM protocol as detailed in Chapter 
2. Processing components pertinent to this study will be emphasised here.
Customised Templates
A whole brain template was created from 120 constituent images chosen 
pseudorandomly from the group, consisting of 60 males (30 left-handed) and 60 
females (30 left-handed) matched for age, with a mean age corresponding to that of the 
whole group. Each image was normalised to the SPM T1 template, which 
approximates Talairach space. These normalised images were averaged and the 
resulting image was smoothed with an 8 mm Gaussian kernel to create a template in 
which the left side of the image represents the left hemisphere. Grey and white matter 
templates were derived separately by normalising all 465 images to the whole brain 
template, then segmenting, extracting, smoothing and finally averaging all the 
grey/white matter images to create separate grey/ white matter templates (details of 
each step to follow). Symmetric grey and white matter and whole brain templates were 
derived separately by averaging each teitiplate with its left-right flipped version. In 
these symmetrical templates, each side of the image represents an average of both 
hemispheres.
Normalisation for asymmetry analyses
The standard optimised normalisation protocol was followed using the 
symmetrical grey and white matter templates.
Normalisation for sex and handedness analyses
Exactly the same procedures were followed, but using non-symmetric (normal) 
grey and white matter templates.
Statistical design for analysis of brain asymmetry.
2 x 2 x 2  (flipped/unflipped by sex by handedness) factorial analyses were 
performed on modulated and unmodulated grey and white matter and CSF images 
respectively to assess brain asymmetry and the effects of sex and handedness. I
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performed conjunction analyses to detect common asymmetry effects (for example, 
which asymmetries are found in both males and females).
Statistical analyses of sex and handedness effects
Global effects of sex and handedness were assessed by multiple regression 
analyses of voxel values of grey matter, white matter and CSF respectively in a model 
including linear and quadratic expansions of age. Regional effects were assessed by a 
factorial design of sex and handedness with linear and quadratic expansions of age and 
globals as confounding covariates. I applied this design separately to grey and white 
matter modulated and unmodulated data.
Handedness analysis
A separate handedness analysis was conducted using handedness as a factor, 
with sex and the first order effects of age as covariates. Effects of sex and handedness 
on global measures were assessed by multiple regression of summed voxel values from 
grey matter, white matter and CSF respectively in a model including linear and 
quadratic expansions of age.
Results
Grey matter
Asymmetry
Extensive grey matter asymmetries commoii to all groups (conjunction 
analysis) were observed, namely larger left occipital, right frontal and right temporal 
lobes (the petalia) (Fig. 4.1a). Furthermore, more focal leftward (left > right) 
asymmetry was seen in the transverse temporal (Heschl’s) gyri, frontal operculum, in 
the depths of the superior and inferior frontal sulci, in the mesial temporal lobe 
(including amygdala and hippocampus), anterior cingulate sulcus, caudate head (Fig. 
4.1a) and medial cerebellum (not illustrated). Focal rightward (right>left) asymmetry 
was seen in the lateral thalamus, around the calcarine sulcus, anterior cingulate (Fig. 
4.1a) and in the lateral cerebellum (not shown). There was a significant interaction of 
sex with asymmetry at the medial end of Heschl’s sulcus, at the junction with PT, with 
males having greater leftward asymmetry (Fig. 4.1b). There was no interaction of
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handedness with asymmetry, even with reduced thresholds and small volume 
corrections for the left posterior temporal lobe (PT), central sulci and left occipital lobe 
(regions where handedness effects have previously been described).
Figure 4.1a: Grey matter: asymmetry common effects
Grey matter volume (modulated data) asymmetries common to all groups superimposed 
on the normalised symmetrical mean grey matter image. Significant voxels (p<0.05 
corrected) represent ipsilateral side > contralateral side asymmetry (and thus also 
contralateral< ipsilateral asymmetry). The colour bar represents the T score. The right 
frontal and temporal and left occipital lobar asymmetries are shown (petalia). Focal 
left>right asymmetry is seen in the frontal operculum, posterior insula (extending into 
Heschl’s gyrus and planum temporale (PT), not shown), in the depths of the superior 
and inferior frontal sulci, mesial temporal lobe (including amygdala and hippocampus), 
anterior cingulate sulcus and caudate head. Focal right>left asymmetry is seen in the 
lateral thalamus, around the calcarine sulcus and anterior cingulate. (Cerebellar 
asymmetries are not shown).
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Figure 4.1b: Grey matter: increased asymmetry in males
Regions corresponding to an interaction of asymmetry with sex are superimposed on the 
normalised symmetrical mean grey matter image. The colour bar represents the T score. 
Significant voxels (p<0.05, corrected) are seen at the medial end of left HeschTs sulcus, 
at the junction with PT, with males having increased leftward asymmetry
Global effects of sex
Although age was approximately matched between females and males (females 
33.5 ± 13.6 years, males 30.9 ±11.1 years), linear and quadratic expansions of age 
were included as covariates in the analysis since age has a marked effect on brain 
morphology (Good et al., 2001). The mean grey matter volume was significantly 
greater in men (0.829 ± 0.069 litres) than in women (0.747 ± 0.064 litres), F 
(1,458)=239.85, p<0.0001) (Fig. 4.2). The mean fractional volume of grey matter (as a 
percentage of total intracranial volume) was also significantly greater for males than 
females (p<0.0001). The grey-white absolute volume ratio was 1.89 for females and 
1.89 for males. The grey-white fractional volume ratio was 1.82 for females and 1.82 
for males.
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Figure 4.2: Main effect of sex on global brain tissue compartments
Box and whisker plots show the mean global volumes (modulated data) of grey matter 
(red), white matter (green) and CSF (blue) in females (n=200) and males (n=265). The 
box represents the interquartile range and the whiskers the 95% confidence intervals. 
The wide spread of data reflects the wide age range. Global grey matter and white 
matter volumes are increased in males compared with females.
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Regional effects of sex
There were no interactions between sex and handedness. There was a 
significant main effect of sex. Males have significantly increased grey matter volume 
bilaterally in the amygdala, hippocampi, entorhinal and perirhinal cortex, in the 
anterior lobes of cerebellum and in the left anterior superior temporal gyrus (Fig. 4.3a 
(i and ii)). I did not detect any regions of significantly increased grey matter 
concentration in males. Females have significantly increased grey matter volume in the 
right middle temporal, lateral orbital and left parahippocampal gyri (Fig. 4.3b(i)), in 
the right transverse temporal (Heschl’s) and both inferior frontal gyri (not illustrated), 
in right planum temporale (PT) and within the right inferior parietal and cingulate gyri 
(Fig. 4.3b(ii)). There was also increased grey matter volume in the banks of the left 
superior temporal sulcus and the banks of both central sulci (Fig. 4.3b(iii)). Females 
have significantly increased grey matter concentration extensively and relatively 
symmetrically in the frontal, posterior temporal and parietal cortical mantle, 
parahippocampal gyri, adjacent to the caudate heads and within the banks of the 
cingulate and calcarine sulci (Fig. 4.3c (i and ii)).
These regional main effects of sex were also observed as individual simple 
effects for right and left-handers. The stereotaxic coordinates of the maxima and 
corresponding p and T values are tabulated in Table 4.1
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Table 4.1: Main effect of sex on grey matter.
X y z p (corrected) T statistic location
Grey matter volume: modulated females > males
-42 -30 -4 pcO.0001 6.16 L superior temporal sulcus
72 -14 10 pcO.0001 5.99 R planum temporale/Heschl’s g
57 40 -9 pcO.0001 5.94 R lateral orbital gyrus
24 64 -8 pcO.OOOl 5.90 R frontomarginal gyrus
-15 -34 -4 p<0.0001 5.85 L parahippocampal gyrus
-39 -32 34 p<0.0001 5.79 L central sulcus
76 -34 -4 p<0.0001 5.61 R middle temporal gyrus
36 -26 36 p=0.002 5.37 R central sulcus
2 -22 50 p=0.001 5.54 Posterior cingulate
52 36 21 p=0.003 5.24 R inferior frontal gyrus
-58 34 9 p=0.005 5.16 L inferior frontal gyrus
-32 -88 34 p=0.002 5.35 L angular gyrus
66 -19.5 27 p=0.002 5.25 R inferior parietal gyrus
Grey matter volume: modulated ihales > females
27 -2 -28 pcO.0001 7.29 R amygdala/hippocampus
-20 -3 -24 pcO.0001 7.24 L amygdala/hippocampus
-45 28 -26 pcO.OOOl 6.18 L anterior superior temporal g
-27 -60 -22 p=0.001 5.53 L cerebellum
-33 -58 -22 p=0.001 5.50 R cerebellum
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Figure 4.3a: Grey m atter volume: regional increases in males vs. females
Regions of increased grey matter volume (modulated data) are superimposed on a 
normalised symmetrical grey matter mean image (i) and a normalised single subject 
structural image (ii). The colour bar represents the T score. Significant voxels (p<0.05 
corrected) are seen symmetrically in the mesial temporal lobes, in amygdaloid 
hippocampal complexes, entorhinal and perirhinal cortex, in the anterior lobes of the 
cerebellum, and in the left anterior superior temporal gyrus (ii). A few voxels can be 
seen at the junction of the superior edge of the right putamen and internal capsule (i), 
which may be misclassified.
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Figure 4.3b: Grey matter volume: regional increases in females vs. males
Regions of increased grey matter volume (modulated data) are superimposed on a 
normalised mean grey matter image (i, ii) and a normalised single subject whole brain 
image (iii). The colour bar represents the T score. Significant voxels (p<0.05 corrected) 
are seen in the right middle temporal gyrus, left parahippocampal gyrus, right lateral 
orbital and frontomarginal gyri (i); in the right inferior parietal gyrus, cingulate gyrus 
and right transverse temporal gyri (Heschl’s) gyri/ planum temporale (PT)(ii), and 
within the banks of the left superior temporal and both central sulci (iii). (Significant 
voxels in the inferior frontal gyri are not shown).
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Figure 4.3c: Grey matter concentration: regional increases in females vs. males
Regions of increased grey matter concentration (unmodulated data) are superimposed 
on a normalised single subject image (i) and the normalised symmetrical grey matter 
mean image (ii). The colour bar represents the T score. Significant voxels are seen 
diffusely in the cortical mantle, parahippocampal gyri and in the banks of the cingulate 
and calcarine sulci. Significant voxels are also seen around the anterior limbs of the 
internal capsules, possibly reflecting caudate/lentiform nucleus changes, but probably 
also misclassification of voxels into grey/white matter.
Global effects of handedness
The mean age of left and right-handers differed significantly (p<0.001), left 
handers (36.8 ±13.9 years) and right-handers (31.2 ± 11.8 years). When linear and 
quadratic effects of age were covaried out, there was no significant difference in global 
grey matter volume between left and right-handers, F (1,458)<1.
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Regional effects of handedness
There was no significant difference in grey matter volume or concentration 
between right and left-handers on any of the handedness analyses. Furthermore, I did 
not detect regional differences, even with lowered thresholds and small volume 
corrections for primary motor and sensory cortex (particularly in the hand area) 
according to my prior hypothesis.
White matter 
Asymmetry
Extensive white matter asymmetries common to all groups (conjunction 
analysis) were detected adjacent to areas of grey matter asymmetry (Fig. 4.4). There 
was a significant interaction of sex with asymmetry with increased leftward asymmetry 
adjacent to Heschl’s gyrus/PT (Fig. 4.5).
Figure 4.4: White matter asymmetries
Regional areas of asymmetry common to the whole group are superimposed on the 
normalised symmetrical white matter mean image. The colour bar represents the T 
score. Significant voxels are seen adjacent to the regions of grey matter asymmetry
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Figure 4.5: White matter: Interaction of sex with asymmetry
Regions corresponding to an interaction of asymmetry with sex are superimposed on the 
normalised symmetrical white matter mean image. The colour bar represents the T 
score. Significant voxels are seen adjacent to the medial end of left Heschl’s gyrus and 
PT, with males having increased leftward asymmetry
Global effects of sex
The mean white matter volume was significantly greater in men (0.454 ± 0.044 
litres) than in women (0.395 ± 0.041 litres), F (1,458)=209.33, p<0.0001 (Fig. 4.2).
Regional effects of sex
There were no interactions between sex and handedness. There was a 
significant main effect of sex. Males had significantly increased white matter volume 
bilaterally in the anterior temporal white matter extending into the internal capsules 
(temporal stems)(Fig. 4.6a), and significantly increased white matter concentration 
bilaterally in the anterior temporal and posterior frontal lobes (Fig. 4.6b). Females had 
significantly increased white matter volume bilaterally in posterior frontal lobes and in
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the left temporal stem/optic radiation (Fig. 4.7a). Females had significantly increased 
white matter concentration bilaterally in the internal and external capsules and optic 
radiations (Fig.4.7b). These changes were also observed as individual simple effects in 
right and left-handers. No corpus callosum differences were observed.
Figure 4.6a: White matter volume: increases in males vs. females
Regions of increased white matter volume (modulated data) are superimposed on a 
normalised mean white matter image. Significant voxels are seen in both temporal 
lobes, extending upwards into the temporal stems and internal capsules.
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Figure 4.6b: White m atter concentration: increases in males vs. females
Regions of increased white matter concentration (unmodulated data) are superimposed 
on the normalised mean white matter image. Significant voxels are seen bilaterally in 
anterior temporal white matter, and adjacent to the central sulcus.
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Figure 4.7a: White matter volume: increases in females vs. males.
Regions of increased white matter volume (modulated data) are superimposed on the 
normalised mean white matter image. Significant voxels are seen bilaterally in posterior 
frontal white matter, left temporal stem and optic radiation.
8
7
6
5
4
3
2
1
0
Figure 4.7b: White matter concentration: increases in females vs. males.
Regions of increased white matter concentration (unmodulated data) are superimposed 
on the normalised mean white matter image. Significant voxels are seen bilaterally in 
internal and external capsules and optic radiations. A number of voxels are also seen in 
globus pallidus and putamen on both sides, and are probably misclassified voxels owing 
to poor tissue contrast in these regions.
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Global effects of handedness
There was no significant difference in global white matter volume between left 
and right-handers
Regional effects of handedness
Neither white matter volume nor concentration differed between right and left­
handers. In order to prevent potential type 2 error owing to stringent whole brain 
correction, thresholds were reduced (down to 0.05 uncorrected) and small volume 
corrections performed on regions where I had a prior hypothesis for differences (such 
as hand/foot primary motor and sensory cortex). But still no structural difference was 
evident.
CSF
Asymmetry:
CSF asymmetry was noted around the regions of grey matter asymmetry, 
particularly in the right hemisphere and most prominently in the right Sylvian fissure
Global effects of sex and handedness:
The mean CSF volume did not differ significantly between males (0.397 ± 
0.040 litres) and females (0.401 ± 0.048 litres), F (1,458)=1.91, p=0.22). There was no 
significant effect of handedness on CSF volume F (1,458)<1 (Fig. 2).
Regional effects of sex and handedness
There was no interaction between sex and handedness and no main effect of 
handedness. There was a significant main effect of sex. Females had increased CSF 
volume in the lateral ventricles. Males had increased CSF volume in the peri- 
mesencephalic cistern, anterior and superior interhemispheric fissure.
Discussion
Brain asymmetry, and interactions with sex and handedness
My data confirm larger left occipital and right frontal lobes, consistent with
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previous reports (e.g., Chiu and Damasio 1980; Geschwind and Galaburda 1985a; 
Gundara and Zivanovic 1968; Kennedy et al 1999; LeMay 1986). The right frontal 
asymmetry extended into central and even temporoparietal regions, although the 
reasons for this are unclear. Focal asymmetric enlargement of grey matter was seen at 
the posteromedial edge of the anterior transverse temporal (Heschl’s) gyrus on the left, 
adjacent to the planum temporale, corroborating recent studies using accurate cortical 
mapping techniques (Thompson et al 1998; Thompson et al 2001a) and post mortem 
data (e.g. Geschwind and Levitsky 1968; Geschwind and Galaburda 1985a). In males 
this leftward asymmetry was more pronounced, and was observed in both grey and 
white matter. These data are consistent, in part, with those of Penhune et al (1996), 
who found a greater volume of white matter (but not grey matter) in left Heschl’s 
gyrus, but did not observe an interaction with sex. The discrepant results could reflect 
the smaller sample size in the Penhune study, or the local nature of the sex effect: 
Penhune’s analyses were conducted on measurements of the whole of Heschl’s gyrus. 
The observation of increased leftward asymmetry in males also concur with Kulynych 
et a l (1994) and Kansaku et al (2000), who localised the leftward asymmetry to PT, 
and Witelson and Kigar (1992) who showed increased asymmetry of the horizontal 
segment of the Sylvian fissure (an indirect index of PT) in males. A recent study using 
accurate cortical mapping techniques corroborated these findings (Thompson et al 
2001a) and also reported superior and inferior temporal sulcal asymmetries (left 
anterior to right) and post-central cortex asymmetries (further anterior on the right). 
Voxel-based morphometry demonstrated additional temporal lobe asymmetries, 
namely, increased grey matter in the right lateral temporal lobe and left mesial 
temporal lobe, as well as caudate and cerebellar asymmetries.
Asymmetric white matter changes were observed predominantly adjacent to 
respective grey matter changes. Biologically, it seems plausible that regional cortical 
change is associated with corresponding change in the adjacent white matter 
connections. This observation may however in part reflect an edge effect, for example, 
if the interface of one tissue compartment is displaced the difference might be reflected 
in both compartments. A recent post mortem study ascribed leftward PT asymmetry to 
larger white matter volumes and axons with thicker myelin sheaths, and not to 
proliferation of glia or the density of cortical to cortical projections of neurons. These 
data confirm leftward asymmetry of white matter adjacent to the left PT, although, 
many other regions of white matter asymmetry were also detected.
I l l
Sex differences
These data concur with well-established findings of increased global brain 
volumes in males. The mean absolute and relative grey-white volume ratios were 1.89 
and 1.82 respectively with no difference between males and females. Grey-white 
matter ratios vary widely in the literature, for example post mortem and in vivo studies, 
using a variety of techniques, report ratios in a wide range between approximately 1 
and 3 (see Good et al. 2001c). Furthermore VBM reveals increased grey matter 
concentration extensively in the cortical mantle in females, corroborating previous 
histopathological reports of increased neuronal density and number in female temporal 
cortex (Witelson et al. 1995). More recent histopathological data from adolescent 
brains show the reverse, with larger neuronal density in 60 cortical loci in males 
(Rabinowicz et al. 1996; Rabinowicz et al. 1999), although clearly, such data cannot 
simply be projected to the adult population in view of continued brain maturation into 
adolescence that can vary between the sexes (Giedd et al. 1996; Lange et al. 1997). 
More interestingly, VBM reveals a significant main effect of sex on regional brain 
tissue composition. Grey matter volume is increased bilaterally and symmetrically in 
the amygdala/hippocampal complexes including entorhinal and perirhinal cortex and 
superior cerebellum, as well as in the left anterior temporal pole in males. In females, 
several relatively asymmetric foci of increased grey matter volume can be seen in the 
posterior temporal lobes, including right Heschl’s gyri and PT; in the right orbital gyri; 
adjacent to the depths of the central sulci and in the inferior frontal gyri bilaterally and 
in left angular gyrus. As in the analyses for asymmetry, sex-related white matter 
changes were in most cases observed adjacent to respective grey matter changes. 
Precise interpretation of these regional structural differences is difficult giving the 
paucity and inconsistency of prior reports in the literature. It is beyond the scope of 
this manuscript to relate these findings to interpretations of brain function. Rather the 
aim is to present archival data in a large normal sample that will serve as a framework 
against which further structural and functional studies can be compared.
Handedness
VBM did not show any main effects of handedness on brain morphology, not 
even in the sensorimotor regions, as I had predicted. This was surprising, considering 
the large study group and the sensitivity of VBM to detect subtle asymmetry and sex 
effects and furthermore its ability to demonstrate subtle changes in the hippocampus
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(Maguire et al 2000), brainstem (Krams et al 1999) and hypothalamus (May et al 
1999a) in substantially smaller study groups. But there is the possibility of insufficient 
power in this study to detect handedness effects. Given that many of the reported 
handedness effects have been found in sulcal topography (e.g., Amunts et al 2000; 
White et al 1997), it is plausible that VBM, in its current state of development is not 
sensitive enough to detect subtle sulcal differences. Furthermore, it is well known that 
there is a great degree of gyral and sulcal variation not only between individuals but 
also between brain regions (Kennedy et al 1998). The data of White et al (1997) 
suggest that the preferred use of the right hand in humans occurs without gross lateral 
asymmetry of the primary sensorimotor system. If indeed volumetric differences do 
occur in areas 3 and 4, then they are, at most, subtle. More importantly, White et al 
(1997) noted large interindividual differences in the overall extent of areas 3 and 4. 
Another explanation for my negative result could be an inadequate assessment of 
handedness and thus relative heterogeneity of the right-handed groups: time constraints 
made it impractical to administer a comprehensive handedness/footedness 
questionnaire, such as the Waterloo Handedness and Footedness Questionnaire (Elias 
et al 1998), Annett’s handedness questionnaire (Annett 1970) or the Edinburgh 
Handedness Inventory (Oldfield 1971). Nevertheless, hand used for writing correlates 
substantially (in Western populations) with laterality scores, “foot used to kick ball” 
was largely consistent with handedness self-reports and furthermore I excluded 
subjects who were not spontaneously right handed.
Conclusion
These data replicate many well established post mortem and in vivo findings of 
human brain structural asymmetry, Whilst expanding on the regional details. The use of 
large numbers of subjects in this study permitted the examination of relatively subtle 
asymmetry and sex effects, although surprisingly, I did not detect any brain structural 
correlate of handedness. Significantly, these data have been characterised with a fully 
automated whole brain technique that avoids the subjectivity of region of interest 
approaches. VBM is thus emerging as a powerful unbiased technique for evaluating 
human brain structure in life, with important implications for the exploration of 
structural correlates of normality and disease.
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CHAPTER 5 
CLINICAL GROUPS 
DEMENTIA
Guide to Reader
In this study voxel-based morphometry (VBM) is compared rigorously with the 
current “gold standard” morphometric technique namely independent accurate region 
of interest (ROI) measurements in order to validate VBM in the clinical setting. I have 
chosen two distinct forms of dementia that have been characterised extensively in the 
histopathological and neuroimaging literature so that VBM can be compared with 
“established” knowledge. In this sense VBM findings can be judged for biological 
plausibility and construct validity (comparison with the most commonly used 
morphometric method) in two forms of neurodegeneration exhibiting different patterns 
of cortical and deep grey matter atrophy.
Introduction
The gold standard for in vivo quantitative assessment of patterns of brain 
atrophy in health and disease is currently ROI-based. However, ROI measurements are 
laborious and time consuming. They do not accommodate changes at sites distant to 
the ROI and thus may be inherently biased (in spatial terms). In addition, ROI 
measurement errors are likely to be greater for smaller structures with complex 
architectures, particularly if anatomical borders are defined by arbitrary criteria. These 
assessments may thus be subject to wide inter- rater and intra- rater variability unless 
performed by dedicated experts where reproducibility is in the order of 5% (Chan et al. 
2001). For these reasons, ROI-based morphometries cannot provide comprehensive 
structural assessments of the entire brain and results are difficult to replicate and 
compare between laboratories. A fully automated whole brain technique such as voxel- 
based morphometry (VBM) avoids many of the constraints of ROI analyses, but it 
incorporates a series of pre-processing steps that may potentially complicate the simple
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interpretation of regional changes in terms of grey matter loss. VBM therefore needs to 
be rigorously assessed and compared with the best techniques currently available.
In this study VBM is compared with accurate and reproducible region of 
interest (ROI) morphometries (Chan et al 2001) in two groups of patients with 
clinically and neuroradiologically distinct features. Alzheimer’s disease (AD) is a 
diffuse neurodegenerative process characterised by the insidious onset of episodic 
memory impairment, gradually progressing to global cognitive impairment. In the 
early stages of the disease, imaging reveals predominantly mesial temporal atrophy (de 
Leon et al 1993; de Leon et al 1995; Fox et al 1996c; Fox et al 1996b; Killiany et 
al 1993) as shown in two earlier VBM studies (Baron et al 2001; Rombouts et al
2000), progressing to generalised cortical atrophy in the advanced stages (Chan et al
2001). Frontotemporal lobar degeneration (FTLD) is associated with three syndromic 
variants: frontotemporal dementia, semantic dementia (SD) and progressive non­
fluent aphasia. Semantic dementia presents with semantic memory impairment in the 
context of preserved episodic memory (Snowden and Goulding 1989; Warrington 
1975). Typically SD patients have fluent speech with normal articulation and prosody 
and relative preservation of syntax. Other features include surface dyslexia, dysgraphia 
and impaired object recognition. In contrast to AD, neutoimaging in SD reveals 
striking asymmetric temporal lobe atrophy, more marked on the left (dominant) side 
with particular involvement of the anteroinferior and anteromedial temporal structures.
The aims of this study were firstly to compare VBM with the best available 
equivalent of a gold standard, namely reproducible ROI measurements of temporal 
lobe structures (Chan et al 2001) in these disease groups; and secondly to report the 
overall patterns of grey and white matter atrophy as detected by VBM in these two 
distinct disease groups. Ideally I would have liked to compare gyrus for gyrus across 
the whole brain and not limit comparisons to arbitrarily defined temporal regions of 
interest, but the practical limitations of obtaining accurate reproducible independent 
ROI measurements constrained my study design. In order to confirm the exact 
reproducibility of the VBM method with different operators, VBM was performed 
independently in two different imaging laboratories.
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Methods
Subjects
Patients were recruited from the Cognitive Disorders Clinic at the National 
Hospital for Neurology and Neurosurgery, London. Ten moderately affected patients 
with probable sporadic Alzheimer’s disease (AD), diagnosed according to NINCDS- 
ADRDA criteria (McKhann et al 1984) were included in the study. The second patient 
group consisted of ten subjects who fulfilled criteria for the diagnosis of semantic 
dementia (Hodges et al. 1992; Hodges et al 1998; Neary et al 1998). In addition to 
comprehensive neuropsychological assessment by the Dementia Unit (ION, UCL), all 
patients underwent routine laboratory investigations for dementia. The two patient 
groups were matched for severity according to the Mini Mental State Examination 
(Folstein et al 1975). An age and sex-matched group often individuals who had 
undergone MRI and neuropsychological assessments were selected from our group of 
normal controls.
The demographics of the subject groups are provided in Table 1. All subjects 
gave consent both for the MRI scan, and for participation in longitudinal research 
studies, which had the approval of the Local Research Ethics Committee of the 
National Hospital for Neurology and Neurosurgery (NHS Trust) and the Institute of 
Neurology (UCL).
Brain Imaging
T1-weighted, volumetric SPGR MRI scans were performed on a 1.5 Tesla 
Signa unit (General Electric, Milwaukee) yielding 124 contiguous 1.5 mm coronal 
slices through the head with a 256 x 128 image matrix (acquisition parameters: 
FOV/TR/TE/NEX/FLIP -  24/35/5/1/35°). Axial dual-echo sequences (T2- and proton 
density-weighted) were also acquired for diagnostic neuroradiological evaluation.
Voxel based morphometry
VBM was replicated independently by two researchers on two sites (myself 
and RS) using the optimised method as detailed in Chapter 2. Processing components 
pertinent to this study will be emphasised here.
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Customised templates
Customised grey and white matter and CSF templates were created from the 
study group (30 subjects). This involved spatially normalising all the structural scans 
to the SPM T1 template, segmenting each normalised image into grey and white matter 
and CSF compartments and smoothing each grey and white matter segment with an 
8mm FWHM smoothing kernel. Finally all the smoothed segments were averaged to 
create grey and white matter and CSF templates respectively.
Segmentation
Scan-rescan reproducibility for the optimised VBM segmentation technique 
yields coefficients of variation (100*sd/mean) of 0.41%, 0.59%, 1.07% and 0.17% for 
grey matter, white matter, CSF and total intracranial volume (TIV) respectively, 
scanning 10 subjects twice on the same day (Good et al., 2001). In order to facilitate 
optimal segmentation of elderly patient and control MRI scans, I used our customised 
grey and white matter and CSF templates as prior probability maps (priors). I then 
compared segmentation with the customised priors versus default priors, which are 
based upon MRI brain scans from young healthy subjects.
Smoothing
All segments were smoothed with a 10mm FWHM isotropic Gaussian kernel. 
After smoothing, each voxel represents the local average amount of grey (or white) 
matter in the surrounding region, the size of which is defined by the size of the 
smoothing kernel.
Global volume statistical Analysis
Global volumes of grey matter, white matter, CSF and whole brain (grey plus 
white matter) were normalised to the TtV and ehtered into an analysis of variance 
(ANOVA) between the three subject groups. In addition, Tukey posthoc analysis was 
employed to determine the significance of mean differences between group pairs, 
using SPSS version 9.0 (SPSS Inc., Chicago, Illinois, USA).
VBM statistical analysis:
The smoothed data were analysed using MATLAB 5.3 (MathWorks, Natick, 
Mass., USA) and statistical parametric mapping (SPM99) employing the framework of 
the General Linear Model. Regionally specific differences in grey and white matter
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were assessed statistically using a two-tailed test, namely testing for increases or 
decreases in grey (or white) matter. In order to match the ROI analyses more closely 
(ROI analyses measured only temporal lobe structures), significance levels for 
temporal lobe structures were set at p<0.05, corrected for temporal lobe volume which 
was chosen arbitrarily as a rectangle of dimensions 40mm x 60mm x 40mm, providing 
a volume of 0.1 litre (a generous estimate of temporal lobe volume - ROI analyses 
measured the left and right temporal lobe volumes as approximately 0.07 litres each 
(Chan et al 2001)). Significance levels for extra-temporal structures were set at 
p<0.05 corrected for the whole brain volume.
Voxel-wise analyses of grey and white matter were performed separately using 
three group effects (AD, SD and controls) with age and sex as confounding covariates. 
VBM analyses aim to find regionally specific changes that cannot be explained by 
global or distributed changes. To characterise the dependency of our changes on the 
global effect analyses were replicated three times using three methods of global 
modelling (i) total grey (or white) matter (TGWM) as a confounding covariate, (ii)
TIV as a confounding covariate and (iii) no global confounding covariate. Clearly the 
TGWM and TIV reflect different aspects of global difference. TIV was calculated 
before spatial normalisation.
In order to compare VBM statistical parametric maps generated from images 
segmented with customised and default priors I constructed a separate design matrix. 
Conditions included 1) controls (default priors), 2) controls (customised priors), 3 AD 
(default priors) and 4) AD (customised priors). Global grey matter, age and sex were 
modelled as confoundiiig covariates.
Comparison o f  ROI and VBM methods
The T statistics from the two techniques were correlated, providing plots and 
correlation coefficients.
Region o f  interest volumetric measurements
Medical Image Display and Analysis Software (MIDAS) was used for 
segmentation and volumetric analysis (Freeborough et a l 1997). The reproducibility 
error for ROI measurements was expressed as a coefficient of variation (100*sd/mean) 
for repeat measurements performed by the same rater at different times.
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Whole brain and total intracranial volume
Whole brain segmentation (MIDAS) was performed using a semi-automated 
procedure that applies thresholding and a series of erosions and dilations to delineate 
brain tissue. TIV was used as an estimate of maximum pre-morbid brain size. TIV was 
measured using T2-weighted scans according to the technique described by (Jenkins et 
al 2000) with a coefficient of variation of less than 1%.
Regions of interest (ROI)
ROI measurements were performed by Dennis Chan and Rachael Scahill 
(Dementia Research Unit, ION) according to previously described techniques and 
anatomical landmarks (Chan et al 2001). The regions included whole temporal lobe, 
amygdala, hippocampus, entorhinal cortex, fusiform gyrus, parahippocampal gyrus, 
superior temporal gyrus and the combination of inferior and middle temporal gyri. The 
coefficients of variation (100*sd/mean) were 1.9%, 2.9%, 2.1%, 4.1%, 2.5%, 3%,
1.7% and 4.3% respectively. The entorhinal cortex (EC) region did not include the 
medial bank of the collateral sulcus owing to the interindividual variation in the 
position of the lateral border of the EC. Apart from the EC region, which contained 
only grey matter, all other regions contained a combination of grey and white matter. 
All volumetric measurements were corrected for head size by normalising to TIV.
Results
Global differences in whole brain, grey and white matter
ANOVA (summarised in Table 5.1) revealed significant differences in 
normalised global volumes (relative to TIV) of whole brain (p<0.001), grey matter 
(pO.OOl) and CSF (pO.OOl) across the three groups, but not for white matter. Post 
hoc analysis revealed significant decreases (pO.OOl) in normalised global grey matter 
and whole brain volumes in SD and AD compared with controls. There was no 
significant difference in normalised global grey matter, white matter or whole brain 
volumes between SD and AD. There was no significant difference in normalised 
global white matter volume in SD or AD compared with controls. There were 
differences in the absolute and normalised measurements of whole brain volume 
between the frilly automated VBM and semi-automated MIDAS techniques, but only 
minimal differences in ANOVA and post hoc probabilities (Table 5.1).
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Table 5.1: Global volumes
Control AD SD ANOVA
Male/female 5/5 6/4 6/4
Handedness 9/1 9/1 9/1
MMSE score 
(max = 30)
29.8 (0.4) 21.2 (5.0) 21.8(4.9)
Age 60(6) 63(6) 60(8) 0.420
Global grey 
matter 0.685 (0.060) 0.610(0.075) 0.588 (0.049) 0.005
(VBM)
%TIV 49% 44% 45% <0.001u
Global white 
matter 
(VBM) 
%TFV
0.406 (0.051) 
29%
0.412(0.053)
30%
0.383 (0.066) 
29%
0.66
0.38
CSF
(VBM)
%TIV
0.293 (0.038) 
21%
0.362 (0.050) 
26%
0.347 (0.059) 
26%
0.014
O.OOl1,2
TIV (VBM) 1.385 (0.136) 1.384 (0.166) 1.318(0.164) 0.56
TIV (MIDAS) 1.427 (0.182) 1.411 (0.182) 1.368 (0.148) 0.62
Whole Brain 
(VBM) 
%TIV
1.091 (0.106) 
79%
1.022 (0.123) 
74%
0.971(0.110)
74%
0.078 
<0.00 l u
Whole Brain 
(MIDAS) 
%TIV
1.190 (0.117) 
84%
1.096 (0.135) 
78%
1.064 (0.133) 
78%
0.096 
0.0031,2
All volume measurements in litres (mean (SD)) TIV= total intracranial volume
MIDAS= Medical Image Display and Analysis Software 
ANOVA= analysis of variance
Posthoc analysis: 1 significant difference between control and AD, pO.OOl
2 significant differences between control and SD, p< 0.001
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Temporal lobe structures: a comparison o f  VBM and ROI
Tables 5.2 and 5.3 summarise VBM and ROI comparisons of temporal lobe 
structures for AD and SD respectively. Figure 5.1 (a, b) demonstrates VBM detected 
atrophy, having covaried out changes in TIV, in AD and SD projected onto a mean 
normalised image.
In AD, VBM detected most significant grey matter reduction in the right 
middle temporal gyrus, followed by relatively symmetrical reduction along the lengths 
of both hippocampi, right fusiform gyrus, left middle temporal gyrus, left superior 
temporal gyrus, right superior temporal gyrus and left fusiform gyrus (Figs 5.1a and 
5.7a (in red)). Only the right middle temporal gyrus voxels were significant at p<0.05, 
corrected. The remainder did not survive correction for multiple comparisons. VBM 
detected least significant grey matter reduction in the entorhinal cortices, amygdalae 
and the anterior temporal poles. These findings differed from the ROI analyses, which 
detected most significant volume reductions in the amygdalae, right middle and 
inferior temporal gyrus, entorhinal cortices and left posterior hippocampus, all of 
which survived Bonferroni correction (see Table 5.2 for p values and T statistics).
In SD, VBM detected most significant grey matter reduction in the left 
amygdala followed by left anterior and middle hippocampus and left entorhinal cortex 
(Figs. 5.1b and 5.7b (in red)). The pattern of grey matter loss was strikingly different 
from the AD pattern. There was an anteroposterior gradient of grey matter reduction in 
the left and to a lesser extent right hippocampus. The right-sided structures were less 
reduced than the left, aiid the most severely affected right-sided structure was the 
amygdala. VBM detected a greater significance of grey matter loss in all temporal lobe 
structures, apart from the right middle temporal gyrus, in SD than AD.
ROI analyses showed a very similar pattern of volume loss, with most 
significant volume reduction in the left amygdala, followed by the left middle and 
inferior temporal gyri, left entorhinal cortex and right amygdala (see Table 5.3).
A comparison of ROI and VBM detected volume reductions in the anterior, 
mid and posterior hippocampus are plotted in Figure 5.2 and entorhinal cortex in 
Figure 5.3. The correlation coefficients (and their significance) for anterior, mid and 
posterior hippocampus were 0.28 (p=0.1), 0.574 (p=0.001) and 0.286 (p=0.125) 
respectively. Qualitatively, VBM shows slightly better separation of hippocampal data 
between the groups compared to ROI. For the left and right entorhinal cortices, the
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correlation coefficients and their significance were 0.724 (pO.OOl) and 0.490 (p=0.06) 
respectively.
Table 5.2: Alzheimer’s disease
A lzh eim er’s D isease
VBM ROI
(grey matter) (total volume)
Location T (1,26) p T (1,26) p
R MTG/MITG 5.3 0.000* 3.5 0.001*
L hippocampus (*total vol) 4.0 0.001*
anterior 4.1 0.000 0.6 0.262
mid 4.4 0.000 3.0 0.004
posterior 4.2 0.000 3.4 0.002*
R hippocampus (4total vol) 3.4 0.004*
anterior 4.0 0.000 2.8 0.006
mid 4.3 0.000 1.4 0.085
posterior 3.1 0.002 1.6 0.064
R fusiform 4.1 0.000 0.7 0.255
L MTG/MITG 3.8 0.000 2.3 0.018
LSTG (lateral) 3.8 0.000 1.1 0.139
R STG (lateral) 3.6 0.001 0.5 0.317
L fusiform 3.4 0.001 1.4 0.086
R entorhinal 3.1 0.002 3.4 0.002*
L entorhinal 3.0 0.003 3.4 0.002*
RITG 3.0 0.003 not measured
LITG 3.0 0.003 not measured
L anterior temporal pole 2.2 0.019 not measured
(anterior STG)
R amygdala 2.32 0.014 3.6 0.001*
L amygdala 2.12 0.022 3.9 0.001*
R anterior temporal pole — — not measured
(anterior STG)
* significant, pO.05, corrected for temporal lobe volume (VBM) or Bonferroni 
corrected (ROI)
ITG= inferior temporal gyrus (VBM only)
MTG/MITG = middle temporal gyrus (VBM)/middle and inferior temporal gyri (ROI) 
STG = superior temporal gyrus (4total volume): ROI measured total volume of 
hippocampus anatomically, and sub-regions as anterior, middle and posterior thirds.
122
Table 5.3: Semantic dementia
Sem antic D em entia  
VBM ROI
T P
T P
L amygdala 13.3 0.000** 13.1 0.000**
L hippocampus (* total vol) 5.8 0.000**
anterior 12.3 0.000** 1.8 0.047*
mid 10.2 0.000** 3.7 0.001**
posterior 7.7 0.000** 1.6 0.065*
L entorhinal 9.5 0.000** 10.6 0.000**
L fusiform 7.9 0.000** 6.7 0.000**
R amygdala 7.7 0.000** 8.4 0.000**
LITG 7.1 0.000**
L anterior temporal pole 6.44 0.000** not measured
(anterior STG)
R hippocampus (* total vol.) 3.9 0.001
anterior 6.42 0.000** 3.1 0.003
mid 5.41 0.000** 0.8 0.203
posterior 5.04 0.000** 0.4 0.360
L MTG/MITG 6.37 0.000** 10.9 0.000**
L STG (lateral) 6.2 0.000** 6.1 0.000**
R fusiform 4.5 0.000 2.7 0.007
R MTG/MITG 4.31 0.000 4.5 0.000*
RITG not measured
R entorhinal 4.0 0.000 5.9 0.000*
R STG 3.8 0.000 4.1 0.000**
(lateral)
R anterior temporal pole 3.6 0.001* not measured
(anterior STG)
* significant, p<0.05 corrected for temporal lobe volume (VBM) or Bonferroni 
corrected (ROI)
* significantly more atrophy in SD than AD, p<0.05 corrected 
ITG= inferior temporal gyrus (VBM only)
MTG/MITG = middle temporal gyrus (VBM)/middle and inferior temporal gyri (ROI) 
STG = superior temporal gyrus
(* total volume): ROI measured total volume of hippocampus anatomically, and sub- 
regions as anterior, middle and posterior thirds
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Figure 5.1a: Grey matter atrophy in AD
VBM detected regions of temporal grey matter loss in AD (threshold T> 2 for 
illustrative purposes only) projected over coronal slices of the normalised group mean 
image. TIV was included as a confounding covariate.
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Figure 5.1b: Grey matter atrophy in SD
VBM detected regions of temporal grey matter loss in SD (threshold T> 2 for 
illustrative purposes only) projected over coronal slices of the normalised group mean 
image. TIV was included as a confounding covariate.
125
Figure 5.2: Hippocampal volumes
Scatter plots of left anterior (a), middle (b) and posterior (c) hippocampal volume 
detected by ROI on the y-axis and VBM on the x-axis. VBM measures grey matter 
volume (mm3) within a single voxel (1.5mm3) placed in the left anterior, middle and 
posterior hippocampus respectively. ROI measures total volume (predominantly grey 
matter) for each section of the hippocampus normalised to TIV. The groups are colour 
coded: blue (SD), green (AD) and red (controls). Volume loss is most marked in SD and 
the separation of the groups appears best with VBM.
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Figure 5.3: Entorhinal cortex volume
Scatter plots of right (a) and left (b) entorhinal cortex volume detected by ROI on the y- 
axis and VBM on the x-axis. VBM measures grey matter volume (mm3) within a single 
voxel (1.5mm3) placed in the right and left entorhinal cortex respectively. ROI measures 
total volume (predominantly grey matter) for right and left entorhinal cortex normalised 
to TIV. The groups are colour coded: blue (SD), green (AD) and red (controls). Volume 
loss is most marked in SD.
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In order to more formally compare the automated technique with the accepted 
gold standard, I plotted the T statistics for ROI and VBM measurements of temporal 
lobe structures (Fig. 5.4). In AD, ROI measurements appear more sensitive for the 
volume loss in the amygdala, whereas VBM measurements appear more sensitive for 
volume loss in both superior and right middle temporal gyri, both fusiform gyri and 
regional hippocampal volumes (right mid and posterior hippocampus, left anterior 
hippocampus). The correlation between the two techniques was not significant (r= -  
0.25 (p=0.341)) In SD; ROI measurements appear more sensitive for volume loss in 
the left MITG whereas VBM appears more sensitive to regional hippocampal atrophy. 
The correlation between the two techniques was good apart from the hippocampal 
differences, which reflect in the correlation coefficient (r=0.28 (p=0.29)). It is worth 
noting that the correlation appears higher for higher T statistics (as in SD) and lower 
for lower T statistics (as in AD).
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Figure 5.4: Correlation of T statistics for ROI and VBM
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Comparison of segmentation using customised priors and default priors
A qualitative comparison of grey matter segments derived from segmentation 
using customised versus default priors revealed only minor differences with no clear 
improvement using customised priors. Inspection also revealed sub optimal 
classification of grey and white matter in the mesial temporal lobes in one elderly 
control, one patient with SD and three patients with AD. Figure 5.5 demonstrates 
segmented grey matter images derived from the standard SPM priors (a) and the 
customised priors (b) in one of the AD patients with sub optimal classification of grey 
and white matter in the anteromesial temporal lobe.
Formal VBM statistical comparison revealed no interaction between the choice 
of priors and differences between controls and AD patients, but did reveal a significant 
main effect of priors that was seen separately in the control and AD groups. In a 
comparison of default priors - customised priors there was a large cluster of significant 
voxels within the pons (Fig. 5.6a) (p<0.05, corrected) and additional voxels extended 
throughout the cingulate gyrus at a lower threshold (pO.OOl, uncorrected) (Fig. 5.6b). 
Conversely, there were no significant voxels in the customised priors -  default priors 
contrast for either control or AD groups (Fig. 5.6b). There were also subtle differences 
in the T scores of the maxima when looking at SPMs of control -  AD groups for 
customised and default priors with customised priors yielding higher T scores (Table 
5.4). These findings suggest that customised priors allow more precise classification 
and registration of voxels within healthy and diseased subjects.
Table 5.4: Maxima for control -  AD
Customized priors Default priors
Location Coordinates T p, corrected T p, corrected
L parietal -56 -66 33 8.08 <0.000 7.00 <0.000
Post -2 -58 28 7.14 <0.000 7.17 <0.000
cingulate
R parietal 58 -60 36 6.85 <0.000 6.245 <0.000
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Figure 5.5: Effect of priors on segmentation
Segmented grey matter image derived from a) default SPM prior probability maps and 
b) customised disease-, age- and sex-matched prior probability maps. There is little 
qualitative difference in tissue classification between the two methods despite the 
theoretical advantage offered by customised priors.
Default SPM priors
Customised disease and age matched priors
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Figure 5.6ab: Statistical comparison of customised and default priors.
Main effect of priors within the control group: default priors -  customised priors. 
Significant voxels (P<0.05, corrected (a) within the pons and p<0.001, uncorrected (b) 
extending along the cingulate gyrus are projected over a single scan in stereotaxic space. 
The crosshairs represent the maximum and the colour bar represents the T score. 
Conversely in the comparison customised priors -  default priors no significant voxels 
were detected
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Additional VBM findings not assessed in the ROI analysis
Extra-temporal grey matter
Figures 5.7 and 5.8 show the VBM detected patterns of grey matter reduction 
in AD and SD and highlight the differences between the grey matter analyses with no 
global covariate (5.7a, 5.8a), TIV as a covariate (5.7b, 5.8b) and grey matter mean 
global volume as a covariate (5.7c, 5.8c).
In AD, VBM detected a relatively diffuse and symmetrical pattern of grey 
matter loss, most prominent in the parietal lobes and posterior cingulate cortex. When 
the mean global grey matter was modelled as a confounding covariate in order to 
determine regionally specific patterns of loss within the grey matter compartment 
itself, significant atrophy was seen in the parietal lobes, posterior cingulate cortex, 
caudate nuclei and thalami and not in the anteromesial temporal structures (Fig. 5.7c).
Figure 5. 7a: C-AD (no global covariate)
VBM detected grey matter atrophy in AD. With no global covariate there is distributed
volume loss in the temporal, parietal and frontal lobes
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Figure 5.7b:C-AD (TIV)
VBM detected atrophy in AD. With TIV as a covariate to remove any head size 
differences, there is a similar pattern of atrophy to Fig. 5.7a with distributed volume loss 
in the temporal, parietal and frontal lobes (see Table 5.2 for full details)
Figure 5.7c: C-AD (grey matter globals)
VBM detected atrophy in AD. With global grey matter volume as a covariate, areas of 
volume loss more than global loss are being detected. Here, most significant volume 
loss is seen in the parietal cortices and posterior cingulate
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In SD, VBM detected asymmetric regional temporal lobe atrophy, with only 
minimal atrophy in frontal cortex. The pattern of grey matter reduction was similar, 
irrespective of the inclusion or exclusion of a global covariate (TIV or mean global 
grey matter), the main difference being the detection of perisylvian grey matter and 
cingulate reduction when no global covariate was included.
There were no significant regional increases of grey and white matter in AD 
and SD relative to controls.
Figure 5.8a: C-SD (no global covariate)
VBM detected grey matter atrophy in SD. With no global covariate there is asymmetric 
regional volume loss in the temporal lobes, particularly on the left side. Volume loss is 
also noted in the anterior cingulate, left thalamus and caudate nucleus.
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Figure 5.8b:C-SD (TIV)
VBM detected atrophy in SD. With TIV as a covariate, head size differences have been 
removed. The pattern of atrophy is similar to Fig. 5.8a with atrophy most pronounced in 
the temporal lobes (L>R)
Figure 5.8c: C-SD (grey matter globals)
VBM detected atrophy in SD. With global grey matter volume as a covariate areas of 
volume loss more than global loss are being detected. The pattern of atrophy remains 
most pronounced in the temporal lobes (L>R)
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White matter reduction
In AD, VBM (with TIV as a covariate) detected a relatively symmetric pattern 
of white matter reduction (in the subcortical white matter around the insula, in the 
parietal lobes, in the peritrigonal white matter and in the columns of the fornix. 
Regionally specific white matter reduction (after covarying out global white matter 
changes) was observed in the periventricular white matter, especially around the lateral 
ventricles and diffusely within the corpus callosum. VBM detected apparent increases 
in white matter in misclassified thalamic and caudate voxels (see discussion). In SD, 
VBM (with TIV as a covariate) detected asymmetric regional reduction in the temporal 
white matter, particularly on the left side (Fig. 5.9b in blue) and asymmetric atrophy of 
the periventricular white matter and corpus callosum, particularly on the left side. 
Similar changes were observed after covarying out global white matter changes.
CSF change
In AD, VBM detected increased CSF in the Sylvian fissures (Fig. 5.9a in 
green), interhemispheric fissures, lateral ventricles and collateral sulci (right more than 
left). There were no regions of decreased CSF.
In SD, VBM detected asymmetric (left > right) increased CSF in the Sylvian 
fissures, collateral sulci, temporal horn and hippocampal fissure, around the temporal 
poles, in the body of the left lateral ventricle and in the interhemispheric fissure (Fig. 
5.9b in green). There were no regions of decreased CSF.
As expected with an automated technique, the VBM analyses performed 
independently by the different researchers on different sites gave identical results.
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Figure 5.9: Atrophy patterns in AD and SD
A comparison of patterns of atrophy in AD (a) and SD (b) projected over a single 
temporal coronal slice. Grey matter atrophy is depicted in red, white matter atrophy in 
blue and CSF enlargement in green (p<0.001 uncorrected)
a) AD b) SD
Discussion
Comparison o f  VBM and independent ROI data fo r  temporal lobe structures
While ROI volumetric analyses and VBM are not directly comparable, this 
paper attempts to validate the automated VBM method against manual volumetric 
measurements of temporal lobe regions in two diseases with very different patterns of 
atrophy. The ROI analyses measured differences in regional volume of brain structures 
(normalised to TIV) in the temporal lobes only whereas VBM detected regional 
differences in grey and white matter on a voxel by voxel basis throughout the brain. 
The atrophy outside the temporal lobes detected with VBM could not be directly 
related to the ROI analyses, which only measured temporal lobe structures. The TIV 
and whole brain volumes were slightly smaller when measured with VBM compared 
with MIDAS. These differences were not unexpected and probably relate to partial 
volume corrected labelling based upon prior probabilities and the explicit removal of 
non-brain voxels in the former and intensity thresholding with whole voxel 
inclusion/exclusion in the latter. It is well known that measurements of segmented 
brain volumes can vary quite considerably depending upon the segmentation technique
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used. What is more important is that they are reproducible, as is the case for both the 
MIDAS and SPM segmentation techniques.
Looking specifically at temporal lobe atrophy, there were similarities and 
differences between the VBM and ROI results. In AD, the difference between the two 
morphometry techniques was most marked for ranking atrophy severity. ROI analyses 
appeared more sensitive to volume loss in the amygdalae whereas VBM analyses 
appeared more sensitive to right middle temporal gyrus and regional hippocampal 
volume loss. The T scores were generally higher for VBM than ROI, but the stringent 
correction for multiple comparisons in the less constrained VBM produced less 
significant corrected p values. This is not a failing of VBM, rather it emphasises the 
need to examine the data under less stringent correction thresholds.In AD, where the T 
scores were generally lower than SD, VBM only detected significant (corrected) 
volume loss in the right MTG whereas ROI analyses showed significant (corrected) 
volume loss in many more temporal structures (the amygdalae, right middle and 
inferior temporal gyri, entorhinal cortices, total hippocampi and left posterior 
hippocampus). In SD, the T scores were generally higher than in AD and there was 
relatively good correlation between the two techniques, but there were slight 
differences in the relative significance of changes. ROI analyses appeared more 
sensitive to left middle and inferior temporal gyrus volume loss whereas VBM 
appeared more sensitive to regional hippocampal volume loss. The areas of 
consistency between the two techniques are reassuring. For areas of inconsistency the 
questions therefore are: which is the more accurate measurement, and why? There is 
no simple answer to these questions, but an understanding of how temporal lobe 
structures were measured by each technique, will identify potential sources of 
discrepancy.
VBM measurements
VBM consists of a number of automated morphological operations, thus the 
cause of regionally significant differences can potentially enter at each step. Although 
these operations are complicated they render the data more directly related to the 
anatomical metric of interest (e.g. grey matter volume). It is important to realise, 
however, that changes in local grey matter volume can have a number of causes that 
include (i) loss of grey matter (e.g. cortical atrophy), (ii) disproportionate increases in 
brain volume (e.g. hydrocephalus) and (iii) displacement of grey matter from its
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normal location (e.g. tumour). To attribute significant results to atrophy, other 
potential causes must be discounted by considering their interaction with spatial 
normalisation and segmentation.
Spatial normalisation
The spatial normalisation step aims to map each structural MRI to a template in 
standard stereotaxic space. The customised templates were created from all the patients 
and controls in order to minimise the degree of non-linear warping required. The non­
linear spatial transformations used in this study do not attempt to match every gyrus in 
the brain exactly; rather the goal is to discount global brain shape differences (i.e. 
displacement of grey matter from its normal location). A number of potential 
systematic differences can arise from misregistration during the spatial normalisation 
step. For example, the patient group may have systematic differences in the relative 
intensity of grey matter voxels compared to white matter, or may be subject to more 
motion artefact. Differences in spatial normalisation accuracy have not yet been 
formally studied, and certainly there is the potential for greater errors in the patient 
group leading to non-sphericity problems, although these can be corrected. It is 
important to note that inaccuracies in spatial normalisation cannot introduce bias or 
false positives per se. Even if there are brain structures that are difficult to normalise, 
any differences detected by VBM must be caused by systematic differences in the 
anatomy of these structures. By using more accurate spatial normalisation, VBM 
detected differences between patients and controls could be more directly attributed to 
volumetric differences in grey matter however, a method with enough freedom to warp 
one image perfectly to another is not necessarily a better option. More degrees of 
freedom incur more potential local minima, so that while the images may be globally 
well matched, gyral and sulcal correspondence is not necessarily precise (Ashbumer 
and Friston 1999; Ashbumer and Friston 2000; de Leon et al 1993; de Leon et al 
1995).
Small structures such as the amygdala, hippocampus and entorhinal cortex, not 
only have a complex architecture, but may also be highly variable between subjects on 
visual inspection, particularly in elderly and diseased subjects. This regional variance 
has implications for the sensitivity of any morphometric technique to detect changes. 
VBM may be relatively insensitive to subtle atrophy in regions of high variance in the 
studied population whilst more sensitive to atrophy in regions of low variance.
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However, SPM employs a voxel-wise estimate of variance. VBM has previously 
demonstrated subtle changes within the anterior and posterior hippocampus in a group 
of taxi-drivers, that corroborated independent accurate ROI measurements and 
functional data (Maguire et al 2000), suggesting that this technique can register and 
segment small structures with some degree of accuracy in normal subjects. 
Furthermore, VBM detected anteromesial temporal lobe atrophy, including the 
hippocampi, amygdalae and entorhinal cortex in early Alzheimer’s disease (Baron et 
al 2001; Rombouts et al 2000), bilateral hippocampal atrophy in children with 
hypoxic ischaemic damage (Salmond et a l 2000) and reductions in left hippocampal 
grey matter density in chronic unipolar depression, that correlated with verbal memory 
scores (Shah et al 1998). More importantly VBM can separate normals from subjects 
with mild cognitive impairment (Chetelat et al, 2002) who show grey matter loss in 
the hippocampi and cingulate gyrus.
By incorporating a modulation step to the VBM analysis (Ashbumer and 
Friston 2000; Ashbumer and Friston 2001) information is added from the deformation 
fields generated during spatial normalisation themselves to render the VBM analyses 
more similar to ROI analyses. This is because each voxel in a modulated smoothed 
segment of tissue contains a count of absolute amount of grey matter in a “region of
i
interest” defined by the smoothing kerhel. Since I have incorporated this correction for 
volume change induced by spatial normalisation, it is appropriate to include TIV as a 
confounding covariate to remove any variance due to differences in head size. Without 
the modulation step, spatial normalisation removes differences in head size and thus 
TIV does hot need to be included as a confounding covariate.
Segmentation
Diseased brains are a challenge for any automated or manual segmentation 
technique. In AD and SD and to a lesser extent elderly controls, there are two 
particular problems. Firstly the brains are atrophic. In regions of atrophy, there is more 
potential for partial volume effect between grey matter and CSF, and consequently 
voxels may be misclassified. However this does not matter in terms of inferring 
regional change, it only affects the attribution of change in terms of the tissue class 
affected. Misclassification can be reduced by using high-resolution scans with small 
voxel size, preferably isotropic 1mm3. In this study the voxels were anisotropic: 
lmmxlmmx 1.5mm. Secondly, and probably more importantly, pathology (and to a
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lesser extent ageing) may be associated with signal change and a reduction in the 
grey/white matter contrast, and this was particularly true for the temporal lobes in AD 
and SD: In AD I observed apparent increases of white matter in the thalami and 
caudate nuclei. This may in part reflect misclassification of grey matter voxels, which 
can be seen on inspection of grey and white matter segmented images. The default 
SPM prior probability maps are based on MRIs from young normal subjects, which 
differ quite markedly from MRIs of elderly and diseased subjects. I therefore used 
customised age and disease matched priors and demonstrate that these allow improved 
classification of voxels, particularly in the brainstem and cingulate gyrus and higher T 
scores for statistical inferences compared with default priors.
Smoothing
The final step of VBM pre-processing is smoothing with an isotropic Gaussian 
kernel. This makes the subsequent voxel-wise analysis comparable to a region of 
interest approach, since each voxel in a smoothed, normalised, modulated grey matter 
image contains the average amount of grey matter within a region (defined by the 
smoothing kernel) surrounding that voxel. The size of the smoothing kernel should be 
comparable to the size of the expected regional differences between groups, but there 
is a trade-off between localisation accuracy and the number of independent 
comparisons between the resulting ‘resolution elements’ (RESELS) performed. If the 
objective is to increase sensitivity so that correction for multiple comparisons is less 
severe, then more smoothing must be used. If the objective is for localisation accuracy 
a smaller smoothing kernel should be used, although this will provide less 
compensation for inexact spatial normalisation. I used a 10mm smoothing kernel as the 
best compromise. I also tested the data with a 6mm smoothing kernel, and obtained 
almost identical results. In small adjacent brain regions such as the amygdala and 
entorhinal cortex, localisation accuracy may become an issue: a voxel may reflect a 
composite average from both regions which could explain why expertly defined ROI 
measurements are more sensitive than VBM in these small structures in AD.
Regional changes due to displacement of tissue
VBM detects changes in grey, white and CSF compartments. If the interfaces 
between compartments move due to mass effect or volume loss, the changes can be 
reflected in both compartments. For example, in conditions associated with ventricular
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enlargement (physiological such as ageing, or pathological such as AD and SD), VBM 
shows changes in the CSF and white matter compartments. This does not necessarily 
imply white matter atrophy, and inspection of the original structural images, as well as 
the segmented images will help determine whether a structure is truly altered in 
volume, or merely displaced. It is therefore helpful to the interpretation of VBM results 
to perform analyses of all three tissue compartments. In AD and SD I observed 
apparent decreases in white matter volume in the corpus callosum and periventricular 
regions. Inspection of the structural images shows ventricular enlargement, and in 
many cases thinning of the corpus callosum. I conclude, that in this patient group, 
some of the white matter changes are real, but some could reflect ventricular 
enlargement. A similar effect is noted in the white matter adjacent to the enlarged 
Sylvian fissures, which probably reflects a boundary shift.
ROI Measurements
ROI measurements were manually defined on a segmented brain image (having 
removed CSF with a threshold at 60% of mean brain intensity) using a mouse driven 
cursor. Regions were defined and edited in real time in three planes with a 
reproducibility error of 1.9-4.3%. Most temporal regions included grey and white 
matter so it is more appropriate to refer to volume reductions of these structures rather 
than grey matter atrophy. The entorhinal cortex ROI only included grey matter, but the 
medial portion of entorhinal cortex along the collateral sulcus was excluded due to the 
variance of this structure. In addition, the middle and inferior temporal gyri were 
included in the same ROI, making direct regional comparisons with VBM difficult. 
Furthermore, ROI measurements of total hippocampal volume (which excluded the 
hippocampal tail) cannot be directly compared with VBM measurements, rather the 
measurements of anterior, middle and posterior thirds are more comparable (see tables 
2&3). As with VBM there are potential sources of volume changes not directly related 
to atrophy. Firstly, in these elderly patients with cerebral atrophy, partial volume 
artefact can occur between brain/CSF interfaces leading to misclassification of voxels. 
Secondly, with reduced grey/white contrast, the borders of complex anatomical 
structures are difficult to define accurately by visual inspection. Thirdly, by excluding 
part of the entorhinal cortex, namely the part with greatest variance, the ROI data are 
not a true reflection of the state of the whole entorhinal cortex.
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Previous morphometry studies
Little information is available on the whole brain patterns of atrophy in 
moderate or severe AD, although within subject longitudinal data suggest global 
cortical atrophy in more advanced stages (Fox et al 1996a; Fox and Freeborough 
1997; Scahill et al 2002). Most previous quantitative morphometries have focussed 
only on temporal lobe measurements making comparisons with our VBM data 
difficult. In early AD, previous VBM (Baron et al 2001; Rombouts et al 2000) and 
ROI-based MR morphometry studies (e.g. Chan et al 2001; de Leon et al 1993; de 
Leon et al 1995; Fox et al 1996c; Frisoni et al 1999; Jack, Jr. et al 1997; Jack, Jr. et 
al 1998; Juottonen et al 1998; Juottonen et al 1999; Killiany et al 1993; Laakso et 
al 1998; Laakso et al 2000) have documented predominant anteromesial temporal 
lobe atrophy. Opinions differ on whether or not the hippocampi or entorhinal cortex 
are more severely affected. Juottonen et al (1999) suggest that entorhinal cortex is 
preferentially atrophied however Laakso et al (2000) showed more atrophy in the right 
hippocampus and lesser but equivalent atrophy in the left hippocampus and both 
entorhinal cortices in AD. Xu et al (2000b) noted that despite the expectation of 
preferential entorhinal atrophy in early AD based on pathological data, MR data 
showed equivalent measurements for entorhinal cortex and hippocampus. They 
surmised this was due to anatomic ambiguity of the borders of the entorhinal cortex, 
image artefact, or both, and suggested that hippocampal measurements may be more 
useful for differentiating AD from normality. A recent morphometry study using a 
temporal rating scale (validated with ROI measurements) with good inter-rater and 
intra-rater variability studied 30 mild-moderate AD and 17 SD patients and 18 control 
subjects (Galton et al 2001). The study showed hippocampal atrophy in 50% of AD 
patients but no significant differences in entorhinal cortex, parahippocampal gyrus, or 
other temporal areas relative to controls, although it should be noted that entorhinal 
cortex was not explicitly defined and was included as part of a parahippocampal gyrus 
region. Direct comparisons of their data with the ROI data of this study are therefore 
not possible.
In SD, Galton et al (2001) showed significantly more atrophy than AD in all 
temporal lobe structures (except the right hippocampus). A previous VBM study of six 
patients with SD showed asymmetric temporal lobe atrophy, more pronounced on the 
left side but did not find significant atrophy in the hippocampus and entorhinal cortex
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(Mummery et al 2000). These data differ in part from ours, since I detected most 
significant atrophy in the left amygdala, hippocampus and entorhinal cortex. This 
discrepancy reflects in part the evolution of VBM techniques, in particular 
optimisations of spatial normalisation and segmentation that have been recently 
introduced (Good et al 2001c; Good et al 2001b). My method, in contrast to that of 
(Mummery et al 2000) included updated SPM software, an automated brain extraction 
step, customised templates, a modulation step to incorporate information from 
deformation fields and statistical analyses modelling TIV as well as global grey matter.
Histopathological data
In AD, histopathological data suggest early entorhinal cortex involvement 
(Braak and Braak 1991) with subsequent spread to the hippocampus proper, other 
temporal gyri, parietal and posterior cingulate cortices (Braak and Braak 1996; Braak 
et al 1998). In SD, there is a spectrum of non-Alzheimer pathological findings 
identical to those reported in the frontal variant of FTLD, but with most pathology in 
the temporal lobes, particularly anteriorly (Hodges et al 1998), either with or without 
specific neuronal inclusions (tau or ubiquitin positive). There are few pathological data 
on entorhinal cortex involvement in FTLD, and the literature on hippocampal atrophy 
is conflicting, most reports suggesting only minor atrophy.
VBM data fo r  extra-temporal structures
Unfortunately these results cannot be corroborated with ROI analyses, since it 
is impractical to collect ROI data for each and every cortical structure. In AD, VBM 
detected most significant atrophy in the parietal and posterior cingulate cortices, with 
sparing of occipital and sensorimotor cortex. Interestingly, when the global amount of 
grey matter was modelled as a confounding covariate, no atrophy greater than that 
found generally was detected in the hippocampus, or elsewhere in the temporal lobes. 
This suggests that the degree of hippocampal atrophy does not exceed that for grey 
matter in general in patients with moderately severe AD. This was contrary to a prior 
expectation of increased mesial temporal lobe atrophy, over and above distributed 
changes. One might speculate that early on in AD atrophy is most marked in 
anteromesial temporal structures as has been suggested by a number of previous 
structural imaging studies (e.g. de Leon et al 1993; de Leon et al 1995; Fox et al 
1996c; Jack, Jr. et al 1997; Juottonen et al 1998; Juottonen et al 1999; Killiany et al
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1993), but as the disease progresses to the moderate and severe stages, atrophy 
becomes more generalised. In this study all the AD patients were impaired, with global 
impairment in 6 out of 10 patients. Impairment was moderately severe, with scores 
between the first and fifth percentiles of performance on both verbal and visual 
subtests, so it is not surprising that VBM detected global cortical atrophy.
Furthermore, the pattern of posterior atrophy detected by VBM matches the parietal 
and posterior cingulate distribution of oxygen and glucose hypometabolism on PET 
studies (Baron et al 2001; Foster et al 1983; Frackowiak et al 1981). Interestingly 
PET data suggest that these regions appear to be affected earlier than the mesial 
temporal regions in AD (Minoshima et al 1997; Small et al 2000) although this is 
contrary to histopathological evidence of the hierarchical spread of neurofibrillary 
tangles in AD (Braak and Braak 1996; Braak et al 1998; Delacourte et al 1999). 
Recent work by Thompson et al (2001a) using an accurate cortical mapping technique 
and voxel-wise assessment of grey matter also show a pattern of temporo parietal 
atrophy in AD. It is worth noting that two recent VBM studies detected predominant 
mesial temporal lobe atrophy (anterior hippocampus, amygdala and entorhinal cortex) 
in patients with early Alzheimer’s disease (Baron et al 2001; Rombouts et a l 2000).
In SD, VBM detected a regional pattern of temporal lobe atrophy in all 
analyses, corroborating previous imaging data (Baroil et a l 2001; Frisoni et al 1999; 
Laakso et al 2000).
Callosal atrophy has been documented in AD, FTLD and other degenerative 
conditions and has been found to be associated with cognitive impairment and cerebral 
cortical hypometabolism, probably reflecting cortical disconnection and axonal 
degeneration (Hampel et al 1998; Teipel et al 1999; Yamauchi et al 1993; Yamauchi 
et al 2000). In my study VBM showed white matter volume loss in the region of the 
left side of the corpus callosum in the St) group. As mentioned earlier, this probably 
reflects an interface shift due to the adjacent enlarged lateral ventricle, since 
asymmetric atrophy of callosal white matter tracts would seem anatomically 
implausible. The changes in the caudate nucleus and thalamus are more difficult to 
interpret. Atrophy of the caudate nucleus has been observed in a previous VBM study 
(Rombouts et al 2000) and histopathological changes have been observed in the striata 
of AD brains (Braak and Braak 1990). Atrophy of the thalamus has been associated 
with poor verbal learning in Alzheimer’s disease (Stout et al 1999), although there is 
little further corroborating evidence from previous MRI studies to confirm or refute
147
these findings. Some of these VBM detected thalamic and caudate changes may reflect 
misclassified voxels and interface shifts due to ventricular enlargement, and should 
thus be interpreted with some caution. There are clearly differences in these regions 
but a simple attribution to grey matter atrophy may be premature.
Conclusion
In this study VBM is compared with the best available approximation to a gold 
standard for measurements of temporal lobe atrophy in AD and SD. The agreements 
and differences between VBM and classical ROI-based analyses are highlighted and 
the different measurement techniques and potential sources of misattribution are 
discussed. The results from the automated and manual methods are not expected to be 
identical, just as the ROI based approach would not produce the same results if a 
different parcellation scheme were adopted. The principal requirement is that the two 
approaches should show the same general trends. VBM produces comparable results to 
a time consuming manual technique that requires brain structures to be expertly 
labelled but provides far more additional detail. In several regions VBM is more 
sensitive than ROI measurements, furthermore VBM has the distinct advantage of 
showing changes throughout the brain on a voxel-wise basis and the versatility of the 
SPM framework allows global and regional changes to be finessed. This allows 
biologically important changes outside the temporal lobe to be highlighted rather than 
be ignored (as in so many ROI based studies). Significantly VBM avoids the 
subjectivity of ROI approaches introduced by observer bias, and results are thus 
comparable betweeil laboratories. With ever increasing improvements in image 
acquisition and computational power there will be greater value in automated unbiased 
whole brain techniques such as VBM. I would however caution users of automated 
techniques such as VBM for disease based studies to carefully inspect each stage of 
image pre-processing in order to improve interpretation.
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CHAPTER 6 
CLINICAL GROUPS 
TEMPORAL LOBE EPILEPSY
Guide to Reader
A previous study using VBM in its earliest form of development failed to 
detect focal hippocampal atrophy in a small group of patients with histologically 
proven mesial temporal sclerosis and temporal lobe epilepsy (Woermann et al 1999b) 
raising concerns about the validity and sensitivity of the technique. In order to further 
establish the clinical validity of the optimised method of VBM, I test here whether 
VBM can identify and characterise ipsilateral hippocampal atrophy in groups of 
patients with temporal lobe epilepsy, histologically proven unilateral mesial temporal 
sclerosis and reduced unilateral hippocampal volume on ROI morphometry. I also test 
whether preoperative ROI morphometry and VBM can predict clinical outcome after 
temporal lobectomy.
Introduction
The high prevalence and morbidity of epilepsy along with the development of 
new medical and surgical therapies have stimulated major advances in morphometric 
techniques of the brain. In many instances a patient is severely debilitated with 
epilepsy, but the MRI appears normal and functional tests may be contradictory. VBM 
may offer some hope for detecting occult epileptogenic foci and is currently being 
introduced in the research setting. In patients with malformations of cortical 
development, for example, VBM detects anatomical abnormalities that correlate with 
benzodiazepine receptor density and functional imaging changes. Importantly, these 
anatomical changes were invisible on high resolution MRI and missed by independent 
blinded region of interest measurements (Richardson et al. 1997). This study 
implemented voxel-wise comparisons of structural and functional data for the first 
time, which may have great potential for future studies if the methodological 
challenges can be met. VBM has been applied also to other forms of epilepsy: in 20
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patients with juvenile myoclonic epilepsy and normal diagnostic MRI, VBM detects 
increased grey matter in the mesial frontal lobes (Woermann et al 1999b). 
Paradoxically in another study by the same group, VBM (using a very early form) did 
not detect hippocampal atrophy in 10 patients with histologically proven mesial 
temporal sclerosis (MTS) (Woermann et al 1999a) raising concerns about the 
technique.
Approximately thirty percent of patients with refractory mesial temporal 
epilepsy (mTLE) and hippocampal sclerosis (HS) experience persistent seizures after 
appropriate temporal lobe surgery. Unilateral hippocampal volume loss and increased 
T2 signal on preoperative magnetic resonance imaging (MRI) are favourable factors, 
but some patients with histological proven HS and apparently complete resections do 
not become seizure free (Berkovic et al 1991; Berkovic et al 1995). Not all 
pathologies are visible on MRI and there may be subtle abnormalities in addition to 
visible changes of HS on preoperative MRI.
MRI post-processing techniques can identify extra-hippocampal abnormalities 
that are not apparent on visual inspection (Sisodiya et a l 1996). A quantitative 
analysis of mesial and lateral temporal lobe volumes in mTLE patients revealed 
atrophy in all mesial and lateral temporal lobe structures examined except the 
amygdala, for which reliable identification of boundaries was difficult (Moran et al 
1999; Moran et al 2001). The presence of extra-hippocampal abnormalities of cerebral 
configuration, identified quantitatively on visually normal-appearing brain MRI, was 
associated with a reduced chance of a good outcome in patients with HS (Sisodiya et 
al 1997). These methods employed large ROIs and therefore did not allow detection 
of subtle regional changes within the ROI nor changes outside the ROI. Clearly a 
whole brain morphometric technique such as VBM that allows unbiased whole brain 
voxel-wise assessment of grey and white matter differences offers distinct advantages, 
but equally would need to be proved valid.
The aims of this study were firstly to determine whether VBM could reliably 
detect regional grey matter (GM) abnormalities on pre-operative structural MR images 
in patients with mTLE (in light of the early VBM study which did not reliably detect 
mTLE in 10 patients either as a group effect or within individual subjects). Secondly to 
determine whether there were differences in the distribution of atrophy between left 
and right mTLE. Thirdly to determine whether there were differences between groups 
who were either seizure-free or who continued to have seizures following temporal
150
lobe resection.
Methods:
Subjects
The study group comprised thirty patients (19 female, median age 32 years, 
range 20 to 49 years) with left mTLE and twenty-two patients (14 female, median age 
33, range 22-56) with right mTLE who were evaluated for epilepsy surgery at the 
National Hospital for Neurology and neurosurgery, UCLH and Charlfont Centre for 
Epilepsy. All patients had a clear MRI diagnosis of hippocampal sclerosis (HS) 
according to accepted qualitative arid quantitative MRI criteria with unilaterally 
reduced hippocampal volumes corrected for intracranial volume, abnormal 
hippocampal volume asymmetry indices, and increased hippocampal T2 times. Thirty 
patients underwent standardized anterior temporal resections performed by Mr William 
Harkness, with removal of the affected hippocampus, part of the amygdala, and 
anterior 3 cm of lateral temporal neocortex. The MRI finding of HS was histologically 
verified in the excised mesial temporal structures ill all patients.
Thirty neurologically normal control subjects (18 female, median age 30 years, 
range 16 to 46 years) Were scanned for comparison. Written informed consent was 
obtained in all cases according to the Declaration of Helsinki, and approval for the 
study was obtained from the Local Research Ethics Committee of the National 
Hospital for Neurology and Neurosurgery (UCLH, NHS Trust) and the Institute of 
Neurology (UCL).
Outcome
All patients had a minimum duration of follow-up of 2 years after surgery. 
Outcome was assessed using a strict interpretation of Engel’s scale (Engel et al 1993) 
in that patients were considered to be seizure free only if they had not had any seizures 
or auras for a continuous period of at least 2 years up to the last follow-up.
M RI scanning
Preoperative MRI images were obtained at the Chalfont Centre for Epilepsy on 
a 1.5T GE Signa scanner (GE Medical Systems, Milwaukee, Wis., USA) using a Tl- 
weighted inversion-recovery prepared volume acquisition [IRSPGE: Tl/TR/TE/flip =
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450/15/4.2/20; 124 x 1.5mm thick contiguous coronal slices; matrix 256 x 192,24 cm 
x 18 cm FOV (field of view)(Tl = inversion time; TR = repetition time; TE = echo 
time]. All images were reviewed by an experienced neuroradiologist focusing 
particularly on abnormalities outside the affected hippocampus.
Image processing
The optimised method of VBM was followed (see Chapter 2) using the SPM 
apriori grey and white matter templates for grey and white matter analyses 
respectively.
VBM statistical analysis
The smoothed modulated and unmodulated data were analysed. Significance 
levels were set at p<0.05, corrected for whole brain volume, and in addition 
temporolimbic voxels were small volume corrected (SVC) using a mask covering 
temporo-limbic structures, including hippocampus, amygdala, parahippocampal gyrus 
and orbitofrontal cortex bilaterally. The aim was to assess the effect of post-operative 
seizure outcome when comparing mTLE patients versus controls. For this purpose 
regions showing a difference between patients and controls were further assessed for 
differences between seizure-free patients and patients suffering from seizures post- 
operatively (using inclusive masking). Duration of epilepsy was defined as a covariate 
of interest in a separate parametric analysis with age and gender as confounding 
covariates.
Results
Comparison o f  pre-operative mTLE patients versus controls
Voxel-based comparison of patients and controls revealed a group main effect 
of grey matter volume (modulated data) and concentration (unmodulated data) with 
decreases in the patient population in the ipsilateral hippocampus (x=-30, y=-15,z=-20; 
Z=6.13, p<0.001), amygdala (Z=5.59, p<0.001), dorsal mid thalamic region (x=-8, y=- 
33,z=6; Z=5.26, p<0.005) and superior temporal gyrus (x=-36, y=28,z=-30; Z=4.94, 
p<0.05) (Figs. 6.land 6.2).
Comparing patients with left and right MTS, VBM detected grey matter 
volume (and concentration) loss was asymmetric, with more extensive grey matter loss
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being observed in left MTS (Fig. 6.2)
Figure 6.1: Grey matter concentration loss in temporal lobe epilepsy
Reduced grey matter concentration in 30 left TLE patients compared to 30 controls, 
displayed on a single normalised T1 volume MRI image thresholded at p<0.001 
uncorrected for display. The colour bar represents the T score
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Figure 6.2: Asymmetry of MTS atrophy
VBM detected grey matter volume loss in left mesial temporal sclerosis (MTS) (in red) 
and right MTS (in green) projected over the group mean normalised image. Atrophy is 
asymmetric, with more extensive grey matter loss being observed in left MTS.
□ left sided mesial temporal sclerosis (pre-operative) 
g  right sided mesial temporal sclerosis (pre-operative)
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Comparison ofpostoperative seizure-free left mTLE patients versus patients with 
post-operative seizures
16 patients (10 female, median age 33 years, range 28 to 48 years) with a 
median follow-up of 48 months (range: 24 -  60 months) remained seizure-free 
postoperatively and 14 patients (8 female, median age 31 years, range 20 to 49 years) 
with a median follow-up: 36 months (range: 24 -  60 months) continued to experience 
seizures after surgery. There were no differences in quantitative ROI hippocampal 
volume measurements between these two groups.
VBM group-comparison showed significantly larger grey matter reductions in 
the ipsilateral mesial temporal lobe and orbitofrontal cortex (x=-18, y=2,z=-14; 
Z=4.33, p <0.005) in patients who continued to have seizures after temporal lobe 
surgery, compared with those who remained seizure free post operatively (Fig. 6.3, 
6.4). In those patients that remained seizure free, grey matter loss was more 
pronounced in the anterior hippocampus (x= -30, y = -15,z=-20; Z=6.31, p<0.001) and 
inferior temporal gyrus (x=-32, y=18, z=-30, Z=4.94, p<0.05) (Fig. 6.5). Furthermore, 
VBM also shows more extensive white matter loss in patients with postoperative 
seizures.
Figure 6.3: Unfavourable post-operative outcome and grey matter concentration
Decreases in grey matter concentration in 14 left TLE patients with post-operative 
seizures compared to 16 left TLE post-operatively seizure-free patients, masked 
inclusively with grey matter reduction in left TLE versus controls. Significantly larger 
grey matter reductions are seen in the ipsilateral orbitofrontal cortex (x=-18, y=2,z=-14; 
Z=4.33, p <0.005) and mesial temporal lobe (not shown) in patients who continued to
Figure 6.4: Post-operative outcome and grey matter volume
Grey matter volume loss in patients with left MTS who continued to have 
seizures after left temporal lobectomy
*  Grey matter volume loss in patients with left MTS who remained seizure 
free following left temporal lobectomy
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Figure 6.5: Favourable post-operative outcome and grey matter concentration
Decreases in grey matter concentration in 16 post-operative left TLE patients who 
remained seizure-free compared to 14 left TLE patients with persistent post-operative 
seizures, masked inclusively with the grey matter reductions in left TLE versus controls. 
The colour bar represents the Z score. Grey matter loss is more pronounced in the 
anterior hippocampus (x= -30, y = -15,z=-20; Z=6.31, p<0.001) and inferior temporal 
gyrus (not shown) (x=-32, y=18, z=-30, Z=4.94, p<0.05)
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Covariate analysis: duration o f  epilepsy
There was no correlation between duration of epilepsy and grey matter 
concentration or volume in the hippocampus or elsewhere in the brain.
Discussion
These in-vivo MRI findings confirm numerous observations of pathology in 
mTLE beyond the sclerotic hippocampus in the adjacent regions of the amygdala, 
entorhinal cortex, and thalamus (DeCarli et al. 1998; Moran et al. 2001). The 
advantage of VBM over region-based approaches is that it is a fully automated whole 
brain technique and thus is not biased to a subjectively chosen region. This study 
confirms that the optimised method of VBM is sensitive to regional hippocampal 
atrophy due to mesial temporal sclerosis, refuting concerns generated by the early 
VBM study of 10 patients with MTS (Woermann et al 1999). VBM shows a clear 
difference in the extent of atrophy in right and left MTS, with more extensive atrophy 
in left MTS. More importantly VBM is sensitive to subtle regional structural changes 
within the hippocampal GM that were undetectable on standard imaging methods. This 
finding suggests differences in the distribution of hippocampal atrophy and that 
volume profiles of the hippocampus may be more important than total hippocampal 
volumes in predicting seizure outcome. If pathology is confined to the surgical 
resection site, the patient is more likely to be seizure-free post-operatively.
Using VBM I confirm previous reports of extra-hippocampal damage in 
patients with poor outcome (Lieb et a l 1991) and localise these changes to the 
posterior orbitofrontal cortex around the anterior perforated space, a region of strong 
reciprocal connections with the hippocampus (Lieb et al 1991). VBM detected focal 
ipsilateral grey matter reduction in the mid dorsal thalamus of patients with poor 
outcome. As I have mentioned earlier, it is important to exclude boundary shift in this 
region, but none of the patients showed asymmetrical enlargement of the body of the 
lateral ventricle, so it is likely that the thalamic volume loss is real. These findings 
concur with previous ROI volumetric measurements of thalamic atrophy in MTS 
(DeCarli et al 1998; Dreifuss et al 2001). The hippocampal formation receives 
substantial innervation from a number of thalamic nuclei with widespread, mostly
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reciprocal connections of the medial dorsal thalamic nucleus with mesial temporal 
structures (Lieb et al 1991). Although these reports cannot define the basis for 
macroscopic morphological changes within the thalamus or the functional 
consequences of such changes, they do suggest a potential role of the thalamus in TLE.
Conclusion
This study confirms that VBM is a useful technique for characterising the 
pattern of atrophy in patients with mTLE. Moreover, VBM detects changes that are 
occult on expert visual appraisal of MRI. These data confirm evidence of widespread 
pathology in mTLE beyond the sclerotic hippocampus (DeCarli et al 1998; Dreifuss et 
al 2001; Keller et al 2002; Lieb et al 1991; Moran et al 1999; Moran et al 2001; 
Sisodiya et al 1997). In addition, the group of patients with a favourable post­
operative outcome have structural MRI abnormalities detectable by VBM and not ROI 
morphometry that are confined to the resected temporal lobe with the anterior 
hippocampus being most affected, whereas those patients with an unfavourable 
outcome have structural abnormalities extending outside the resection zone, in 
particular into the orbitofrontal cortex.
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CHAPTER 7 
CLINICAL GROUPS 
MIGRAINE
Guide to Reader
Migraine is a common, disabling form of headache that has generally been 
attributed to primary pathophysiology within the cranial vasculature. More recently a 
number of functional imaging studies of primary headache have demonstrated 
activations within generic pain regions such as cingulate cortex and insulae and more 
specific activation of the dorsal pons suggesting that migraine may be based 
fundamentally on focal brain dysfunction. Conventional neuroimaging may reveal 
evanescent white matter foci, but no consistent structural abnormality has yet been 
identified. In light of an early VBM study showing hypothalamic grey matter changes 
in patients with cluster headache exactly itiatching a region of hyperactivation on 
functional imaging, I test here whether VBM can reveal a putative structural correlate 
to the dorsal pontine activations seen in migraine patients.
Introduction
Migraine, an episodic pain condition with associated features, is a common 
clinical problem that affects approximately 15% of the population (Lipton et al 2003; 
Stewart et al 1992; Menken et al 2000). This form of episodic primary neurovascular 
headache is likely to be based fundamentally on dysfunction within the brain. Recent 
advances in the underlying pathophysiological mechanisms of migraine and new 
therapeutic strategies have provided considerable insights into the problem. Since 
migraine is a form of primary headache (Headache Classification Committee of the 
International Headache Society 1988) it is generally hypothesized that the underlying 
problem is biochemical or biophysical in nature and consequently macroscopic brain 
structure should be normal.
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Recent developments in functional brain imaging have allowed improved 
understanding of many aspects of neurophysiology. For example, focal activations in 
brain areas known to be associated with pain, such as cingulate cortex and insulae, 
have been demonstrated in patients with primary headaches such as migraine (Bahra et 
al 2001; Weiller et al 1995) and cluster headache (May et al 1998a; May et al 2000; 
May and Goadsby 2001). These areas are similarly activated when pain is induced by 
injection of capsaicin into the forehead of volunteers (May et al 1998b). In addition to 
these generic pain areas, activations can be seen in specific brain regions in migraine 
and cluster headache that are not observed when the first (ophthalmic) division pain 
pathways are activated by the capsaicin injections. For example, brainstem areas are 
activated in migraine (Weiller et al 1995), which have recently been localised to the 
dorsal pons (Bahra et al 2001). In contrast the posterior hypothalamic grey matter is 
uniquely activated in cluster headache and SUNCT (short-lasting unilateral 
neuralgiform with conjunctival injection and tearing) (May et al 1999c).
An early VBM study has suggested that there is a correlation between the brain 
area specifically activated in acute cluster headache (May et a l 1998a), the posterior 
hypothalamic grey matter and some macroscopic change in grey matter in the same 
region (May et al 1999b). This finding needs careful evaluation on its own merits, but 
does stimulate the question as to whether other primary headaches, particularly 
migraine, show similar functional-structural correlations. In this study I use VBM to 
investigate whether there are structural changes associated with previously 
documented activations in the brainstem, in particular the dorsal pons and/or 
hypothalamus of migraine sufferets.
Methods
Subjects
Approval for the study was obtained from the Local Research Ethics 
Committee of the National Hospital for Neurology and Neurosurgery (UCLH, NHS 
Trust) and the Institute of Neurology (UCL). Patients with migraine were recruited 
from patients attending the Hospital and patient support groups by Professor 
Goadsby’s clinical team, in particular Dr Manjit Matharu. The study group comprised 
11 patients with migraine with aura (10 females, 1 male: 23-52 years, mean 31); 11 
controls (10 females, 1 male: 23-52, mean 31); 17 patients with migraine without aura
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(16 females, 1 male: 24-57, mean 34); 17 controls (16 females, 1 male: 24-57, mean 
34).
Structural MRI scanning protocol
High-resolution magnetic resonance imaging was performed on a 2 Tesla 
Siemens MAGNETOM Vision scanner. A 3D structural MRI was acquired on each 
subject using a T-l weighted MPRAGE sequence TR/TE/TI/NEX 9.7/4/ 600/1, flip 
angle 12°, matrix size 256 x 192, FOV 256 x 192, yielding 108 sagittal slices, slice 
thickness of 1.5mm and in plane resolution of 1mm x 1mm.
Data Pre-processing and analysis
The optimised voxel-based morphometry protocol was used for image pre­
processing (see Chapter 2 for details).
I used customised grey and white matter templates for spatial normalisation, 
which were created from a separate group of 180 normal subjects with no history of 
migraine (168 females and 12 males; 18-70 years, mean 32 years), imaged on the same 
scanner with identical parameters in order to remove any scanner dependent bias.
VBM statistical analysis
Separate analyses were performed for grey and white matter using modulated 
and unmodulated data. 4 conditions were assigned, namely migraine with aura, 
migraine without aura and 2 age and sex matched control groups. Since patients with 
migraine and their respective controls were exactly age and sex matched, no age or sex 
confounds were included. I controlled for global differences in voxel intensity across 
scans by proportionally scaling the global mean voxel intensity value. I also included 
analyses with no global modelling. Significance levels were initially set at p<0.05, 
corrected for multiple comparisons. In order to improve sensitivity (and minimize the 
possibility of false negatives), the data were subjected to further scrutiny as follows: 
since the dorsal pons and hypothalamus had been identified a priori as possible 
candidates for structural change, the analysis was repeated with more liberal 
significance levels set at p<0.005 uncorrected for multiple comparisons (the intention 
being to use small volume correction if any pontine or hypothalamic changes were 
observed). I arbitrarily chose spheres of 20 and 10mm diameter as conservative 
estimates of dorsal pons and hypothalamus volume, respectively.
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Results
Global grey matter
There was no significant difference in global grey matter volume between 
either patients with migraine and controls (F<1), or patients with aura and without aura 
(F<1).
Regional grey matter
VBM detected no significant difference in grey matter volume or concentration 
between patients and their respective control groups, or a common difference between 
patients with migraine (with and without aura) and both control groups (Fig. 7.1).
Global white matter volume
There was no significant difference in global white matter volume between 
either patients with migraine and controls (F<1), or patients with aura and without aura 
(F<1).
Regional white matter
VBM detected no significant difference in white matter volume or 
concentration between patients and their respective control groups, or a common 
difference between patients with migraine (with and without aura) and both control 
groups.
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Figure 7.1: No structural difference between migraineurs and controls
Glass brain image on the left showing no significant voxels for the contrast migraine - 
controls. Design matrix on the right. Column 1 represents controls for migraine with 
aura patients; Column 2 represents migraine with aura patients; Column 3 represents 
controls for migraine without aura patients; Column 4 represents migraine without aura 
patients and Column 6 represents the global mean grey matter value. Each row 
represents an individual subject.
m igraine-cont
...r
<T °  
S  °
Oh o'
contrast(s)
s P M fr51!
SPMresults: . / la tes t_op t_ana lys is  
Height th reshold  T = 5.32 
Extent th reshold  k = 0 voxels
1 2 3 4 5
Design matrix
1
4
7
10
13
16
19
22
25
28
31
34
37
40
43
46
49
52
56
Discussion
In this study I have employed VBM to compare the brains of migraine sufferers 
with healthy non-headache controls. Migraine patients were sub-classified according to 
their dominant phenotype namely migraine with aura or migraine without aura, in line 
with the International Headache Society classification guidelines (Headache 
Classification Committee of the International Headache Society 1988). I observed no 
difference in either group when compared to appropriate distinct age and sex matched 
control groups. These results suggest that either migraine sufferers do not have 
consistent macroscopic structural brain changes in regions known to be functionally
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implicated, or that any putative changes may vary with some biological trait other than 
simply headache phenotype.
I have shown in previous chapters that the optimised method of VBM 
replicates established pathological and neuroimaging findings in normal subjects 
(Chapters 3 and 4), patients with distinct forms of dementia (Chapter 5) and temporal 
lobe epilepsy (Chapter 6). I have also shown (Chapter 6) and will show (Chapters 
8,9,11) that VBM is sensitive to subtle regional structural changes in grey and white 
matter that are undetectable on standard imaging methods (see also Abell et al 1999; 
Krams et al 1999; May et al 1999a; Salmond et al 2000; Richardson et al 1997; 
Woermann et al 1999c; Woermann et al 1999a). Furthermore, an early VBM study 
has shown macroscopic grey matter changes matching PET activation in the posterior 
hypothalamus of patients with acute cluster headache. It follows therefore that VBM, 
particularly the optimised form, should be able to detect consistent macroscopic 
changes if they are indeed present in patients with migraine. VBM cannot inform about 
microstructural details such as cytoarchitectonics or histochemistry, rather it can detect 
differences in tissue volume and concentration on a voxel-wise macroscopic or 
mesoscopic level.
Focal evanescent white matter lesions have been previously described in 
migraineurs (Igarashi et al 1991; Soges et al 1988). I would not expect them to be 
detected by VBM since they occur in variable locations within the white matter, and 
would thus not be seen as a consistent structural difference between groups. VBM 
aims to detect consistent structural differences between groups of subjects that can be 
related to functional correlates and thus further our understanding of disease 
pathophysiology.
The absence of macroscopic structural change in migraine concurs with current 
views of the condition (Olesen et a l 2000). If indeed migraine is primarily a 
biochemical/biophysical disorder it is not surprising that the brain structure is normal. 
This would be the simplest explanation for my negative results. However, it is 
appropriate to consider some alternative possibilities. This study used the simplest 
division of migraine into patients with and without aura. One could argue that this may 
not be the ideal way to classify the patients for this type of study. For example there 
was no subdivision into laterality of headache or aura. Migraine has a strong genetic 
component, in terms of predisposition to the disorder (Ferrari 1998) and it seems most 
likely that this genetic tendency will be heterogenous. Definite genetic links have been
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found with specific forms of migraine. For example, familial hemiplegic migraine, a 
rare well characterised autosomal dominant form of migraine with a prolonged aura, 
was first genetically characterised with mis-sense mutations in the chromosome 19 
located gene for the a\2.\ sub-unit of the P/Q voltage gated calcium channel (Ophoff 
et al 1997). This accounts for about 55% of affected families (33), while some 
families appear to map to chromosome 1 (Ducros et al 1997; Gardner et al 1997) and 
still others have defects that map to a third, or perhaps more sites. It is possible that 
structural neuroimaging studies of a genetically heterogenous condition, such as 
migraine, may miss subtle changes that might segregate with a more homogenous 
genotype. In order to further examine this possibility I have applied VBM to a specific 
kindred with a homogeneous genotype (see Chapter 12)
Another consideration is the relationship between migraine headache and aura. 
It can be argued that migraine aura is a parallel process to the headache (Goadsby 
2001). Aura typically precedes headache but may also occur with headache, after 
headache or indeed without headache. The relationship between a predisposition to 
aura and any putative structural change related to the headache is unknown. On a 
positive note, although migraine with aura has a small association with an increased 
risk for stroke (Tzourio et al 2000), the brains of patients with aura show no consistent 
loss of either grey or white matter. Furthermore, if there are indeed structural changes 
to be found in migraine that are of a causal nature to the basic disorder, based on PET 
studies, one would expect them to be in the diencephalon and brainstem (Bahra et al 
2001; Weiller et al 1995) which are challenging areas to compare owing to poor tissue 
contrast. Perhaps more homogenous populations and even more refined methods may 
be required to detect such changes.
Conclusion
There is no evidence of consistent macroscopic structural change in the brains 
of migraine sufferers with or without aura using VBM. These data suggest that 
migraine is a biochemical/biophysical problem without macroscopic structural 
consequences. Since the migraine phenotype is heterogeneous, if putative structural 
changes do exist further studies will probably need to carefully divide patients based 
on genotype or response to treatment, rather than simply on headache phenotype.
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CHAPTER 8 
CLINICAL GROUPS 
SCHIZOPHRENIA
Guide to Reader
The morphological literature on schizophrenia is large and conflicting owing to 
a wide variety of study designs and predominantly region of interest based 
measurement techniques. The most consistent structural alterations in schizophrenia 
include ventricular enlargement and distributed grey matter loss. Less consistent 
findings are reports of regional abnormalities such as selective reductions in thalamic 
volume. In this study I use VBM to characterise the structural brain alterations in a 
group of 20 schizophrenic patients. I test firstly whether VBM reproduces the most 
consistent imaging findings and secondly if it reveals new findings in biologically 
plausible locations that match functional imaging abnormalities.
Introduction
Schizophrenia is a complex mental illness with a worldwide prevalence of 
approximately 1%. This condition is characterised in acute phases by hallucinations, 
delusions and disordered thinking, and chronically by flat affect, apathy and social 
withdrawal. “Negative” cognitive symptoms are common.
Despite extensive research, the underlying pathophysiology of schizophrenia 
remains poorly understood. Many propose an underlying neurodegenerative process 
but histological evidence for this is limited by a relative paucity of autopsy studies and 
methodological inconsistencies. High resolution in vivo neuroimaging offers the 
potential of detecting altered brain morphology that might provide insight into 
underlying functional and biological processes. Although the neuroimaging literature 
on schizophrenia is large it is for the most part inconsistent and conflicting. Study 
sample sizes are often small and most reports are based upon region of interest 
methods that vary widely across laboratories. In addition, groups of schizophrenic 
patients tend to be phenotypically heterogeneous with no consistent genotype. For
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these reasons, meta-analyses are being increasingly employed to assist interpretation of 
the literature. The most consistent imaging findings in schizophrenia include reduction 
in global brain volume, increased CSF volume and regional volume reductions in the 
amygdala/hippocampal formations (e.g. Weinberger 1984; Weinberger et al 1979b; 
Weinberger et al 1979a; Fannon et al 2000; Harvey et al 1993; Lim et al 1996; 
Wright et al 1999; Wright et al 2000a). Observations of localised morphometric 
abnormalities are generally variable across studies. In a meta-analysis of 58 
morphometric studies of schizophrenia, the majority employing manual ROI metrics, 
volume reductions in medial temporal lobe structures were the most frequent 
observation (Wright et al 2000a). Morphometric abnormalities in the thalamus have 
also been reported (Andreasen et al 1994; Gilbert et al 2001; Konick and Friedman 
2001) particularly within the mediodorsal thalamic nucleus and pulvinar (Byne et al 
2001; Byne et al 2002). Such findings support the theory that thalamic dysfunction, 
potentially leading to impaired sensory filtering and gating mechanisms, underlies the 
psychological abnormalities Of schizophrenia (Andreasen et al 1996; Andreasen 1997; 
Frith et al 1995; Schultz and Andreasen 1999).
In schizophrenia, the first application of VBM demonstrated reduced grey 
matter density in insula, prefrontal arid lateral temporal cortices (Wright et al 1995b).
A more recent VBM study of childhood-onset schizophrenia reported structural 
abnormalities of thalamus, posterior cingulate, basal ganglia and ventricular volume 
(Sowell et al 2000). Voxel-wise assessment of magnetic transfer imaging, an MRI 
technique sensitive to subtle changes in regional macromolecular integrity, provides 
additional information about the underlying pathology of schizophrenia (Foong et al 
2001). Schizophrenic patients demonstrate frontotemporal abnormalities that correlate 
with severity of negative symptoms reflecting abnormal integrity of medial prefrontal 
and adjacent anterior cingulate cortices. It therefore seems likely that schizophrenia is 
characterised by a combination of widespread grey matter atrophy and more localised 
frontotemporal changes, perhaps selectively involving thalamocortical circuitry.
Methods
Subjects
Twenty patients with a clinical diagnosis of schizophrenia (ICD-10R) were 
recruited from the inpatient and outpatient departments of the Royal Free and
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associated hospitals by Dr H Ananth and Dr I Popescu. All patients gave informed 
consent to participate in the study. Ethical approval was granted by the National 
Hospital for Neurology and Neurosurgery and Institute of Neurology Joint Research 
Ethics Committee. Controls were recruited from healthy volunteers who were 
matched closely with the patients on the basis of age, gender, social class and ethnicity 
(mean ± S.D., controls versus schizophrenic patients; age (years), 38.6 ± 9.7 versus 
37.8 ±9.5; 10 males and 10 females in each group). Detailed clinical data of patients 
were obtained from medical notes and corroborated by clinical interview on the day of 
scanning. All schizophrenic patients had a history of treatment with antipsychotic 
medication (mean treatment duration was 15 ± 9 years) and were clinically stable at 
the time of scanning. No subjects had a history of additional neurological or systemic 
illness, head injury or excessive drug and/or alcohol misuse.
MR scanning
Subjects were scanned on a 2 Tesla Siemens MAGNETOM Vision scanner by 
Dr Hugo Critchley. A 3-dimensional structural MR scan was acquired on each subject 
using a T-l weighted MPRAGE sequence (TR/TE/TI/NEX 9.7/4/ 600/1, flip angle 
12°, matrix size 256 x 192, FOV 256 x 192, yielding 120 sagittal slices and a slice 
thickness of 1.5mm with in plane resolution of 1mm x 1mm).
Data pre-processing fo r  voxel-based morphometry
Data pre-processing and analysis was performed by myself using the optimised 
method of VBM (see Chapter 2 for full details). Customised grey and white matter 
templates were created from the study group according to previously described 
methods.
Statistical Analysis
Firstly, I tested global volume measures of grey matter, white matter and CSF 
calculated from the non-normalised segmented images for group differences in overall 
tissue compartment volumes. Secondly, for each tissue compartment, I constructed 
separate design matrices to test for regional group differences in grey and white matter 
between schizophrenic patients and control subjects. Age, gender and total intracranial 
volume (TIV, derived from sum of the global measures of compartmental volumes) 
were entered into each analysis as confounding covariates.
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Thirdly, I tested for morphometric changes across the schizophrenic patient 
group correlating with individual variables that are putative influences on psychosis. 
These included age of illness onset, handedness, level of educational achievement, 
family history of psychosis, past substance abuse, age and gender. Regressors were 
constructed for each of these factors and entered into correlation analyses. Clinical 
details were obtained from patient notes and confirmed by direct interview with the 
subjects and carer (Dr H Ananth and Dr I Popescu). Educational achievement was 
rated on a 3-point scale, 0 indicating no academic qualifications and 3 indicating 
attainment of a degree or equivalent. Family history of psychosis was scored as; 0: no 
family history, 1: a second-degree relative and 2: a first-degree relative. Past substance 
abuse was scored clinically as 0: no significant history to 3: past diagnosis of 
dependence syndrome, poly-substance abuse or dual diagnosis (a score of 3 excluded 
the subject from the study).
Statistical parametric maps were constructed to test for morphological 
differences between schizophrenics and controls (main effects), and for correlations 
between contextual variables within the schizophrenic group. The distribution of 
morphological differences across the whole brain was initially assessed using a liberal 
threshold of p<0.001, uncorrected for multiple comparisons, however inferences are 
centred on differences that achieved significance at p<0.05, corrected for whole brain 
volume.
Results
Global differences
There was no significant between-group difference in a measure of total 
intracranial volume (TIV) (F(38) = 0.05, p=0.8). Patients with schizophrenia had 
significantly lower global cerebral grey matter than controls (absolute volume (ml), 
controls vs. patients, mean ± S.D.; 516 ± 50 vs. 453 ± 48, F(38) = 15.4, p<0.01), but 
there were no significant differences in overall white matter or CSF volumes (controls 
vs. patients, white matter, 441± 51 vs. 415 ± 56, F(38) = 2.6; CSF, 321± 45 vs. 331 ± 
54, F(38) =1.15) (Fig. 8.1a). Finally, there were no between group differences in the 
relative proportions of grey and white matter and CSF, by controlling for TIV. 
Schizophrenic patients showed a reduction in the relative amount of grey matter 
(controls versus patients; 51.6% versus 48.9%, p<0.001) and increased relative CSF
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volume (controls versus patients; 20.6% versus 23.6%, p<0.05) compared to controls. 
No difference in between-group proportion of white matter was observed (controls 
versus patients; 27.7% versus 27.5%, p=0.7).
Figure 8.1a: Global tissue compartment volumes
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Figure 8.1b: Grey matter volume loss in schizophrenia
The figure shows the location and statistical magnitude (colour bar of T-score) of 
between-group differences in grey matter volume across the whole brain, to illustrate 
the widespread distribution of grey matter loss in schizophrenic subjects
Regional differences
To test for regionally selective differences in cerebral morphology associated 
with schizophrenia, voxel-wise comparisons of segmented grey matter, white matter 
and CSF images were performed, using global grey and white matter volumes as 
confounding covariates. At a low threshold (p<0.001,uncorrected), widespread grey 
matter reductions were observed in cortical and subcortical regions in schizophrenic 
patients compared to controls (Fig. 8.2). Many brain areas remained significant after a 
stringent correction for multiple comparisons across whole brain (p<0.05, corrected)
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(Table 8.1), with the most robust difference in regional grey matter volume being 
observed in mediodorsal thalamus, especially on the left (Fig. 8.2). Other regional 
reductions were observed in occipitoparietal cortex, premotor, medial and orbital 
prefrontal cortices and inferolateral temporal lobe (Table 8.1, Figure 8.3). There were 
no regions of significantly increased grey matter volume in the schizophrenic group, 
even without correction for multiple comparisons. Only one region showed a between- 
group difference in regional white matter volume, the right optic radiation in occipital 
cortex, which was significantly reduced in the schizophrenic patients (p<0.05, 
corrected). Schizophrenic patients did not show any localised increases in white 
matter.
Figure 8.2: Regional grey matter decreases in schizophrenic patients.
Most significant grey matter reduction in the mediodorsal thalamus (p<0.05 corrected) 
projected on parasagittal and coronal sections of the normalized unsmoothed template
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Table 8.1: Grey matter reductions in schizophrenia
Location
(x,y,z coordinates of peak difference)
Mediodorsal thalamus (-8,-15,17)
Fusiform gyrus (-23,-74,-9)
Peristriate visual cortex (-6,-75,18) 
Inferior frontal gyrus (-45,15,36) 
Precentral gyrus (-39,-5,68)
Medial frontal pole (2,63,14)
Middle occipital gyrus (45,-74,18) 
Premotor/motor cortex (42,-5,65) 
Inferior temporal gyrus (66,-35,-6) 
Postcentral gyrus (47,-20,68)
Superior frontal gyrus (23,38,53) 
Inferior parietal lobule (51,-69,38) 
Orbitofrontal cortex (30,33,-9)
Side T-score
(p<0.05, corrected)
L 7.70
L 6.92
L 6.75
L 6.61
L 6.61
L&R 7.32
R 7.52
R 7.04
R 7.03
R 6.68
R 6.62
R 6.61
R 6.50
175
Figure 8.3: Regional reductions in grey m atter volume in schizophrenia.
Orbitofrontal cortex (1), medial frontal pole (2), inferolateral temporal lobe (3), 
mediodorsal thalamus (4), insula (5) and occipitoparietal cortex (6).
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Correlations within patient group
In order to gain further insight into the pathoaetiological associations of 
detected morphological abnormalities in patients with schizophrenia additional 
analyses tested for correlations between reductions in grey matter volume and 
variables that may influence psychosis (handedness, substance misuse and level of 
educational achievement) and more specific illness-related factors, i.e. age, family 
history of psychosis and illness-onset. There was a significant negative correlation 
between global grey matter volume and age of schizophrenic patients (R=-0.66, 
p<0.01). Moreover, preservation of (mediodorsal) thalamic grey matter was 
associated with greater educational achievement (Pearson R= 0.48, p=0.04, 2-tailed). 
Regression analyses of regional grey matter revealed a relationship between thalamic 
grey matter loss and age (0.55, p=0.01). A region of ventromedial prefrontal cortex 
showed a significant relationship with family history of schizophrenia (Fig. 8.4).
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Figure 8.4: Effect of family history of schizophrenia
Correlation of medial prefrontal cortex volume (18 40.6 7.6) and a positive family 
history of schizophrenia / psychosis (p<0.001, uncorrected). On the top, group data is 
projected on the unsmoothed template. On the bottom, adjusted raw data plotted against 
a regressor for family history of schizophrenia.
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Discussion
In this study VBM confirms the most consistent previous reports of reductions 
in global grey matter and increases in cerebrospinal fluid in schizophrenic patients 
(Wright et al 2000b). In addition to widespread frontal, temporal, parietal and 
occipital cortical involvement, there are also regionally specific cortical morphological 
changes. The most significant local effect is selective thalamic grey matter loss in 
schizophrenic subjects relative to controls. This observation, together with a 
significant correlation of both global and thalamic grey matter loss with age, provide 
insight into underlying pathoaetiological mechanisms implicit in the schizophrenia 
phenotype.
Autopsy studies of schizophrenics have confirmed marked neuronal loss in the 
thalamus, with greatest cell depletion in medial / mediodorsal thalamus (Pakkenberg 
1990; Popken et al 2000). This region of thalamus projects to prefrontal cortex, which 
has been implicated in a variety of cognitive deficits and symptom patterns associated 
with schizophrenia (Barch et al. 2001; Callicott et al. 2000; Dolan et al. 1993; Liddle 
and Morris 1991; Weinberger 1988). Previous neuroimaging studies have also 
observed thalamic structural abnormalities in chronic schizophrenics (Andreasen et al. 
1994; Buchsbaum et al. 1996; Byne et al 2001), untreated schizophrenics (Gur et al 
1998), childhood-onset schizophrenics (Dasari et al 1999; Sowell etal. 2000), 
relatives of schizophrenics (Staal et al 1998; Lawrie et al 1999) and schizotypal 
individuals (Hazlett et al 1999). Meta-analysis of schizophrenia studies (Wright et al 
2000b; Konick and Friedman 2001) reveals a mean thalamic volume loss of 
approximately 4%. In contrast, other studies have not reported any differences in 
thalamic volumes between schizophrenic patients and controls (Arciniegas et al 1999; 
Portas et al 1998) though psychotic symptoms have been shown to be related to 
thalamic volume (Portas et al 1998).
These data add to the weight of evidence for altered thalamic structure in 
schizophrenia. The combination of local thalamic and more widespread global grey 
matter loss, suggests that functional alteration of thalamocortical connectivity may be a 
key feature of schizophrenia, consistent with theoretical models of cognitive 
integration and dysfunction in schizophrenia (Andreasen et al 1996; Tononi and 
Edelman 2000). Anatomically, the thalamus is a crucial relay between sensory
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pathways and cortex and also between sensory cortices and association areas, acting 
possibly as a sensory filter (Andreasen et al 1996; Andreasen 1997; Andreasen et al
1998).
There is strong empirical support for a deficit in thalamocortical function in 
schizophrenia. Functional imaging studies of schizophrenia have shown abnormal 
thalamic activity at rest (Buchsbaum et al 1996), during auditory hallucinations 
(Shergill et al 2000; Silbersweig et al 1995) and during a variety of cognitive tasks 
(Andreasen et al 1995; Heckers et al 2000; Rubia et al 2001; Russell et al 2000). 
Clinical studies also suggest dysfunction within this system. Schizophrenic patients 
demonstrate abnormalities in sensory experience and attribution, neuropsychological 
deficits and abnormalities in motor coordination and execution (Diforio et al 2000; 
Walker et al 1999; Neumann and Walker 1999). These clinical features suggest an 
underlying disorder in the coordinated regulation of sensory, motor and cognitive 
function in schizophrenia. The structural data from this study add further evidence of a 
thalamocortical basis to schizophrenia.
An important observation in this study was the correlation between regional 
differences in grey matter and clinical variables across the schizophrenic patients. In 
particular the significant correlation between global grey matter loss and subject age, 
suggesting progressive neuronal loss in schizophrenic subjects distributed across 
cortical and subcortical regions. Additionally, when global volume differences were 
accounted for, grey tnatter loss within the thalamus also correlated with age, but was 
relatively preserved in those patients with higher level of educational achievement. 
These observations, in the context bf a lack of correlation between the age of illness 
onset or years of neuroleptic treatment, suggest that primary thalamic dysfunction may 
result in progressive involution within thalamus with secondary neuronal depletion 
within distributed cortical areas to which the thalamus is connected. In support of this 
proposal are the observed thalamic structural changes in individuals predisposed to 
schizophrenia or who have never received treatment (Gur et al 1998; Lawrie et al 
1999; Staal et al 1998; Hazlett et al 1999). The finding of most marked volume loss 
in the mediodorsal thalamic nucleus, which connects reciprocally with prefrontal 
regions concurs with earlier reports (Pakkenberg 1990; Popken et al 2000). 
Furthermore prefrontal cortical regions demonstrated the strongest association with a 
positive family history of schizophrenia suggesting that altered thalamoffontal 
connectivity may selectively increase vulnerability to schizophrenia. Educational
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achievement may reflect delayed or less fulminant pathology within thalamocortical 
circuits. Correspondingly, good premorbid functioning (suggested by educational 
achievement) is associated with reduced negative symptomatology and a more positive 
outcome in schizophrenia (Johnstone et al 1995).
Conclusion
VBM confirms the most consistent neuroimaging reports from the 
schizophrenic literature of distributed cortical changes while revealing more specific 
thalamocortical grey matter depletion in schizophrenia. Furthermore prefrontal cortical 
regions demonstrated the strongest correlation with a positive family history of 
schizophrenia suggesting that thalainofrontal dysconnectivity may selectively increase 
vulnerability to schizophrenia. These data add further weight to the theory of an 
underlying thalamocortical basis to schizophrenia.
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CHAPTER 9 
CLINICAL GROUPS 
PURE AUTONOMIC FAILURE
Guide to Reader
Pure autonomic failure (PAF) is an acquired disease characterised by selective, 
peripheral denervation of the autonomic nervous system. In response to physical or 
cognitive effort patients with PAF fail to generate bodily states of arousal via the 
autonomic nervous system. Previous functional imaging studies have implicated a 
number of brain regions in the generation and representation of states of arousal 
including the anterior cingulate, insula, medial prefrontal cortex and pons, however 
conventional neuroimaging studies have failed to demonstrate any structural correlates. 
In this study I use VBM to test the hypothesis that longstanding absence of peripheral 
autonomic responses in PAF patients is accompanied by structural alteration of brain 
regions known to be involved in autonomic control.
Introduction
Animal studies of cerebral autonomic control have focused predominantly on 
hypothalamic, brainstem and cerebellar mechanisms of autoregulatory homoeostatic 
control (Spyer 1999) with less emphasis on the role of higher brain regions. There is 
however experimental evidence that autonomic responses can be modulated by 
specific neocortical, limbic and subcortical structures (Butcher and Cechetto 1995; 
Kaada 1951). In humans, direct stimulation of cingulate (Pool and Ransohoff 1949), 
insula (Oppenheimer et al 1992) and medial temporal lobe (Fish et al 1993) induces 
distinct autonomic responses. Furthermore lesions of the anterior cingulate, 
ventromedial prefrontal cortex, insula and medial temporal lobe diminish autonomic 
responsiveness (Tokgozoglu et al 1999; Tranel and Damasio 1994; Tranel 2000). 
Functional imaging studies have demonstrated involvement of anterior cingulate, 
insula and pons in generation and representation of cardiovascular arousal (Critchley et 
al 2000a), medial prefrontal cortex and anterior insula during variation of
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electrodermal activity (an index of sympathetic arousal) (Critchley et al 2000b) and 
anterior cingulate during states of autonomic arousal with anticipation (Critchley et al 
2000a).
PAF patients cannot modulate their bodily state via the autonomic nervous 
system but demonstrate no other sensory or motor neurological deficit. As a result 
there is no integrated central feedback of information about the autonomic changes that 
normally accompany behaviour (Mathias 2000). A cardinal feature of PAF is the 
failure of neurogenic control of circulation, and in particular orthostatic hypotension 
due to an inability to vasoconstrict during orthostatic challenges (Mathias et al 1999; 
Mathias and Bannister 1999; Mathias 2000). PAF patients do not generate increases in 
heart rate and blood pressure when performing stressor tasks such as effortful exercise 
or mental arithmetic (Mathias et al 1999) and do not increase circulating 
catecholamines during physical or emotional challenges (Mathias et a l 1999). These 
patients also show absent sympathetic skin conductance responses to emotive and 
orienting stimuli (Magnifico et al 1998) and diminished pupillary reflexes (Clark and 
Ewing 1988). Histologically there is evidence of Lewy bodies in peripheral autonomic 
ganglia (Matthews 1999), but the precise underlying pathophysiology remains unclear.
PAF can be clinically differentiated from central neurodegenerative causes of 
autonomic failure such as multiple system atrophy (MSA) or Parkinson’s disease by 
absent clinical and hormonal indicators of central neurological degeneration and 
normal life expectancy (Kimber et al 1997; Mathias et a l 1999; Mathias and 
Bannister 1999; Mathias 2000). Functional abnormalities have been observed in PAF 
patients in the pons, insula and somatosensory cortices associated with homeostatic 
regulation of bodily states. Changes in cingulate activity have been associated with 
context-dependent changes in bodily arousal (Critchley et al 2000b; Critchley et al 
2001b). During fear-conditioning, the absence of peripheral arousal in response to a 
learnt threat-stimulus is associated with reduced activity in amygdalar and insular 
regions (Critchley et al 2002). Such findings provide strong evidence that the 
cingulate, insula, pons and amygdala are involved in autonomic control and highlight 
the importance of afferent feedback in influencing central representations of autonomic 
responses.
Qualitative assessment of brain imaging in PAF patients is characteristically 
normal. In this study, VBM is used to reveal subtle structural changes within regions 
known to be functionally involved in autonomic arousal, but as yet undetected by
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conventional imaging appraisal. The hypothesis being that chronic absence of 
peripheral autonomic responses would result in regional morphometric differences in 
specific brain areas functionally implicated in central autonomic control and 
representation namely cingulate, insulae, pons and amygdalae.
Methods
Subjects
Fifteen patients (9F, 6M; mean age ± S.D. 62yrs ± 8) with an established 
diagnosis of PAF (greater than 5 years of symptoms of orthostatic hypotension and 
dysautonomia, without clinical evidence of non-autonomic pathology or central 
neurological degeneration (cerebellar signs, parkinsonism)) were recruited by Dr Hugo 
Critchley. All patients underwent full clinical assessment by Professor Mathias’ team. 
In addition 15 healthy right-handed age and sex- matched controls were recruited (9F, 
6M; mean age ± S.D. 62yrs ± 9). Diagnostic axial dual-echo MRI scans for each PAF 
subject were examined by an experienced neuroradiologist to exclude patients with 
MRI evidence of additional pathology, in particular neurodegenerative syndromes such 
as multiple system atrophy. All subjects gave full, informed, written consent 
(Declaration of Helsinki, 1991) and approval for the study was obtained from the 
Local Research Ethics Committee of the National Hospital for Neurology and 
Neurosurgery (TJCLH, NHS Trust) and the Institute of Neurology (UCL). Details of 
the PAF patients are listed in Table 9.1.
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Table 9.1: Pure autonomic failure patient details
Gender Age
(years)
Duration of symptoms 
(years)1
ADL score2
Male 69 7 3
Male 42 8 1
Male 63 9 1
Male 55 11 9
Male 65 14 7
Male 66 15 10
Female 63 7 7
Female 61 8 1
Female 65 8 9
Female 64 8 10
Female 54 12 15
Female 61 13 10
Female 79 13 12
Female 64 14 7
Female 64 15 10
Symptom duration was estimated retrospectively from clinical interview with patients 
(Professor Mathias’ team)
2ADL = Activities of Daily Living (Katz et al., 1965), a general questionnaire scoring 
levels of disability in daily life. Variability in ADL score may reflect in part efficacy of 
treatment with hypertensive agents.
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Structural MR scanning
Subjects were scanned on a 2 Tesla Siemens MAGNETOM Vision scanner. A 
3D structural MRI was acquired on each subject using a T-l weighted MPRAGE 
sequence (TR/TE/TI/NEX 9.7/4/ 600/1, flip angle 12°, matrix size 256 x 192, FOV 
256 x 192, yielding 120 sagittal slices and a slice thickness of 1.5mm with in plane 
resolution of 1mm x 1mm).
Data pre-processing fo r  voxel-based morphometry
The optimised VBM protocol was followed (see Chapter 2 for full details). 
Processing components pertinent to this study will be emphasized here. Customised 
grey and white matter templates were created from the study group according to 
previously described methods.
Statistical Analysis
Modulated and unmodulated data were analysed separately. Firstly, regionally 
specific group differences in grey and white matter volume and concentration were 
assessed by constructing separate design matrices using global (grey or white matter) 
voxel intensity, age and gender of subjects as confounding covariates. Secondly, 
across the PAF patient group, regression analyses tested for morphometric changes 
correlating with duration of autonomic symptoms and severity of disability (scored 
using the Activities of Daily Living (ADL) Questionnaire (Katz et al 1965), with age 
and gender as confounding covariates. Differences were reported if significance 
reached p < 0.05, corrected for whole brain, or when corrected for small volume of 
identified a priori regions of interest from human functional neuroimaging evidence, 
specifically published studies of autonomic control in healthy controls and PAF 
patients. The regions of interest were (1) anterior cingulate /medial prefrontal cortex 
(Critchley et al 2000b; Critchley et al 2000a; Critchley et al 2001a; Critchley et al 
2001b); (2) insulae (Critchley et al 2000b; Critchley et al 2001b; Critchley et al 
2002), (3) amygdalae (Critchley et al 2002) and (4) pons (Critchley et al 2000a; 
Critchley et al 2001b). Anatomical regions of interest were delineated bilaterally on 
the unsmoothed customised template (average normalized brain image derived from all 
30 subjects in the study) using MRIcro on a MS-Windows platform 
(http://www.psychology.nottingham.ac.uk/staffrcrl/mricro.html). MRIcro enables the 
manual delineation of volumes of interest in three planes. The anatomical boundaries
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of the amygdalae, anterior cingulate and insular cortices were traced manually in three 
planes with reference to the anatomical atlas of (Duvemoy 1999). The delineated 
volumes were smoothed (4mm FWHM) then saved to produce mask images that 
reflected regional spatial extent and underlying anatomy of the a priori regions of 
interest and enabled simultaneous testing of contralateral areas. The bilateral anterior 
cingulate mask was 20392 voxels; insulae mask, 14612 voxels; amygdala mask, 1268 
voxels; and the pontine mask was 7400 voxels where voxel size was 1.5 x 1.5 x 1.5 
mm3. These masks were applied individually for small volume significance correction 
of regional effects.
Results
Global structural differences
No between group differences (PAF patients and controls) were observed for total brain 
volume (t(28) = 0.5, p= 0.5) or concentration. There were no significant between-group 
differences in global volumes of grey matter, t(28) = 0.82, p = 0.4; white matter, t(28) = 
0.13, p = 0.9 or CSF, t(28) = 0.53, p = 0.6, suggesting that there is no systematic or 
generalized atrophy associated with PAF (Fig. 9.1).
Regional grey matter structural differences
PAF subjects had significant reductions in grey matter volume and 
concentration in the left anterior cingulate (peak coordinates: volume, -11,38,27; 
concentration, -9,35,27; p < 0.05, corrected for bilateral anterior cingulate) (Fig. 9.2), 
and right anterior insula / frontal operculum (48,14,10; 46,21,0, p < 0.05, corrected for 
insular mask), extending to right inferior prefrontal gyrus (57,18,9, p = 0.08). 
Reductions in grey matter concentration were observed at an uncorrected level in 
dorsal and ventral pons of PAF subjects, but did not reach p < 0.05, corrected for the 
whole pontine region (-17,-30,-29, p = 0.08, corrected; and 3,-15,-26, p = 0.12, 
corrected). VBM detected no significant reduction of grey matter volume or 
concentration in the amygdalae of PAF subjects (Table 9.2). There were no significant 
regional increases in grey matter in PAF subjects relative to controls.
Figure 9.1: Global brain volume differences
No significant between-group differences in global volumes of grey matter, t(28) 
0.82, p = 0.4; white matter, t(28) = 0.13, p = 0.9 or CSF, t(28) = 0.53, p = 0.6.
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Table 9.2: Regional grey matter differences between PAF patients and controls
Location Grey matter volume Grey matter concentration
Side Coordinates T Side Coordinates T
value value
Anterior cingulate L
L
-11,38,27
-9,2,36
5.45*
4.09
L -9,35,27 5.02*
Subgenual cingulate - - - L -6,51,-8 3.95
Anterior insula R 57,18,9 5.46* R 54,18,6 4.47
extending to inferior 
frontal gyrus
R 48,14,10 4.19* R 48,21,0 4.60*
Pons -dorsal 
-ventral
- " - L -17,-30,-29 
3,-15,-26
3.94
3.76
* Significant p < 0.05, corrected for full extent of bilateral anatomical structure
Regional white matter structural differences
No significant between-group differences were observed in regional volume or 
concentration of white matter.
Within-group correlations o f  grey matter reductions
VBM assessed whether observed morphometric differences in grey matter were 
influenced by the duration of autonomic symptoms or degree of disability. Age and 
gender were treated as confounding covariates. There was no significant regional 
change of grey matter volume or concentration related to the duration and severity of 
disability across whole brain or in regions of a priori interest in regression analyses 
confined to the 15 PAF patients. The adjusted data for grey matter changes in left 
anterior cingulate in PAF patients, observed in the group comparison with control 
subjects, correlated negatively with the ADL score of the patients (Pearson R = -0.65, 
p < 0.05). This observation suggests that increasing severity of the symptoms of 
peripheral autonomic failure is associated with increased morphological change within 
an anterior cingulate region known to be implicated in autonomic control.
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Figure 9.2: Regional grey matter reduction in PAF
Above, significant anterior cingulate reduction in grey matter volume projected on the 
template. Below, the effect size for grey matter volume differences in the peak voxel for 
this contrast for each PAF and control subject is plotted.
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Discussion
Previous conventional neuroimaging studies have not shown any structural 
alterations in the brains of patients with pure autonomic failure (PAF). Here, using a 
sensitive whole brain technique, guided by strong prior hypotheses for regions known 
to be functionally implicated in autonomic control, biologically plausible structural 
alterations are now revealed. Clinical and pathological evidence suggest that PAF is a 
peripheral disorder with selective compromise of postganglionic autonomic responses 
(Mathias and Bannister 1999; Mathias 2000). In this group of PAF patients VBM 
shows regional reductions in cortical grey matter in distinct brain regions known to be 
involved in the generation and representation of autonomic responses. Moreover a 
correlation is observed between anterior cingulate cortex morphology and severity of 
physical symptoms, suggesting that selective loss of cortical grey matter is a 
consequence of longstanding absence of afferent feedback from autonomic responses. 
There was no significant correlation between observed morphometric changes and 
illness duration. There could be a number of reasons for this. The insidious onset and 
overlap of autonomic symptoms with a range of other physical and psychological 
disorders may delay their recognition by patients and clinicians. Furthermore, 
compensatory physiological, postural and behavioural mechanisms in the early stages 
of autonomic failure may confound retrospective dating of symptom onset, and clinical 
severity scores such as ADL may be influenced by therapeutic interventions (Mathias 
et al 1999; Mathias 2000). These factors, coupled with the small patient group and 
stringent analytical methods of VBM may explain the absence of a correlation between 
regional morphological changes and symptom duration.
Although some single post-mortem studies have reported Lewy bodies in the 
brainstem of PAF patients there has been no previous clinical or radiological evidence 
for an underlying central pathology. Lewy bodies in PAF are characteristically 
confined to peripheral autonomic ganglia, and this condition remains clinically and 
prognostically different from more pernicious diseases such as Multiple System 
Atrophy (MSA, Shy-Drager syndrome) (Mathias 2000). Importantly, VBM reveals no 
group differences in global measures of grey and white matter and CSF suggesting 
normal global cerebral integrity. The regionally specific morphometric differences in 
PAF subjects are therefore more likely to arise as a direct consequence of longstanding 
peripheral autonomic failure.
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VBM reveals local grey matter reductions within anterior cingulate and 
insula/inferior prefrontal cortex in PAF patients relative to controls. These areas are 
known to be involved in generation and representation of autonomic states of bodily 
arousal. Anterior cingulate plays a role in autonomic arousal. Functional imaging 
studies in healthy subjects have shown a correlation between right anterior cingulate 
activity and measures of cardiovascular arousal, such as blood pressure (Critchley et 
al 2000b). Bilateral anterior cingulate activity is modulated by the degree of 
anticipatory aroused (Critchley et al 2001a; Critchley et al 2001b) and increased 
anterior cingulate activity, particularly in the left hemisphere is associated with the 
intention to decrease sympathetic tone during biofeedback relaxation exercises 
(Critchley et al 2001c). Evidence from PAF patients also indicates that anterior 
cingulate contributes to generation of autonomic states of arousal. PAF patients show 
enhanced right anterior cingulate activity while performing effortful tasks that 
normally engender cardiovascular arousal in healthy subjects (Critchley et al 2001b; 
Critchley et al 2001a). A possible explanation for anterior cingulate grey matter loss is 
that poverty of afferent information results in reduced functional representation of 
autonomic states and subsequent morphological adaptation. In accordance with this 
theory is anatomical evidence of direct afferent and efferent connections between 
anterior cingulate, insula and pontine nuclei that are implicated in control of central 
and peripheral arousal (Porrino and Goldman-Rakic 1982).
Insula cortices play an important role in the representation of somatic states and 
bodily responses. Functional imaging studies show insula activity during a variety of 
conditions that elicit or reflect a modulation of visceral state such as micturition (Nour 
et al., 2000), oesophageal distension (Aziz et a l 2000), respiratory challenge (Corfield 
et al 1995), thermosensory stimulation (Craig et al 2000), cardiovascular arousal 
(Critchley et al 2000a) and electrodermal activity (Critchley et al 2000b). In PAF, 
functional imaging shows decreases in insula activity relative to controls (Critchley et 
al 2001b). The observed grey matter reductions within anterior insula cortex of PAF 
patients would also be consistent with involutional adaptation in response to loss of 
integrated feedback of autonomic responses. In this study the volume reductions 
extended into prefrontal operculum and inferior prefrontal gyrus which have both been 
implicated in error detection (Menon et al 2001).
Local decreases in grey matter concentration were observed in the dorsal and 
ventral pons of PAF patients, but did not survive corrected significance. Functional
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imaging of PAF patients shows context-independent increases in dorsal pons activity 
(Critchley et al. 2001b). Brain stem regions including the pons support homoeostatic 
and effector mechanisms for control of autonomic responses (Spyer 1999) and have 
been proposed as a site of first-order representation of bodily states (Damasio 1999). 
The absence of marked morphometric differences in the pons of PAF subjects may 
reflect sub optimal segmentation of pontine tissue into grey and white matter 
compartments owing to poor intrinsic contrast of this region, but since I performed 
grey and white matter analyses any systematic group difference would have been 
revealed. Another possibility is that increased functional activity results in a relative 
preservation of grey matter that maximizes residual autonomic responses during the 
early stages of autonomic failure. However, it is possible that morphometric 
adaptations to absent autonomic responses preferentially impact only on cortical 
regions involved in integrating bodily representations with behavioural experience, 
rather than regions involved primarily in autoregulation. It was surprising that no 
morphometric differences were apparent in the amygdalae since these are known to be 
involved in generation of emotional autonomic responses and also mediate memory- 
enhancement of salient material perhaps through arousal mechanisms. Functional 
imaging in PAF shows markedly reduced amygdalar responses to threat stimuli in 
association with absent peripheral autonomic responses (Critchley et al 2002). There 
is no clear explanation why the morphology of some autonomic brain regions is 
differentially affected.
Conclusion
VBM reveals previously occult structural changes in PAF patients 
corresponding to regions that are known to be functionally implicated in both 
autonomic control and emotional behaviour. PAF patients show significant reductions 
of grey matter concentration and volume within anterior cingulate and insula cortices 
and more subtle changes within the pons. Furthermore, VBM demonstrates a 
relationship between anterior cingulate cortex structure and severity of physical 
symptoms in PAF patients. These data add weight to evidence from functional imaging 
studies of central control of autonomic responses in humans and provides empirical 
evidence for adaptive changes in the adult human brain consequent to peripheral 
autonomic dysfunction.
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CHAPTER 10 
GENOTYPE-PHENOTYPE MAPPING 
VBM MAPPING OF THE X CHROMOSOME
Guide to Reader
Major advances in molecular imaging now allow precise localization of genes 
and an almost complete map of the human genome. As a result of the human genome 
project, new disease genes are discovered almost weekly. Recent important discoveries 
include genes for prostate cancer, breast cancer, holoprosencephaly and Alzheimer’s 
disease. Genotype-phenotype correlations allow insight into illness at a molecular 
level. Over time, this can lead to the development of treatments, prevention strategies 
and accurate diagnostic tests, which in some instances can be life saving. Since VBM 
has been shown to be sensitive to subtle changes in brain morphology, and previous 
studies of Alzheimer’s disease for example, have demonstrated morphological changes 
that precede the onset of clinical symptoms, it follows that the structural brain 
phenotype may correlate more closely with genotype than the clinical phenotype. In 
this study, I test whether VBM is a useful tool to characterise the relationship between 
genotype, structural brain phenotype and cognitive phenotype in patients with 
deletions of one X chromosome. Using the versatility of the General Linear Model, I 
employ a gene deletion mapping strategy to identify regions on the short arm of the X 
chromosome containing putative candidate genes coding for specific structural brain 
phenotypes.
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Introduction
A fundamental role for the X chromosome in neurodevelopment is suggested 
by reports of altered cognitive profiles in those with sex chromosome aneuploidies.
The evolution of the sex chromosomes has given rise to unique mechanisms of 
regulation so as to equalise gene expression between the sexes (Disteche 1999). In 
normal females one of the two X chromosomes is inactivated at random in order to 
ensure equal expression of X-linked genes in male and female mammals (Lyon 1961). 
Genes that escape X inactivation are found at the tips of the X and Y chromosome 
arms, the so called pseudo-autosomal regions, where the equivalent nucleotide 
sequence is identical in both sex chromosomes, thus allowing meiotic recombination to 
take place. Surprisingly, many genes are now known to escape X inactivation 
elsewhere on the X chromosome. These are non-randomly distributed, lie mostly on 
the short arm and do not necessarily have expressed Y homologues (Carrel et al 1999; 
Carrel and Willard 1999). Persistence of dosage imbalance in such genes between 
males (46,XY) and females (46,XX) may be important for sex specific functions 
(Disteche 1999). Turner syndrome (TS) offers a convenient natural experiment to 
study genotype-phenotype correlations of the X chromosome. This sporadic genetic 
disorder of human females is associated with complete or partial absence of one X 
chromosome and is associated with a characteristic neurocognitive and psychosocial 
profile. I suggest that it should be possible to identify the effects of dosage sensitive 
loci on brain development by studying TS females and that this would constitute a 
proof-of-principle study attempting to assess genotype-phenotype correlations of the 
human brain in life.
TS has a prevalence of 1 per 2500 live female births* in which typically all 
(45,X or X-monosomy) or a substantial part of one X chromosome is missing due to 
nondisjunction or chromosome lost during early cleavage of the zygote. In 70% of 
monosomic (45,X) TS the single X is maternally inherited (Jacobs et al 1997), the 
remainder are paternally inherited. In monosomic TS the single X chromosome is 
never inactivated, whereas in normal females (46,XX) one of the two X chromosomes 
is inactivated at random during the blastocyst stage of development (Boumil and Lee 
2001). Dosage-sensitive genes that escape X inactivation may contribute to the TS 
phenotype if haploinsufficient in X monosomy. For example, SHOX (Blaschke and 
Rappold 2001) is now known to contribute to the short stature of the syndrome, and is
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normally expressed from the pseudo-autosomal region (PARI) of both X and Y 
chromosomes.
Most cases of TS syndrome show normal verbal abilities but almost all have 
poor visuospatial skills (Temple and Carney 1993; Temple and Carney 1996). 
Impairments in social skills and affective discrimination affect the majority, who may 
be socially isolated with a poor concept of self (McCauley et al 1987; Ross et al.
2000; Ross et al. 2002). Recent evidence shows that the condition is associated with a 
substantially increased risk of autism (at least 200 fold) (Creswell and Skuse 1999). 
Milder autistic features of behaviour such as failure to understand non verbal social 
cues and poor maintenance of eye contact are much more common affecting up to 30% 
of 45,X females (Lawrence et al. 2003). Phenotypic features of the syndrome relating 
to neuronal dysfunction are due in large part to haploinsufficiency for X linked gene 
products that are normally expressed in two copies from genes that normally escape X 
inactivation in normal 46, XX females (Ross et al 2002). Males are also potentially 
haploinsufficient for these gene products, because few X linked genes that escape X 
inactivation outside the pseudo-autosomal regions at the tips of the X chromosome 
have expressed Y homologues (Disteche 1999). Accordingly one could reason that it 
should be possible, through a study of individuals with X chromosome anomalies, to 
map dosage sensitive genes that influence sexually dimorphic cognitive abilities. This 
hypothesis has received considerable recent support in terms of both theory (Zechner 
et al 2001) and empirical evidence from other species (Xu et al 2002). Owing to the 
predisposition of 45,X females to show autistic features, one could also hypothesise 
that dosage sensitive genes that contribute to this aspect of the TS phenotype may also 
explain male vulnerability to develop disorders of social cognition.
No genes have yet been identified that contribute to the cognitive or 
behavioural disorders of TS. Deficits ip social cognition in particular are highly 
variable in X monosomy when measured by conventional rating scales or interviews. I 
thought that the structural brain phenotype might be more consistently abnormal than 
cognitive deficits in 45,X females relative to normal 46, XX females. In this 
investigation, I aimed to firstly characterise the structural brain phenotype of 
monosomic X females (45,X) and secondly to identify dosage sensitive X linked loci 
that influence the structure and function of neural systems affecting social-cognitive 
development. I used a deletion mapping strategy, based on a study of brain structural 
and cognitive phenotypes in females with variably sized deletions of the X
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Methods
This study, which had the approval of the Local Research Ethics Committee of 
The National Hospital for Neurology and Neurosurgery (UCLH, NHS Trust) and the 
Institute of Neurology (UCL), involved 64 females with X-chromosome anomalies (51 
TS 45,X, ages 15- 44 yr. and 13 partial X chromosome deletions (46,XXp-); ages 9 to 
52 yr.). All were selected on the basis that they had no significant learning difficulties. 
40% had participated in some form of higher education and 20% had attended 
university. Subjects’ consent was obtained according to the declaration of Helsinki 
(BMJ, 1991; 302:1194).
Karyotyping
Karyotypes were determined in the Wessex regional genetics laboratory by N. 
Simon Thomas by analysis of G banded metaphase chromosomes harvested from 
peripheral blood. DNA for molecular studies was extracted by salt precipitation. 
Parental origin of the normal X chromosome was determined using the polymerase 
chain reaction (PCR) to amplify DNA polymorphisms from each proband and their 
parents. Deletion breakpoints (James et al 1998) were also mapped by PCR using a 
panel of short tandem repeat polymorphisms spanning the X chromosome short arm. 
Standard PCR conditions were used throughout and all primer sequences are available 
through the Genome Database. The X inactivation status of a deleted X chromosome 
was determined at the androgen receptor locus. In deletions 5 to 13 the abnormal X 
was unilaterally inactivated. In order to detect possible mosaicism a minimum of 50 
cells per individual, and usually 100 cells, were analysed cytogenetically. All 45,X 
females were apparently non-mosaic in peripheral blood, although this does not 
exclude the presence of an additional cell line in the brain. Among the deletion 
carriers, a 45,X cell line was also present in three cases: in number 1 (10% of cells), 
number 7 (46% of cells) and in number 12 (45% of cells). Thus these three cases have 
an X chromosome complement intermediate between monosomic 45 ,X females and 
normal females.
Subjects
Clinical subjects were selected from a national survey of TS and from the
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records of the Wessex Regional Genetics Laboratory and assessed by Professor D 
Skuse in the Behavioural and Brain Sciences Unit, Institute of Child Health. The mean 
age of the 45,X females was 25.1 years (s.d. 7.1), and that of the 46,XXp- females was 
26.4 years (s.d. 13.2). Mean Verbal IQ of the 45,X and 46,XXp- females was similar 
(96.9 s.d. 13.3 vs. 101.6 s.d. 12.3) as was their Performance IQ (90.3 s.d. 16.0 vs.
91.0 s.d. 17.6). All subjects were healthy with no significant neurological disease. All 
45,X women had been receiving sex steroid replacement therapy since early 
adolescence. The comparison group of 45 normal 46,XX women was matched to the 
45,X group in terms of mean age (24.1 yr., s.d., 4.6) and Verbal IQ (Wechsler, 
1986)(100.9, s.d., 11.7). Their mean Performance IQ of 108.1 (s.d., 14.4) was 
significantly greater than that of 45 ,X females, (p<0.001), as expected (Temple and 
Carney 1993; Temple and Carney 1996). I imaged 21 apparently non-mosaic Turner 
syndrome females with a 45X karyotype (45,X), 17 age and verbal IQ matched control 
females (25 yr. ± 9.0) and 25 age matched normal males (27.1 yr. ± 8.1). Eleven had a 
single X-chromosome of maternal origin (45,Xm) (mean age 24.3 yr. ± 7.5) and 10 of 
paternal origin (45,Xp) (22.3 yr. 6.4).
MR scanning and imaging analysis
High resolution volumetric MR imaging was performed on a Siemens 2T 
Magnetom scanner using an optimised MPRAGE sequence which affords enhanced 
grey /white matter contrast and segmentation (Deichmann et al 2000; Deichmann et 
al. 2002). The acquisition parameters included: TR/TE/TI 11/4/1000, flip angle 12, 
matrix 256 x 224, FOV 256 x 224mm; 176 sagittal slices, 1mm isotropic voxels. The 
optimised method of voxel-based morphometry was used (see Chapter 2). A 
customized grey matter template was derived from all the Turner syndrome patients 
and control subjects in order to avoid any bias during the spatial normalisation step.
Assessment o f  fear recognition
Based on a hypothesis that characteristic social adjustment problems of TS 
(McCauley et al 1987) could be linked to amygdala dysfunction, subjects were tested 
by Professor D. Skuse using Ekman pictures of facial affect (Ekman 1976). Subjects 
were shown sixty pictures of male and female faces and had to decide which emotion 
was being conveyed by the particular facial expression; happiness, sadness, fear, 
surprise, anger or disgust. Fifty-one 45,X individuals were compared to forty-five
198
normal 46,XX females matched for age and verbal IQ.
Statistical analyses
Regionally specific structural differences were assessed statistically using a 
two-tailed test, testing for increased or decreased grey matter. Corrections for the 
search volume, and implicit multiple comparisons, were made to the p values using 
Gaussian random field theory. Significance levels were set at p<0.05, corrected for 
whole brain volume. Because the amygdala had been identified a priori as a possible 
candidate for structural change, amygdala changes were small volume corrected using 
a sphere of 40mm diameter as a generous estimate of total amygdala volume. The 
design matrix modelled the control group, the 45,X group (divided according to the 
maternal or paternal origin of the single X chromosome), and individual partial 
deletions arranged in order of the number of megabases missing from the short arm of 
the X chromosome (Fig. 10.1). The mean global grey matter intensity was modelled as 
a covariate in order to facilitate the detection of regionally specific structural changes 
having discounted global differences. Age was included as a confounding covariate. In 
a separate analysis I compared normal males, normal females and 45,X females with 
mean global grey matter and age as covariates.
A separate analysis tested for fear recognition differences between Turner 
syndrome (45,X) and normal females (46,XX). Scores for the 6 emotions were entered 
into a MANOVA, covarying for Performance IQ, with Bonferroni corrections.
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Figure 10.1: Design matrix for gene deletion mapping
Columns 1-14 represent the different genotypes: column 1 representing normal females 
(46,XX), columns 2-12 representing partial deletions arranged in order of increasing 
size of deletion, columns 13 and 14 represent Turner females with a single X 
chromosome (45,X) divided according to their maternal (13) or paternal (14) origin. 
Age and global voxel intensity are modelled as confounding covariates. In column 3, 2 
subjects (mother and daughter) had the same partial deletion size).
46X X
46X X p- 
partial deletions
■■■
parameters
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Results
VBM detected an altered brain structural phenotype in X-monosomic females 
(45,X) with significantly increased grey matter volumes of the amygdalae with local 
extension into the hippocampal heads and entorhinal cortices (local maxima: -37 -12 - 
22; -12 -18 -21; 21-10 -24) (Fig. 10.2a) and orbitofrontal cortex bilaterally involving 
posterior and lateral orbital gyri and gyri recti (local maxima: -4.5 22 -27; -39 36 -20; 
±31 -82 -21) (Fig. 10.3). In Chapter 4 ,1 showed that VBM reveals a remarkably 
similar pattern of gender difference in the amygdala structure of normal subjects; 
males (46,XY) have increased grey matter compared with females (over and above the 
global grey matter differences between the sexes)(Fig. 10.2b)(Good et al., 
2001a;Murphy et al., 1993). In this study, matched samples of normal males with 
46,XX and 45,X females revealed that, although males did have larger amygdalae than 
normal females (p<0.001 uncorrected), those of 45,X females were larger still (p<0.05 
corrected). These findings suggest a dose-response relationship between the expression 
of one or more X-linked genes that escape inactivation (and which lack Y- 
homologues) and the structural development of the amygdala. In Chapter 4 ,1 detected 
no physiological gender difference (46XX vs 46XY) in orbitofrontal cortex grey 
matter volume or concentration, suggesting that separate processes influence the 
development of this brain region.
Figure 10.2: The Turner brain phenotype.
Similarities between the Turner brain phenotype and physiological male-female 
differences (see Chapter 4) with regionally specific increases in amygdala volume 
Turner females and normal males compared to normal females. (Coronal images 
through y =1 for each contrast for illustrative purposes)
(a) 45,X -  46,XX 
Turner -  normal females
(b) 46,XY -  46,XX 
normal males - females
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Figure 10.3: VBM detected brain structural phenotype in Turner syndrome.
Regionally specific bilateral grey matter volume increases within orbitofrontal cortex 
centred on posterior and lateral orbital gyri and gyri recti, p<0.05, corrected) in Turner 
females (45,X) compared with normal females (45,XX) projected onto a normalised 
image from a single Turner subject (a) (-39 33-21) and the smoothed customised 
template (b) (-4.5 22.5 25.5). The colour bar represents the T score for (a).
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45,X females were substantially impaired at recognizing fear (p<. 0001, effect 
size = 1.3) and anger (p<. 006, effect size = 1.0) relative to 46,XX females (Fig. 10.4), 
but they were unimpaired in the recognition of other facial emotions. None was aware 
of their perceptual deficit. They could provide plausible situations in which fear or 
anger might be experienced, but many could not recount times when they themselves 
had experienced these emotions. Face emotion perception was similar in normal 
females and an age and IQ matched sample of 16 normal males. Males lacked the fear 
recognition deficit of 45,X TS, despite their single X-chromosome and relatively larger 
amygdalae than 46,XX females. This dissociation suggests that the increased grey 
matter I observed in the orbitofrontal cortex (OFC) of 45 ,X females, which was not 
seen in normal males (compared to normal females), was associated with compromised 
functional integrity of an emotion processing neural circuit in the 45,X group. Face- 
selective neurons can be identified in the primate orbitofrontal cortex (Scalaidhe et al
1999)and ventral frontal lobe damage in humans impairs the identification of face 
expression, but not of face identity (Homak et al 1996). The orbitofrontal cortex 
(OFC) receives inputs of the same general type as the amygdala, and is certainly 
connected intimately with it (Rolls 2003).
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Figure 10.4. Recognition of fear in facial expressions.
Mean ratings of fear recognition for subject groups presented as standard deviation 
scores below population norms. Bars indicate 2 standard errors. There is no significant 
difference in the fear recognition skills of 46,XX females (n=17) and 46,XXp- females 
with small deletions extending no further than DXS1058 (cases 4-8 in Figure 2). 45,X 
Turner syndrome females (n=51) and 46,XXp- females with larger deletions extending 
beyond DXS8083 (cases 10-13 in Figure 2) demonstrate significantly less accurate fear 
recognition than 46,XX controls (p<.005, effect size = 1.5). Patient DR (who underwent 
bilateral amygdalectomy) was tested on the same fear recognition task.
- 0.0
ok—oo<o
N
-5.0
- 10.0
46,X X  cases cases 45,X  patien t DR
4-8 10-13
Using the subjects with partial deletions of the short arm of the X chromosome 
(46,XXp-), I then employed a gene deletion mapping strategy to attempt to identify a 
putative dosage-sensitive locus coding for the structural brain phenotype. This sample 
of 13 females had variably sized breakpoints, all but one terminal, which ranged in size 
from 5Mb to 55Mb from the telomere. For the purpose of analysis they have been 
numbered 1-13 in increasing size of deletion (Fig. 10.1). Subjects with breakpoints
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including or proximal to the locus DXS8083 (44.07 Mb from Xpter) were 
phenotypicaJly similar to 45,X, with significantly increased grey matter in the 
amygdala and orbitofrontal cortex (Fig. 10.5 and 10.6). In contrast, these brain 
structures were indistinguishable from normal in 46,XXp- females with breakpoints 
distal to the locus DXS1368 (39.11 Mb from Xpter). Partially deleted subjects had fear 
recognition skills that closely mirrored their brain phenotypes (Fig. 10.4). No other 
aspect of cognitive or somatic phenotype differentiated those with deletions that 
extended beyond the critical region from the remainder.
These findings suggest that a dosage-sensitive locus, influencing both 
amygdala and orbitofrontal cortex development in 45,X females, lies in the interval 
between 39.11 and 44.07 Mb from the telomere of the short arm. This critical region is 
defined by loci DXS1368 (distally) and DXS8083 (proximally) (Fig. 10.7) and must 
contain one or more genes which escape X inactivation, and are thus needed in two 
copies in 46,XX females for normal development to occur. Genes escaping X- 
inactivation tend to exist in clusters and, significantly, at least one cluster maps within 
the DXS1368 - DXS8083 interval (Carrel et al 1999; Carrel and Willard 1999; 
Disteche 1999; Sudbrack R 2001). Within this 4.96 Mb interval there are 25 known 
genes and also 12 putative genes with potential open reading frames. However, the 
sequence between DXS1368 and DXS8083 contains seven large gaps of unknown size 
and therefore there are likely to be additional genes to those already described. There is 
a block of homology between this region of the X chromosome corresponding to 
cytogenetic bands Xpl 1.4 and Xpl 1.3 and a non-recombining part of the Y 
chromosome, Ypl 1.2. Of the 20 X-linked genes within this critical region that are 
known to escape inactivation, or whose inactivation status is uncertain, only three 
(USP9X, DDX3 and UTX) have functional Y-homologues. Completion of the Human 
Genome sequencing project and more extensive gene annotation may identify 
additional X/Y gene pairs.
206
Figure 10.5: VBM mapping of partial deletions of the X chromosome
Subjects with breakpoints including or proximal to the locus DXS8083 (44.07 Mb from 
Xpter) were phenotypically similar to 45,X, with significantly increased grey matter in 
the amygdala and orbitofrontal cortex (depicted in red). In contrast, these brain 
structures were indistinguishable from normal in 46,XXp- females with breakpoints 
distal to the locus DXS1368 (39.11 Mb from Xpter).
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Figure 10.6: Gene deletion mapping of the X chromosome
Parameter estimates for VBM detected percentage volume change of the amygdala (a) 
and orbitofrontal cortex (b). The coordinates (x.y.z) at the voxel of maximal effect are 
shown on the vertical axis. Mean values ( ± 2 standard errors) are given, relative to the 
grand mean, for 17 46,XX females, at position 1,11 45,Xm females at position 14 and 
10 45,Xp females at position 15. At positions 2-13 data for 13 individual Xp deletion 
subjects are given in order of increasing size of deletion from the telomere. (There are 
two individuals at position 3 with identical deletions- a mother and daughter). Grey 
matter volume changes occur between subjects 8 and 9 at both locations.
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(b): Left orbitofrontal cortex maximum
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Among the genes in this critical region lie the monoamine oxidases A & B. 
These are nuclear encoded mitochondrial isoenzymes which catalyse the oxidative 
deamination of a number of biogenic amines including the neurotransmitters serotonin 
(5-HT), norepinephrine (NE), and dopamine (DA) as well as the neuromodulator 
phenylethylamine (PEA). Both enzymes have been implicated in predisposition to a 
range of psychiatric disorders (Shih and Thompson 1999) and both genes are 
expressed in human amygdala. MAOB is also expressed in platelets, in which activity 
levels are believed to reflect genotypic variation. Methylation analysis of the MAOB 
5’ CpG island has shown that all CpG dinucleotides tested in DNA extracted from 
lymphocytes were unmethylated on both the active (Xa) and inactive (Xi) X 
chromosomes (Chen et al. 1992). This suggests the gene is expressed from both X- 
chromosomes in normal females, and is not subject to X inactivation. There is no
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functional Y-homologue of MAOB (males in whom it is deleted have no measurable 
MAOB activity). Accordingly, males and 45,X females could be haploinsufficient for 
the gene products, relative to normal females, if up-regulation of their single copy does 
not occur, and 45,X females will show male-typical levels of activity. Work in 
Professor Skuse’s laboratory confirmed prior evidence that the platelet activity of 
MAOB is sexually dimorphic (e.g. Harro et al. 2001), levels in males being 
approximately 30% lower than levels in normal females. He also showed, in a 
preliminary investigation of MAOB activity in non-smokers, mean male levels and 
mean TS (45,X) levels were almost identical. In contrast, mean normal female levels 
were significantly higher (p=0.05).
Discussion
The increased amygdala volumes of 45,X subjects is consistent with previous 
studies that have found an inverse correlation of amygdala volume with the number of 
X-chromosomes, irrespective of sex. Two studies (Goldstein et al. 2001; Good et al. 
2001b) have reported larger volumes in normal males 46,XY compared with normal 
females 46,XX. 47,XXY males have amygdalae of similar volume to 46,XX females, 
whereas the amygdalae of 47,XXX females are significantly smaller than either group 
(Patwardhan et al. 2002). Individual nuclei within the amygdala subserve different 
functions but I was unable, with the scanning resolution available, to distinguish 
whether these substructures were differentially affected.
The amygdala is a critical component of the social cognition circuitry in 
primates. Modular cognitive processes are committed to making social judgments, in 
particular the perception of facial expressions plays a critical role in social intelligence 
(Adolphs et al. 1999; Winston et al. 2002). An influential neurobiological model of 
social cognition (Brothers 1997) postulates that socially relevant information processed 
by sensory and association cortices is imbued with emotional significance by the 
amygdala and orbitofrontal cortex. This model has received widespread support from 
research in both primates and humans (Amaral 2002). Lesion and functional imaging 
studies in humans have demonstrated the amygdala’s role in identifying emotions in 
others. Humans and primates with complete bilateral amygdala damage have difficulty 
recognizing fear (and anger) in facial expressions and they demonstrate subtle
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abnormalities of normal social responsiveness (Adolphs et al. 1999; Young et al. 1995; 
Young etal. 1996).
Within the critical region mapped in this investigation of females with partial 
deletions of the short arm of the X-chromosome, the monoamine oxidase genes are 
clearly contenders for a potential influence upon amygdala development. A recent 
study showed that three of four members of a family of G protein-coupled receptors 
that are activated by trace amines, such as beta-phenylethylamine, are expressed 
exclusively in the human amygdala (Borowsky et al., 2001). Trace amines are 
exceptionally sensitive to the deaminergic actions of MAO genes (in the case of 
phenylethylamine it is especially MAOB (Grimsby et al. 1997)). Accordingly, 
relatively low levels of MAOB activity due to haploinsufficiency in males and 45,X 
females, may produce male-typical patterns of amygdala responsiveness, such as in the 
context of emotional learning (Canli et al. 2002).
Genes that are subject to X-inactivation do not have functional Y-homologues, 
and since expression is from a single X-chromosome in males and females, dosage is 
likely to be equivalent in both sexes. Furthermore, because in Turner syndrome (45,X) 
the single X-chromosome is invariably active it is unlikely that such genes contribute 
in any significant way to the Turner phenotype. In contrast to MAOB, methylation 
analysis of the MAOA CpG island has suggested the gene might be subject to 
inactivation (Hendriks et al., 1992). Although expression of MAOA has not been 
detected from Xi in cDNA from cloned human cell lines, the approach used - reverse 
transcription of intronic polymorphisms (Hendriks et al. 1992)- has limited sensitivity. 
Heterogeneous expression from Xi has been demonstrated for some X-linked genes, 
indicating variability of inactivation between tissues and even between individual 
females (Carrel and Willard 1999). Testing of somatic cell hybrids suggests some 5- 
15% of X-linked genes behave this way (Carrel et al. 1999). It is thus possible that 
MAOA escapes X-inactivation in some tissues. If so, activity would be relatively 
lower in 45 ,X than 46,XX females, as well as being potentially sexually dimorphic 
with lower activity in males. Such a mechanism could exacerbate sex differences in 
vulnerability to disorders affecting predominantly males (e.g. Caspi et al. 2002).
Figure 10.7: Putative candidate genes in the VBM detected locus on the short arm of X chromosome
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Haplo-insufficiency for genes at a dosage-sensitive X-linked locus is not the 
only possible explanation for the structural and cognitive characteristics of brains of 
45,X females. One contributory factor that cannot be discounted by this experiment is 
an interaction between sex steroid abnormalities and neurodevelopment. In 45,X TS 
there is typically ovarian dysgenesis and failure of endogenous oestrogen production. 
Oestrogen receptors are widely expressed in the forebrain, with highest concentrations 
of the alpha-subtype in the amygdala and certain hypothalamic nuclei in both primates 
and humans (Osterlund and Hurd 2001). However, no correlation existed between 
menstrual history and amygdala structure or fear recognition skills in these partial 
deletion subjects. The 46,XXp- female deleted to DXS8083, subject 9, had conceived 
spontaneously and two subjects with larger deletions (subjects 10 and 11) had normal 
menstrual histories. Consequently, oestrogen deficiency is unlikely to be directly 
responsible for abnormalities of brain structure and function, among the 46,XXp- 
sample. It is also possible that environmental influences, perhaps a disadvantage 
relating to short stature, could systematically have affected brain development of the 
45,X relative to 46,XX females. This explanation could not account for the within- 
group differences in brain phenotype of our 46,XXp- subjects, who were all of short 
stature.
It has been shown previously (Skuse et al 1997) that the social adjustment of 
45,X females is influenced by the parental origin of their single X-chromosome. It is 
therefore possible that there is an X linked imprinted locus that is preferentially 
expressed only from the paternally derived X-chromosome -Xp (normally found only 
in 46,XX females). In this investigation of 45,X TS females there were no significant 
differences in the structure of the amygdala or the orbitofrontal cortex nor in the deficit 
in fear recognition according to the parental origin of the single X-chromosome (Xp or 
Xm). However, there are preliminary data showing that an X-linked imprinted locus 
may nevertheless influence the process of emotional learning. A strong correlation has 
been found between accuracy of fear detection from facial features and facial 
recognition memory in normal females (Campbell et al 2002) and in unpublished 
work in 45,Xp Turner syndrome subjects. There is no significant correlation between 
these variables in normal males, or in 45,Xm Turner syndrome subjects who are similar 
to males in their possession of a single maternally derived X-chromosome.
The findings could have relevance to the aetiology of male susceptibility to
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disorders that are associated with social cognitive impairment, such as autism. This 
condition is at least four times as common in males as females. Among subjects whose 
IQ is in the normal range (full scale >70) the ratio is substantially greater. No 
explanation has yet been found for this discrepancy in prevalence, but one possibility 
is that the phenotypic penetrance of genetic susceptibility due to autosomal loci is 
decreased in females, because they possess two X-chromosomes (Folstein and Rosen- 
Sheidley 2001).
Converging strands of evidence suggest the amygdala is functionally and also 
structurally abnormal in autistic individuals (Grelotti et al 2002). They show a lack of 
amygdala activation in fMRI studies of exposure to facial expressions that would 
normally evoke a response, and poor cognitive performance on tasks that involve 
neural processing by this structure. Specifically, amygdala-related cognitive deficits 
include poor facial recognition memory (Davies et al 1994), a failure to recognize 
specific facial emotions, especially fear (Howard et al 2000) and a lack of interest in 
and failure to follow normally eye gaze (Baron-Cohen et al 1997). The data I report 
show that each one of these deficits is characteristic of females with 45,X Turner 
syndrome (Elgar et al 2002).
X-monosomic females also display high levels of autistic symptomatology 
(Creswell and Skuse 1999) which may reflect the developmental consequences of 
failing to acquire normal expertise with faces due to amygdala (and OFC) dysfunction. 
Serotonin (5-hydroxytryptamine, 5-HT) blood levels have often been reported elevated 
in platelets in about one third of autistic subjects and their first-degree relatives 
(Betancur et al 2002). More than 99% of blood 5-HT is in the platelet fraction and 
normal levels of platelet 5-HT are higher in males than females. So far no explanation 
for the excessively high level in autism has been found, but a lack of MAOB activity, 
which is associated with relatively impaired aminergic degradation, is one possibility.
In summary, my data suggest that one or more non-inactivated X-linked genes 
(within a 4.96Mb interval at Xpl 1.3-Xpl 1.4) is involved in the development of a 
neural system that influences social cognitive processing, in which the amygdala plays 
a critical role. If that neural system should become dysfunctional for whatever reason, 
the resultant phenotype would be expected to be sexually dimorphic because of 
amygdala recruitment. My findings suggest that the critical gene is expressed in two 
copies in normal 46,XX females, and that full dosage compensation does not occur in 
46,XY males, or in 45 ,X- monosomy. Sexual dimorphism in the expression patterns of
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one or more genes at this locus is therefore predicted. MAOB is proposed as a 
candidate gene, with an important contributory role in the structural development of 
the amygdala.
Conclusion
High-resolution structural brain imaging and a deletion mapping strategy have 
been used to identify a dosage-sensitive locus on the X chromosome that plays an 
important role in the development and function of the amygdala. This is the first time 
that a scientific methodology has mapped genetic structure and brain morphology at a 
molecular level. The consequences of haplo-insufficiency for this locus are that 45,XO 
females are socially poorly adjusted and have a predisposition to autistic-like 
behaviours. The finding of sexually dimorphic amygdala structure and function in 
social learning has relevance for the male preponderance of social communication 
problems and indeed autism, suggesting why males find social learning from 
emotional experience more difficult.
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CHAPTER 11 
GENOTYPE-PHENOTYPE MAPPING 
PRE-SYMPTOMATIC HUNTINGTON’S DISEASE
Guide to Reader
This study represents a collaboration with colleagues in Sydney, Australia who 
made available a set of MRI images from a unique population of families with 
members suffering from Huntington’s disease (HD). I analysed these from the 
perspective of my interest in genotype-phenotype correlations using the techniques 
described in Chapter 2.
The use of putative neuroprotective agents in HD may be optimised if the drugs 
can be given before brain pathology becomes manifest clinically. If these agents are to 
be tested in clinical trials, a reliable surrogate marker of the burden and rate of 
progression of pathologic change in a pre-clinical group is needed (Hughes, 2001). In 
this study, I use VBM to identify early structural changes in pre-symptomatic patients 
with the HD genotype. I ask whether the HD genotype is associated with regional 
differences in brain structure, in particular, differences that could not be predicted from 
clinical or neuropsychologic assessment. A secondary aim is to seek indirect evidence 
of pathological progression, in the form of changes in local tissue volume with age, 
specifically in those with the HD genotype.
Introduction
Since the discovery that the HD phenotype results from a specific genotype, 
namely an expanded CAG trinucleotide repeat within the IT 15 gene located on 
chromosome 4 (Huntington's Disease Collaborative Research Group 1993), there have 
been rapid advances towards an understanding of the underlying histopathological 
processes implicit in HD. The mutant gene product huntingtin (Htt) is expressed 
throughout the brain in HD (Aronin et al 1995) and there is evidence to suggest that 
differential instability of the CAG mutation causes polyglutamine load differences 
between tissues (Kennedy and Shelboume 2000). Proteolysis of mutant Htt within the
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cytoplasm allows translocation to the nucleus, where the toxic effects are likely to be 
exerted (Sieradzan and Mann 2001). Htt fragments aggregate into neuronal 
intranuclear inclusions (Nil) (Davies et al. 1997; DiFiglia et al. 1997) which are 
widely distributed in the cerebral cortex (Becher et al 1998) particularly in insular and 
cingulate regions (Gutekunst et al. 1999). Cortical Nil can only be demonstrated in 
symptomatic cases (DiFiglia et al. 1997; Gutekunst et al. 1999) where their density 
correlates with CAG repeat number (Becher et al. 1998; Sieradzan and Mann 1997). 
Furthermore reversal of Nil accumulation is associated with resolution of neurological 
signs in a murine model (Yamamoto et al. 2000). Relatively few Nil can be found 
within the striatum (Gutekunst et al. 1999) where the classical histopathological 
changes of HD (neuronal loss and reactive astrocytosis) are prominent (Vonsattel et al. 
1985; Vonsattel and DiFiglia 1998), suggesting that other factors are involved 
(Sieradzan and Mann 2001). Diffuse intranuclear accumulation of polyglutamine 
stretches is pronounced within the striatum (Yamada et al. 2000), which may be more 
vulnerable to the effects of accumulating mutant Htt than other tissues. Researchers 
have proposed that the abnormal gene product unmasks regional developmental 
susceptibility to normally non-lethal stressors such as excitotoxins (Mehler and 
Gokhan 2000) and impairment of mitochondrial function, which manifests as elevated 
striatal lactate evident on magnetic resonance spectroscopy (Jenkins et al. 1998). This 
susceptibility might allow glutamatergic cortical afferents to trigger oxidative stress 
and ultimately neuronal death (Calabresi et al. 20032; Petersen et al. 1999).
Neuroimaging studies have consistently demonstrated striatal volume 
reductions in HD, and there are reports of volume loss in the thalamus and inferior 
cortical areas, especially in mesial temporal lobe structures (Jemigan et al. 1991b). 
Many researchers have attempted to correlate the pattern of striatal neuronal loss with 
clinical stage of HD. Involuntary movement disorder and ‘frontal’ dementia (Watkins 
et al. 2000) are generally attributed to interruption of motor and cognitive basal 
ganglia loops in the putamen and caudate (Alexander and DeLong 1986). Atrophy of 
other components in this pathway, including globus pallidus externa (Halliday et al. 
1998; Vonsattel et al. 1985; Vonsattel and DiFiglia 1998) and subthalamic nucleus 
(Lange et al. 1976) is thought to be secondary to striatal neuronal loss. Vonsattel and 
DiFiglia (1998) suggest that the striatal degeneration appears to move in caudo-rostral 
and dorso-ventral/medio-lateral directions with disease progression. In pre- 
symptomatic cases basal ganglia volume loss can be seen (Aylward et al. 1994; Harris
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et al. 1999), suggesting that striatal neuronal loss occurs early in the clinical course. 
However, in symptomatic subjects, progressive motor and cognitive impairment are 
perhaps better explained by white matter volume loss (Aylward et al. 1997; Aylward et 
al. 1998), reflected in enlargement of the frontal horns of the lateral ventricles (De la 
Monte et al. 1988; Harris et al. 1999). Although striatal volume declines at a greater 
rate in younger symptomatic subjects (Aylward et al. 1997; De la Monte et al. 1988), it 
appears that white matter loss particularly around the lateral ventricles best predicts the 
duration of chorea (Halliday et al. 1998).
Several focal cognitive and neurological features in early HD are difficult to 
explain purely on the basis of striatal dysfunction. Firstly, there is a specific deficit in 
the recognition of facial expression of disgust in symptomatic (Sprengelmeyer et al.
1996) and pre-symptomatic (Gray et al. 1997) HD. This might reflect more general 
limitation of the experience of disgust and may also relate to the specific loss of 
olfactory experience in HD (Hamilton et al 1999; Moberg and Doty 1997; Nordin et 
al. 1995). Such deficits could be explained by striatal interruption of a ventral basal 
ganglia loop with inputs from orbitofrontal cortex and outputs via the medio-dorsal 
thalamus (Alexander and DeLong 1986; Gray et al. 1997; Hamilton et al 1999; 
Lawrence et al 2000; Moberg and Doty 1997). However, recent neuroimaging studies 
suggest that focal damage to insular cortex might provide a simpler explanation. 
Bilateral insular activation upon presentation of ‘disgust’ faces can be demonstrated in 
normal subjects with functional MRI (Phillips et al 1997). Moreover, an isolated focal 
lesion of the left insula results in an identical deficit in disgust recognition to HD 
(Calder et al. 2000).
Additionally there is evidence for midbrain involvement in HD. Aminergic 
neurons in the locus coeruleus are reduced (Zweig et al. 1992) and striatal 
monoaminergic terminals are decreased (Bohnen et al. 2000). Studies of oculomotor 
physiology reveal increased latency of the pupillary light reflex attributed to 
involvement of the pre-tectal and Edinger-Westphal nuclei and intercalated neurons in 
the rostral midbrain (Den Heijer et al. 1988). There is slowing of oculomotor saccades 
in the vertical plane (Leigh et al 1983; Leigh et a l 1985) even early in disease 
(Kirkwood et al 2000), possibly related to loss of burst neurons in the rostral 
interstitial nucleus of the medial longitudinal fasciculus (riMLF) (Leigh et al. 1983; 
Leigh et al. 1985) or perhaps in the nucleus pontis centralis caudalis (Koeppen 1989). 
In addition, all levels of the dorsal brainstem show prominent diffuse intranuclear
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accumulation of polyglutamine stretches (Yamada et al. 2000).
The oculomotor deficit in HD also includes increased latency in saccadic 
initiation, particularly apparent on an anti-saccade task, where errors are also frequent 
(Zasker and Zee 1997). Recent functional imaging data suggest that anti-saccades 
activate an inferior parietal network centred in the intra-parietal sulcus, involved in 
covert attention (Connolly et al. 2000). Notably, attentional shifts are impaired in early 
HD (Lawrence et ail. 2000). Visuospatial deficits are also noted in early HD (Lawrence 
et al. 2000), particularly an inability to perform spatial transformations on fragmented 
figures (Gomez-Tortosa et al. 1996). Furthermore striking loss of pyramidal neurons 
has been demonstrated in the adjacent angular gyrus of HD patients (McDonald et al.
1997).
All these studies reinforce the notion that HD is indeed a multifocal process 
(Lange et al. 1976), and therefore any imaging analysis technique constrained to a 
small number of structures and metrics will fail to characterise the distribution of 
pathology appropriately. Accordingly in this study, I use VBM to provide whole brain 
assessment of HD patients in order to locate regionally specific structural differences 
in grey and white matter within and between gene-status groups, previously identified 
by predictive testing. Statistical analysis within the flexible General Linear Model 
framework allows effects to be partitioned between several explanatory variables in a 
principled manner (see Chapter 2). In particular, to address questions of relevance to 
future clinical trials: whether changes in structural imaging in early HD can be 
predicted from detailed clinical and neuropsychological assessment; whether there are 
changes in local tissue volume that have a non-linear relationship to CAG repeat 
number; and whether there are progressive structural changes over time, specific to the 
HD genotype.
Methods
This study was a collaboration between the Wellcome Dept of Imaging 
Neuroscience, UCL, London and the departments of Neurology, Radiology and 
Clinical Genetics, Westmead Hospital, New South Wales, Australia. The patients were 
recruited and assessed in Australia and I performed all imaging analysis in London. 
The Western Sydney Area Health Service ethics committee and the Local Research 
Ethics Committee of the National Hospital for Neurology and Neurosurgery (UCLH,
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NHS Trust) and the Institute of Neurology (UCL) approved the project.
Subjects
The disease and control groups were selected from a population that had 
undergone predictive genetic testing with the NSW genetics service. According to 
standard guidelines (International Huntington's Association (IHA) and the World 
Federation of Neurology (WFN) Research group on Huntington's Chorea. 1994) all 
predictive tests followed a neurological assessment by a specialist neurologist 
confirming no clinical evidence of HD. The study was publicised by the NSW HD 
Association and by the social worker of the genetic service who remained in contact 
with affected families following predictive testing. Selected subjects were at 50% risk 
of HD prior to genetic testing on the basis of a single affected parent and remained 
asymptomatic at the time of the current study. Exclusion criteria included symptoms 
suggesting HD onset, history of other neurological or psychological illness, alcohol 
intake of more than 4 units daily or head trauma associated with loss of consciousness. 
The disease group comprised 34 subjects, 16 had less than 36 CAG repeats in the 
longest allele (mean repeat number 20.38, standard deviation 3.70) and were classified 
gene-negative (Rubinsztein, 1996; McNeil, 1997). 12 subjects had 40 or more CAG 
repeats and 5 had between 36 and 39 CAG repeats (at risk of HD but with reduced 
penetrance). In 1 subject, the exact number of repeats could not be determined for 
technical reasons, but was nevertheless greater than 35. For the purposes of analysis, 
all those subjects with 36 or more CAG repeats were classified gene-positive (mean 
repeat number of longest allele 41.06, standard deviation 2.70). In total, there were 18 
subjects in the gene-positive group. The range of repeat lengths within this group (38- 
46) is consistent with other studies of adult predictive test populations. Age, sex and 
handedness details of the groups, and the estimated parental age of onset and 
inheritance pattern, are given in Table 11.1. Since age and sex were not exactly 
matched across groups, potential confounding effects were accommodated in the 
clinical and imaging statistical analyses.
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Table 11.1: Subject demographics
Number
(n)
Mean
age
(SD)
Sex
(M:F)
Handedness
(L:R)
Inheritance
(paternal:
maternal)
Parental 
age of 
onset
(SD)
All subjects 34 41(12) 19:15 1:4 1:1 47(13)
Gene-negative 16 38(11) 5:3 1:6 4:3 45(13)
Gene-positive 18 43(12) 1:1 1:3 4:5 48(13)
Clinical assessment
Each subject underwent formal motor examination by 1 of 3 neurologists 
experienced in the clinical assessment of HD who were blinded to genetic status. In 
addition subjects underwent more rigorous assessment for subtle chorea, given the 
importance of the identification of this sign in the diagnosis of early HD (McCusker et. 
al., 2000). For this assessment, a video recording of foot movement was made while 
subjects were stressed using a mental distraction task. Two clinicians independently 
assessed the video for chorea, without being able to identify the subject featured. 
Scores from the two observers were then combined. On the basis of all of these 
assessments, subjects were scored according to the motor component of the United 
Huntington’s Disease Rating Scale (UHDRS). This is a standardised test of motor 
function that includes quantification of chorea, bradykinesia, rigidity, motor 
impersistence, motor sequencing, ocular movements and gait. Scores range from 0 to 
128, higher scores representing greater motor impairment. When applied to the whole 
spectrum of gene-positive subjects, the scale is internally consistent, has inter-observer 
reliability and is useful for tracking progression of disease (Huntington Study Group 
1996).
Cognitive function was assessed according to UHDRS specifications by a 
Phonetic Verbal Fluency Test, Symbol Digit Modalities Test, Stroop Word, Stroop 
Colour and Stroop Interference Tests (Huntington Study Group 1996). Results from 
the six scores (one motor and five cognitive) were expected to be closely correlated.
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MR Imaging
Whole brain structural MRI was performed on all subjects on the same 1.5 
Tesla scanner (Siemens Magnetom Vision, Erlangen, The Netherlands). Images were 
acquired in the sagittal plane, with isotropic 1mm3 voxel size. A high-resolution 3-D 
T1 -weighted MP-RAGE sequence was chosen with the following parameters: 
Tl/TE/TI/NEX: 9.5/4/600/1, flip angle 20°, matrix 256 x 256, FOV 256 mm2. The 
optimised VBM protocol was used for data analysis as detailed in Chapter 2.
Statistical analyses
Firstly to test whether the UHDRS motor score was significantly higher and 
cognitive scores were significantly lower in the genotype positive group a design 
matrix was constructed with gene status conditions, clinical scores as covariates of 
interest and age, sex and education as confounding covariates.
Secondly to test whether structural changes in HD always have a clinical 
correlate evident on thorough clinical testing, a single ‘optimal clinical score’ that best 
discriminated the gene positive and gene negative subjects was generated using linear 
discriminant analysis. This was entered as a confounding covariate in the image 
analysis to determine whether there was a residual significant main effect of HD gene 
status alone on structural integrity. The optimal clinical score was also used as a 
covariate of interest in a parametric design in order to test for the effect of clinical 
stage on structural change within the gene positive group.
Statistical threshold was set at p < 0.05, corrected for multiple comparisons 
across the whole brain. Where a prior hypothesis about regional pathology existed (see 
introduction) correction was limited to a small volume around this region (the radius of 
a sphere used for the small volume correction is given in Table 11.2).
The simplest analyses tested for the main effect of gene status (Fig. 11.2) on 
grey and white matter and CSF. Here, genetic predisposition was treated as a 
categorical variable: variability of genotype within the gene positive group was 
neglected. Analyses were performed both with and without global voxel intensity as a 
confounding covariate, to assess whether significant local effects reflected changes in 
global tissue quantities. Analyses were also performed with and without an optimal 
clinical score confounding covariate, to test the pre-clinical pathology hypothesis. Age 
and sex were included as confounding covariates was based on my findings in
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Chapters 3 and 4. Inheritance (paternal or maternal) was not explicitly modelled since 
there is evidence that anticipation of the HD phenotype with paternal inheritance is 
directly attributable to CAG repeat expansion (Kremer et al 1005; Ranen et al 1995).
The potential dependence of brain structure on differences in repeat number 
within the gene positive and negative categories was investigated with an extension of 
the basic design to include longest allele repeat length covariates for each gene status 
condition, corrected for condition mean. The shorter allele repeat length was included 
as an extra confounding covariate. Contrasts tested for greater loss of grey or white 
matter tissue volume with increasing repeats in the gene-positive relative to the gene- 
negative group. Classification into gene-status categories was also derived from the 
repeat number, so this condition-by-covariate interaction effectively tested for a non­
linear parametric effect of genetic load on brain structure.
Although this study was not designed to investigate progression over time 
within subjects, among the gene-positive group a subject’s age may be considered to 
be an indicator of duration of the pathologic process. Regional loss of grey and white 
matter volume with age has been demonstrated in normal subjects (Chapter 3) so it 
was necessary to test for an interaction of age with gene status. The design matrix in 
this analysis was similar to the repeats analysis described above, with age covariates 
for each gene status condition, and sex and global voxel intensities as confounding 
covariates.
In addition to the repeat and age interaction designs mentioned above, gene 
positive and gene negative groups were also analysed separately in analyses that 
included both age and repeat number as covariates of interest.
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Figure 11.1: Design matrix for the grey matter gene status analysis.
Rows correspond to individual subjects, arranged according to gene status. Cond 0 
represents gene negative and Cond 1 represents gene positive subjects. Age, sex and 
global grey matter voxel intensity are modelled as confounding covariates. p is a 
column of ones which models the mean of the data across subjects.
Parameter
Results
Controlling for potential confounding effects of age, sex and education, the 
HD genotype is associated with a significantly higher UHDRS motor score (p< 0.016) 
and a significantly lower Stroop word score (p< 0.009). There is a non-significant 
trend toward lower scores in the HD genotype on the other cognitive tests. The 
distribution of grey matter volume loss in HD gene positive subjects is shown in 
Figure 11.2. Local maxima for the main effect of gene status are tabulated in Table
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11.2. Significant grey matter volume loss was seen in the left head and body of 
caudate, putamen and globus pallidus. Ventrally, this extended into nucleus accumbens 
and orbito-frontal cortex, particularly the left olfactory sulcus. Right caudate volume 
loss reached only borderline significance. Grey matter volume loss was also seen in the 
midbrain tectum on the left extending into medio-dorsal thalamic nucleus. Volume loss 
in the dorsal medulla and pons did not survive whole brain correction and in the 
absence of a specific prior hypothesis further inference about these regions was 
impossible.
Table 11.2: VBM results
Analysis X y z Z score P corrected 
(SVCmm)
Location
Grey matter
Gene status -12 12 3 4.08 0.003(10) L caudate 
head
-15 9 14 3.44 0.026(10) L caudate 
body
-22 9 0 3.81 0.009(10) L putamen
18 -2 22 3.06 0.070(10) R caudate 
body
-4 -28 -3 3.69 0.003(5) L midbrain 
tectum
30 -72 27 4.57 0.004(20) R intraparietal 
sulcus
38 -8 -4 3.37 0.032(10) R insula
-30 -12 -8 3.76 0.010(10) L insula
-9 33 -24 3.39 0.030(10) L olfactory 
sulcus
Gene status, 
cognitive
-12 12 3 4.08 0.030(10) L caudate 
head
CAG repeat x gene 
status interaction
39 10 21 5.74 0.001 R inf frontal 
sulcus
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Figure 11.2: Main effect of HD gene status on local grey matter volume.
This contrast shows regions of grey matter loss in gene positive relative to gene 
negative subjects. For illustrative purposes the threshold for display is p < 0.005 
uncorrected. The colour bar represents the T score. Grey matter volume reduction is 
shown in the left head and body of caudate, putamen and globus pallidus extending into 
nucleus accumbens and orbito-frontal cortex. On the right, volume loss in the caudate 
nucleus reaches only borderline significance. There is also grey matter volume loss in 
the midbrain tectum on the left extending into the medio-dorsal thalamic nucleus.
Regarding cortical morphological changes, bilateral grey matter loss was seen 
in the posterior insula on the left extending ventro-medially into the amygdala. There 
was also bilateral volume loss in the posterior intra-parietal sulcus, reaching corrected 
significance on the right. A gene status analysis for white matter revealed a reciprocal 
significant increase in white matter volume in gene positive subjects beneath the right
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intra-parietal sulcus (not shown). There were no other significant changes in the white 
matter or CSF gene status analyses.
When the grey matter gene status analysis was performed without including 
global voxel intensity as a confound, the distribution and magnitude of the effects 
remained unchanged, suggesting that these local effects do not reflect distributed 
changes in grey matter volume. When the optimal clinical score was included as a 
confound, grey matter volume loss was similarly distributed remaining significant in 
the head of the left caudate nucleus (Fig. 11.3).
Figure 11.3: Main effect of HD gene status on local grey matter volume.
Regions marked in red reflect the main effect of gene status (as in Fig. 11.2). Regions 
marked in yellow remain significant when the optimal clinical score is included as a 
confound demonstrating that within the gene-positive group there is significant 
structural neuropathology, which has no clinical correlate apparent on thorough testing.
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Fig. 11.4 shows the distribution and significance of white matter loss with age 
in gene positive relative to gene negative subjects. Asymmetric left more than right 
periventricular white matter volume loss was noted, most marked around the left 
frontal horn. A similar distribution of white matter loss with age was found in a 
separate analysis of gene positive subjects. In contrast, significant white matter loss 
with age in gene negative subjects was localised to the posterior limb of internal 
capsule bilaterally. No significant changes in grey matter or CSF volume were 
identified in the age by gene status interaction.
Figure 11.4: Interaction of age and gene status on local white matter volume
This contrast shows periventricular white matter loss with increasing age in gene 
positive relative to gene negative subjects. The threshold for display is p < 0.005 
uncorrected, T score indicated by colour bar.
35^Jr
A significant interaction of CAG repeat number with gene status condition was 
found only in the right inferior frontal sulcus (Fig. 11.5). This reflects a decrease in 
local grey matter volume and a reciprocal increase in white matter volume with 
increasing repeats in the gene positive group.
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Figure 11.5: Interaction of repeat length and gene status on local grey matter 
volume.
This contrast identifies regions of greater loss of grey matter volume with increasing 
repeats in the gene-positive relative to the gene-negative group. This condition-by- 
covariate interaction effectively tests for a non-linear parametric effect of genetic load 
on brain structure. The threshold for display is p < 0.005 uncorrected, T-score indicated 
by colour bar. Significant voxels are shown in the right inferior frontal sulcus.
Discussion
The whole brain approach to volumetric analysis adopted in this study allowed 
the demonstration of widely distributed cortical and subcortical pathological structural 
changes. Conventional morphometric techniques constrained to a small number of 
structures and metrics would inevitably have missed many of these areas. The versatile 
statistical framework of VBM allowed regional prior hypotheses to be tested in a 
principled way and sensitivity has been improved by using small volume corrections. 
Importantly, by introducing appropriate confounding covariates into design matrices, I 
have been able to control for effects of no interest while highlighting several different 
effects of interest. The conventional approach is more restrictive: precise matching of 
disease and control groups for all potential confounding variables is necessary if group 
means are to be compared by a simple t-test, but this inevitably renders the design 
inflexible for testing multiple hypotheses, or attributing variance among a number of
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continuous and discrete explanatory variables.
The principal regional prior hypothesis in this study was that caudate and 
putamen volume would be reduced in subjects carrying the HD triplicate repeat 
expansion, relative to controls of normal genotype. While this was confirmed, the 
asymmetry of volume loss was surprising. A previous MR spectroscopy study of HD 
showed an asymmetric pattern of elevated lactate levels in the left relative to right 
striatum. These results were attributed to increased motor activation in the dominant 
hemisphere, particularly increased glutamatergic synaptic input to striatal cells 
(Jenkins et al 1998). Even if impairment in mitochondrial function were symmetrical, 
differential oxidative stress could lead to asymmetrical striatal neuronal loss. In a 
murine model of HD, manipulation of sensory input and motor activity does indeed 
alter striatal volume (Van Dellen et al 2000). Another surprising feature of the striatal 
volume loss was that it appeared to be concentrated rostrally and ventrally in contrast 
to pathological predictions (Vonsattel et al 1985). A previous histopathological study 
of a pre-symptomatic case identified degenerative changes confined to the dorsal 
striatum (Gutekunst et al 1999) supporting the idea that there is a dorsal to ventral 
gradient of neuronal loss with advancing disease. The reason for this discrepancy with 
our results is unclear. Involvement of ipsilateral orbitofrontal cortex, globus pallidus 
and medio-dorsal thalamus, which together with the ventral striatum constitute the 
orbito-frontal basal ganglia loop, suggest that the VBM findings are real.
The orbito-frontal cortex plays an important role in decision making (Bechara 
et al 1998; Rogers et al 1999) and reversal learning (Watkins et al 2000). Subjects 
with early HD generally perform these functions normally but fail tests of planning 
(Watkins et al 2000) and make perseverative errors in attentional set switching 
paradigms (Lawrence et al 1996). Such deficits are usually attributed to malfunction 
of the dorso-lateral prefrontal cortex or interruption of its efferent connections in the 
dorsal caudate nucleus. In this study, grey matter loss was not seen in dorso-lateral 
prefrontal cortex, premotor cortex or frontal eye fields that provide input to the motor 
and oculomotor basal ganglia loops respectively. In order to resolve this apparent 
conflict between clinical and imaging data more focussed cognitive testing and larger 
patient groups will be required.
The expectation of regional grey matter loss outside the basal ganglia was 
confirmed. Bilateral volume loss in the insular cortex is in accordance with loss of 
recognition of the facial expression of disgust in a similar cohort of pre-symptomatic
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gene positive subjects (Gray et al 1997). These subjects were unimpaired in the 
recognition of fearful expressions, a function previously attributed to the left amygdala 
(Morris et al 1996), yet in my study the grey matter loss encroached partially into the 
left amygdala (Fig. 11.2).
The gene positive subjects in my study had early HD. Nevertheless, the 
distribution of regional volume loss at this stage of disease provides an insight into the 
pathophysiology underlying clinical deficits which manifest later in the course of HD. 
For example, focal pathology of the intra-parietal sulcus and midbrain tectum might 
account for the abnormal eye movement of HD patients. In HD delayed initiation of 
voluntary saccades is commonly attributed to disruption of descending input to the 
superior colliculus from the frontal eye fields (Zasker and Zee 1997). The superior 
colliculus also receives inhibitory input from the oculomotor basal ganglia loop, 
disruption of which is thought to underlie an inability to suppress reflexive saccades.
In this study focal structural change was observed in the midbrain, including the 
superior colliculus. The burst neurons that generate commands for vertical saccades 
are located in the rostral interstitial nucleus of the medial longitudinal fasciculus 
(MLF), allowing a single midbrain lesion to explain both the initiation deficit and 
saccadic slowing. An alternative possibility is that grey matter loss in the parietal eye 
fields could impair saccadic eye movement, particularly in the context of the anti- 
saccade task where deficits are most apparent in HD.
Evidence of neuropathology beyond that which could have been predicted from 
thorough clinical testing confirms the commonly held belief that pathological changes 
of HD precede clinical onset. The time course of this process remains unknown, but 
CAG repeat length plays a role, with greater numbers of repeats resulting in earlier 
clinical onset (Brinkman et al 1997; Duyao et al 21993). However, increasing CAG 
repeat length is not necessarily associated with reduced striatal volume (Harris et al 
1999; Sieradzan and Mann 1997). In this study, the only area of significant volume 
change with increasing CAG repeats specific to the gene positive group was the right 
inferior frontal sulcus (Fig. 11.3) but this could reflect the narrow range of repeat 
lengths in the gene-positive group who had all reached adulthood without symptoms. 
There is some evidence that repeat expansion in the HD gene alters regional cerebral 
development prior to progressive neurodegeneration. In pre-symptomatic gene-positive 
subjects the caudate histology is suggestive of abnormal morphogenesis (Gomez- 
Tortosa et al 1996). It seems more likely though, that the striatal grey matter volume
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loss in the gene-positive group reflects progressive neuronal loss. Paradoxically, in the 
age-by-condition interaction, the only structural change with age specific to the gene 
positive group was white matter loss around the lateral ventricles, not caudate atrophy. 
This may reflect differing time courses for volume change in different tissues.
Conclusion
This study demonstrates that the VBM approach is ideally suited to answer 
more subtle questions in HD. Imaging of large numbers of preclinical subjects may in 
future allow stratification into prognostic groups, enabling prediction of clinical onset 
in individual cases. Pre-clinical subjects approaching disease onset are likely 
candidates for preliminary clinical trials of neuroprotective agents. In order to evaluate 
such agents a reliable measure of pathologic burden in pre-clinical subjects is needed, 
particularly to measure pathology progression within the time window of a realistic 
clinical trial. These data suggest that VBM may prove to be a useful surrogate marker 
of disease progression in pre-clinical HD.
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CHAPTER 12 
GENOTYPE-PHENOTYPE MAPPING 
FAMILIAL ATAXIC MIGRAINE
Guide to Reader
In Chapter 7 ,1 showed no evidence of structural change within brainstem 
regions that demonstrate functional ictal changes in patients with migraine. One of the 
possibilities I suggested for this negative imaging result was that the phenotype of 
migraineurs is heterogeneous making the chance of detecting systematic structural 
change small. In order to test whether putative brainstem structural changes are present 
in a more refined migraine phenotype, I have chosen a select patient group with a 
specific genotype and a homogeneous phenotype. In this particular kindred with 
autosomal dominant familial ataxic migraine, a specific calcium channel gene mutation 
has been identified and the phenotype comprises migraine and cerebellar symptoms. 
Moreover, several family members without the mutation have a similar phenotype.
This allows me to perform correlations between genotype, clinical phenotype and 
structural brain phenotype. Importantly, in a very similar autosomal dominant form of 
migraine with a calcium channel gene mutation and a more heterogeneous genotype 
and phenotype (familial hemiplegic migraine), standard neuroimaging reveals 
cerebellar atrophy in a proportion of affected patients. It follows that cerebellar atrophy 
is likely to be present in affected members of this particular family and this should be 
easily detectable on MRI. This allows me to test firstly whether VBM can detect 
cerebellar atrophy in some affected family members, secondly whether VBM can 
detect brainstem structural changes which, if present, are likely to be more subtle and 
thirdly whether there is a clear genotype-structural brain phenotype correlation.
Introduction
Familial hemiplegic migraine (FHM) is an autosomal dominant form of 
migraine (Headache Classification Committee of the International Headache Society
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1988). This condition often manifests in childhood with attacks of prolonged 
hemiparetic aura lasting for hours or days and patients may exhibit nystagmus and 
mild progressive ataxia between attacks (Terwindt et al 1998). Neuroimaging shows 
cerebellar atrophy in approximately 20% of FHM patients (Elliot et al 1996) but it is 
unclear how this relates to the underlying genotype. The FHM genotype is known to be 
heterogeneous. Approximately half of identified families are linked to mutations of the 
ai2.1 subunit of the Cav2.1 P/Q type brain voltage-gated calcium channel gene, 
CACNA1A, on chromosome 19pl3.1 (Ophoff et al 1997). This neuronal calcium 
channel is widely expressed in the brain with particularly high levels in cerebellar 
Purkinje and granule cells and modulates release of neurotransmitters such as 
monoamines, catecholamines, excitatory amino acids, CGRP and Substance P. About a 
third of families are linked to chromosome lq (Ducros et al 1997; Gardner et al 1997) 
and the remainder are as yet undefined. A genotype-phenotype correlation can be 
demonstrated - 50% of CACNA1A mutations exhibit progressive ataxia whereas 
mutations at the other loci are not associated with a cerebellar syndrome (Ducros et al 
2001).
The CACNA1A mutations in FHM are usually missense mutations causing 
amino acid substitutions. Allelic mutations such as splice and frame shift mutations 
from base pair deletions within CACNA1A (Ophoff et al 1997) are associated with a 
different phenotype; episodic ataxia type 2 (EA-2). This is an autosomal dominant 
disorder characterised by intermittent attacks of midline cerebellar ataxia, interictal 
nystagmus and in about 50% of families migraine attacks with headache and nausea. 
Some patients exhibit mild progressive cerebellar ataxia with gait unsteadiness, limb 
ataxia and dysarthria (Kramer et al 1995) and neuroimaging often shows cerebellar 
atrophy (Vahedi et al 1995; Vighetto et al 1988)(9,10);
A kindred with a variant of FHM, familial ataxic migraine, linked to a novel 
CACNA1A mutation has recently been identified (Terwindt, Giffin and colleagues, 
unpublished data). This mutation is a C-to-G transformation at position 5838 of the 
coding sequence, predicting a premature stop codon, rather than the missense 
mutations more typical of FHM. The mutation is located at the beginning of the 
intracellular C-terminus of the ai2.1 subunit. Affected family members have episodes 
of unsteadiness, slurred speech and occasional disorientation and 50% have associated 
attacks of migraine. Several family members are phenocopies: despite having a
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strikingly similar clinical phenotype with intermittent attacks with migraine, they do 
not have the CACNA1A mutation. There is no difference in age at onset, duration of 
attacks, frequency of attacks and clinical characteristics of attacks between clinically 
affected family members with and without the mutation however the interictal 
cerebellar features are present only in the carriers.
In patients with migraine headache functional neuroimaging has identified 
activations in the brainstem during acute attacks (Bahra et a l 2001; Weiller et al.
1995), but no corresponding brainstem structural changes have been identified (see 
Chapter 7). However, in another primary headache disorder, cluster headache, VBM 
has revealed regional structural change within the hypothalamus (May et al 1999b), 
exactly matching functional changes on PET imaging (May et al 1998a). The reason 
for the negative imaging findings in the migraine study (Chapter 7) is unclear, but 
possible explanations include 1) insufficient power of the VBM study to detect very 
subtle macroscopic change, 2) heterogeneous phenotype of migraine making the 
likelihood of detecting a systematic structural difference in migraineurs small and 3) 
microscopic or no structural change.
In this study I use VBM to further investigate putative brainstem structural 
changes in a more homogenous phenotype of primary headache disorders, and I 
hypothesize that if such changes are present they are more likely to occur in the 
genotype positive group. Since cerebellar atrophy has been shown in FHM, it is likely 
that members of this particular family will also have cerebellar atrophy and this should 
be detectable with VBM. This will allow me to characterise the structural brain 
phenotype (regional grey and white matter) in family members with the FHM 
phenotype with and without the CACNA1A mutation and show genotype-phenotype 
correlations.
Methods
Approval for the study was obtained from the Local Research Ethics 
Committee of the National Hospital for Neurology and Neurosurgery (UCLH, NHS 
Trust) and the Institute of Neurology (UCL). All subjects gave written informed 
consent.
Subjects
The kindred are members of a five-generation British family who have
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undergone genetic analysis (Fig. 12.1). All available members of the family were 
interviewed by a semi-structured questionnaire and full neurological examination was 
performed by members of Professor Goadsby’s clinical team, in particular Dr Nicola 
Giffin. Clinical data are summarised in Figure 12.2.
Six family members with the affected genotype (G+P+), 3 family members 
with the phenotype but without the genotype (G-P+) and 4 with neither the genotype 
nor phenotype (G-P-) were studied. Of the G-P- group, 2 had infrequent migraine 
without aura, but neither had any attacks of unsteadiness or hemiparesis.
Age and sex matched normal control structural MRI scans were obtained from 
my MRI database at the Wellcome Department of Functional Imaging. All control 
subjects were interviewed and those with a personal history of migraine according to 
International Headache Society (IHS) criteria (1) or other major neurological disorder 
were excluded. All controls and subjects were imaged on the same MR scanner with 
identical parameters to remove any scanner dependent bias.
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Figure 12.1: Pedigree with familial ataxic migraine
12 13 14
910 11 1213 14
1
•  G+P+
© G-P+
E G-P-, migraine without aura
n G-P-, no headache
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Table 12.1: Clinical details of familial ataxic migraine kindred
Genotype Age
(yr)
Onset
(decade)
Duration Attacks/yr
(min-max)
Attacks
with
ataxia
Dysarthria Migraine
during
ataxia
Separate
migraine
attacks
Vertigo Interictal
cerebellar
symptoms
III-l + 63 2nd 5-45mins 0-4 + + - + - -
m -2 + 65 2nd minutes ? + - - + - -
m-4 + 63 1st 15-30mins 52-156 + + - - + +
m -ii + 49 1st lOmins-few
hours
4-156 + + - - + +
IV-15 + 21 2nd 1-15 mins 4-6 + - - - - -
IV-19 + 26 1st 2-8hrs 12-104 + + + - + +
IV-6 - 37 2nd minutes rare + - - + - -
V-l - 25 2nd 5mins 2-24 + + + + + ?
m-3 - 55 1st few hours 2-4 + + + + - -
III-7 - 59 - - - - - - - - -
111-10 - 51 - - - - - - - - -
IV-2 - 44 - - - - - - + - -
IV-3 34 _ + .
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MRI scanning
High resolution volumetric MR imaging was performed on a Siemens 2T 
Magnetom scanner using an optimised MPRAGE sequence which affords enhanced 
grey /white matter contrast and segmentation. The acquisition parameters included: 
TR/TE/TI11/4/1000, flip angle 12, matrix 256 * 224, FOV 256 x 224mm; 176 sagittal 
slices, 1mm isotropic voxels (Deichmann).
Voxel-based morphometry
The optimised method of VBM was used for pre-processing (see Chapter 2) of 
images using the SPM apriori grey and white matter templates for spatial 
normalisation.
VBM statistical analysis
To analyse the main group effect of gene status I constructed separate design 
matrices for grey and white matter. I compared genotype/phenotype positive (G+P+), 
genotype negative/phenotype positive (G-P+) and genotype negative/phenotype 
negative (G-P-) groups against separate age and sex matched control groups. I also 
included age, sex and global grey matter voxel intensity as confounding covariates 
(Fig. 12.2). I also conducted the above analyses without including the global voxel 
intensity as a confound. In separate design matrices I compared individual G+P+, G- 
P+ and G-P- family members against age and sex matched control groups. In a further 
analysis I compared the group of individuals with migraine headache against those 
without migraine, irrespective of prolonged aura symptoms.
Significance levels were set at p<0.05, corrected for multiple comparisons. 
When a prior hypothesis about regional pathology existed (see introduction), 
correction was limited to a small volume around this location, of a size appropriate to 
the volume of the structure. For the cerebellum I used a sphere of radius 5 cm, for the 
brainstem I used a sphere of radius 2 cm.
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Figure 12.2: Design matrix
Rows represent individual subjects. Columns represent conditions: 1= control group I, 2 
= G+P+, 3 = control group II, 4 = G-P-, 5 = control group III and 6 = G-P+. Age, sex 
and global grey matter volume are modelled as confounding covariates.
parameters
Results
Grey matter
VBM detected cerebellar atrophy within the vermis and cerebellar hemispheres 
of the G+P+ group, but not the G-P+ or G-P- or control groups (see Fig. 12.4 and 
12.6). These within-group cerebellar changes were also seen within each G+P+ patient, 
but not in any of the G-P+ or G-P- family members. There were no additional 
differences between the group with headache and the group without headache. No 
brainstem grey matter structural changes were detected.
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Figure 12.3: Main effect of gene status- grey matter.
VBM detected grey matter volume loss in the cerebellar vermis and hemispheres of the 
G+P+ group projected over the normalised mean grey matter image from the study 
group. The colour bar represents the T score.
€
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Figure 12.4: Plot of parameter estimates
Parameter estimates of a local maxima in the cerebellar vermis (3, -63, -15, p = 0.026 
corrected, T = 5.10) showing regional grey matter atrophy in the G+P+ group only
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White matter
VBM detected cerebellar white matter atrophy involving the vermis (Fig. 12.5) 
and cerebellar hemispheres in the G+P+ group, but not in the G-P+ or G-P- or control 
groups. These within-group cerebellar changes were also seen within each G+P+ 
patient but not in any of the G-P+ or G-P- family members. There were no additional 
differences between the group with headache and the group without headache. No 
brainstem white matter structural changes were detected.
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Figure 12.5: Main effect of gene status-white matter
White matter volume loss in the cerebellar vermis in the G+P+ group only projected 
over the normalised mean white matter image. The colour bar represents the T score
» i »
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Discussion
I have characterised the structural brain phenotype of a kindred with a novel 
CACNA1A mutation and a specific clinical phenotype. I have shown a main effect of 
gene status, namely cerebellar atrophy in the genotype positive phenotype positive 
(G+P+) group but not in those clinically affected but without the mutation (G-P+). 
Cerebellar atrophy is seen not only as a G+P+ group effect but also within each carrier. 
These data demonstrate a precise genotype/phenotype correlation that predicts specific 
structural change in the brain offering the exciting prospect of selecting patients for 
study based on the powerful combination of the genetic mapping and MRI structural 
imaging.
Cerebellar atrophy was diffuse involving grey and white matter of the vermis 
and cerebellar hemispheres. This concurs with earlier neuroimaging studies that have 
shown CT and MRI evidence of cerebellar vermis and hemisphere atrophy in FHM 
(Elliot et al. 1996; Fitzsimons and Wolfenden 1985; Joutel et al. 1993) and EA-2 
(Vahedi et al. 1995; Vighetto et al. 1988). One of these FHM kindreds has been linked 
to chromosome 19, but as yet no mutation has been identified (Elliot et al. 1996). The 
kindred in this study may be regarded as part of a spectrum of phenotypes between
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FHM and EA-2. Most affected family members had attacks fulfilling the criteria for 
EA-2. Furthermore this mutation codes for a stop codon which is more typical of EA-2 
than FHM. However, the frequency of migraine with, or in addition to ataxic episodes 
is higher than would be expected in EA-2, and the frequency and severity of 
nystagmus is more in keeping with FHM than EA-2. Therefore the term familial ataxic 
migraine has been coined for this particular kindred to emphasise the continuum 
between the two allelic conditions. The presence of phenocopies (G-P+) has been 
described before (Terwindt et al 1998) and there may be a number of possible 
explanations. Firstly ‘mimicking’ of the phenotype by non-carriers; secondly, a 
chance association of migraine without aura, and thirdly, an unlinked gene for episodic 
ataxia within the family.
What is the underlying mechanism of cerebellar atrophy in these subjects? Ictal 
cerebellar features may be a form of migraine aura. Animal models of cortical 
spreading depression (Lauritzen 1994) and perfusion weighted imaging in humans 
(Sanchez del Rio et al. 1999) suggest that cortical hypoperfusion in aura occurs 
secondary to neuronal depolarisation. The cortical perfusion deficit does not reach 
ischaemic levels (Astrup et al 1981) and therefore it is unlikely that cerebellar atrophy 
results from recurrent ischaemia due to repeated episodes of prolonged cerebellar 
hypoperfusion. In the present study, there was no diagnostic neuroimaging evidence of 
significant ischaemic change in any of the family members. The association of 
cerebellar atrophy only with genotype and not with phenotype adds weight to the 
argument that cerebellar atrophy is genetically determined, probably by a direct effect 
of the Cav2.1 channel on cerebellar Purkinje and granule cell function (Dove et al. 
1998). Furthermore, nystagmus and ataxia frequently precede the onset of the migraine 
attacks (Young et al 1970). More recently it has been noted that some FHM mutations 
(in particular 11811L and T666M missense mutations) are associated with cerebellar 
disturbance and others not (Terwindt et a l 1998). Interictal features of cerebellar 
dysfunction are frequently found in FHM, including 50% of those with CACNA1A 
mutations, but the underlying mechanism is unclear. In some kindreds linked to 
chromosome 19 nystagmus and associated vermis atrophy can be detected (Elliot et al
1996). Sub-clinical cerebellar dysfunction can be observed in patients with more 
common forms of non-hemiplegic migraine, both with and without aura (Sandor et al 
2001). Whether this latter finding represents involvement of calcium channel genes in 
the common types of migraine remains to be determined.
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Regarding the prior hypothesis of putative structural change in brain stem 
regions based on previous PET studies of acute migraine (Bahra et al 2001; May and 
Goadsby 1999; Weiller et al 1995), despite the homogeneous genotype and phenotype 
I did not demonstrate any structural changes in the brainstem. There are potential 
explanations for this negative result. This particular family could be more susceptible 
to aura than headache. CACNA1A may be regarded as an aura, rather than a headache, 
susceptibility gene. Only half of the G+P+ subjects had migraine headache and 
furthermore, some G-P- subjects had migraine without aura. Genetic susceptibilities to 
aura and headache are likely to produce different changes to the function and structure 
of the brain. However, separate analysis of the groups with and without migraine 
headache within the family did not show any brainstem changes. The lack of brainstem 
change could also reflect insufficient power of the study to detect subtle effects, even 
within a homogeneous phenotype. The midbrain and hypothalamus have relatively 
poor contrast resolution, owing to their intrinsic anatomy, with embedded nuclei and 
adjacent white matter connections, providing a challenge for segmentation, but VBM 
should still be sensitive to a systematic difference in the anatomy, and for this reason, I 
performed separate grey and white matter analyses. Furthermore the hypothalamus, 
where VBM showed structural changes matching PET activations in patients with 
cluster headache (Bahra et al 2001; May et al 1999b; Weiller et al 1995), has 
similarly poor contrast resolution. It is possible that functional changes within the 
brainstem in primary headache disorders are not associated with macroscopic change 
detectable by VBM or even microscopic structural change. Following the first VBM 
study of a small group of patients with cluster headache (Bahra et al 2001; May et al 
1999b; Weiller et al 1995) I performed a study of a larger group of cluster headache 
divided into episodic and chronic progressive groups using the optimised VBM 
method (unpublished data) and was unable to replicate the earlier findings and as yet 
there has been no microscopic confirmation of any brainstem morphological change in 
this patient group. Similarly, despite a region in the midbrain being reported to show 
ictal hyperactivity in migraine, further evidence for macro or microscopic structural 
change is lacking (Bahra et al 2001; Matharu et a l 2003; Weiller et al 1995). 
Postmortem data from a 16-year-old girl with FHM with ataxia linked to a CACNA1A 
mutation showed no detectable changes in the midbrain or pons but abnormalities of 
the Purkinje, molecular and granule cell layers of the cerebellar hemispheres and 
vermis (Bahra et al 2001; Kors et al 2001; Weiller et al 1995). These findings further
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support my VBM findings.
Conclusion
I have confirmed reports of cerebellar atrophy in a variant of FHM using VBM. 
Importantly, there is a clear genotype-phenotype correlation - these changes are only 
apparent in carriers of a CACNA1A mutation and not in those without the mutation 
even when displaying a similar phenotype. This emphasises that cerebellar atrophy is a 
function of the gene, not a consequence of the attacks. Despite the select patient group 
with a specific genotype and a more refined migraine phenotype, I did not detect any 
structural change in the brainstem of symptomatic family members.
The results from the last three chapters demonstrate that VBM is a useful tool 
to characterise the structural brain phenotypes of diseases with a known genetic basis. 
The versatile statistical framework of VBM allows genotype -  phenotype correlations 
and deletion mapping strategies and demonstrates that the structural brain phenotype 
often matches the underlying genotype more closely than the clinical or cognitive 
phenotype. Importantly the structural changes often precede clinical symptoms 
allowing identification of groups of patients that would be suitable for clinical trials of 
disease modifying agents, offering an exciting example of the possibilities for 
translating genetic studies into clinical practice.
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CHAPTER 13 
CONCLUSIONS
General discussion
Summary o f  VBM studies
This thesis examines the clinical usefulness of voxel-based morphometry for 
characterising human brain structure within a standardised anatomical framework.
Chapter 1 addresses the importance of brain structure and suggests that it plays 
an integral role in neuroscience by providing the anatomical framework for functional 
brain mapping. The evolution of macroscopic structural characterisation is described 
from early crude descriptions to current in vivo morphometric characterisation of high- 
resolution MRI brain scans. Current morphometric methods, namely expertly 
performed region of interest-based metrics (regarded by many as the gold standard) 
are contrasted with the requirement for whole brain techniques that are not biased to 
particular brain regions or dependent upon the skill of the operator. The concept of 
computational neuroanatomy is introduced as a versatile method of analysis of 
structural images that is based upon the framework of statistical parametric mapping 
(SPM). The various types of computational morphometries, namely the triad of voxel- 
based morphometry (VBM), deformation-based morphometry (DBM) and tensor- 
based morphometry (TBM) are defined. Finally the role of this method in clinical 
neuroradiological assessment is examined with reference to diagnosis, monitoring of 
disease processes before and after treatment and the characterisation and monitoring of 
brain structure for clinical research. Flaws in the current methods are revealed and 
discussed with particular emphasis on the need for techniques that can offer appraisal 
of brain structure in a holistic reproducible way whilst accommodating intrinsic 
physiological variability in neuroanatomy.
In order to ascertain the clinical usefulness of VBM the term “usefulness” 
needs to be better defined. The criteria I have used to characterise clinical usefulness 
include: 1) Reproducibility - can the analysis be performed on the same data set in
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different laboratories to produce identical results? 2) Sensitivity - is the method 
sensitive to subtle neuroanatomical changes in a manner that is comparable or better 
than the best available gold standard? 3) Biologically plausible - does the method 
reveal structural alterations that biologically credible. In other words, with what degree 
of certainty can it be concluded that VBM detects changes that are not artefactual false 
positives? 4) Practical - can the analyses be performed within a practical time frame 
using readily available software? 5) Validity - what is the evidence for construct and 
face validity of the method?
Firstly VBM has been used in the analysis of a large normal data set to provide 
information about anatomical characteristics and variability (Chapters 3 and 4). By 
using large data sets, problems with the standard VBM methodology were revealed 
which prompted the development of a series of optimisations that are detailed and 
discussed in Chapter 2. The optimised method incorporates additional information 
derived from the deformation fields used to normalise brain images into standard 
anatomical space, incorporating a modulation step that enables voxel-wise detection of 
changes in grey or white matter volume (modulated data) or concentration 
(unmodulated data). The optimised method can be considered to be a hybrid between 
VBM and TBM analyses in the sense that factors describing voxel-wise volume 
distortions (Jacobian determinants) are incorporated to improve performance.
Chapter 2 also addresses the reproducibility and practicality of the optimised 
technique. A scan-rescan study demonstrates that tissue classification is highly 
reproducible and that the VBM analyses show no significant differences between first 
and second scans even when liberal thresholds are used. Since VBM is a fully 
automated technique, results for a given data set are identical between laboratories if 
the same analysis parameters are used. The technique is practical and the required 
software is freely available so that analyses can be performed on standard personal 
computers (preferably a minimum of a Pentium 3 processor and 256 RAM) or on Sun 
workstations. The time for pre-processing and analyses depends upon studied group 
sizes, complexity of statistical design matrices and computer speed. For a standard 
Pentium 3 processor and a group comparison of 10 patients and 10 controls pre­
processing (optimised method) takes approximately 24 hours allowing for checking 
each pre-processing step and each analysis takes approximately 2 hours. In order to put 
this into context, expert delineation of each and every gyrus in a single brain MRI, if a 
willing neuroanatomist could be persuaded to do the task, would take many weeks.
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Having established reproducibility, validity and practicality, the optimised 
method is then assessed for clinical usefulness in health and disease. In Chapter 3, 
VBM is used on a large normal database to characterise global and regional effects of 
the ageing process. VBM shows a linear pattern of global decline in grey matter, more 
pronounced in males than females, that corroborates a number of previous studies. In 
accordance with most previous reports, VBM shows little global change in the white 
matter compartment with age. Some researchers have suggested that white matter loss 
is accelerated in the later decades in life and it is possible I may be missing a non­
linear trend in elderly subjects in their eighth and ninth decades owing to a paucity of 
subjects over 75 years of age in my study. Importantly, VBM reveals regionally 
specific effects of age over and above global change within grey and white matter and 
CSF compartments. Relatively faster loss of cortical volume occurs with age in the 
insula, superior parietal gyri, central sulci and cingulate sulci bilaterally. Areas 
exhibiting little or no age effect (relative preservation) include the amygdala, 
hippocampi and entorhinal cortex bilaterally. These are new findings and as such 
cannot be currently confirmed or refuted owing to the paucity of regionally specific 
ageing data in the literature. They will serve as a guide for further morphometric 
studies of ageing.
In Chapter 4 ,1 use VBM to characterise asymmetries in human brain anatomy 
and the effects of sex and handedness on brain morphology. VBM confirms the well 
known lobar and Sylvian fissure asymmetries, in this way establishing face and 
construct validity, whilst expanding on regional information, in particular by revealing 
an interaction of sex and asymmetry in Heschl’s gyrus. The well-recognised global 
difference in grey matter between males and females is confirmed and subtle regional 
sex differences in temporal lobe structure are revealed. Since the imaging literature on 
cerebral asymmetry and effects of sex is large and conflicting with a relative paucity of 
regionally specific details, these new findings cannot be presently definitively 
confirmed or refuted but correspondence with functional imaging findings adds to their 
plausibility. Such findings will need further scrutiny in future imaging studies. Despite 
the large group studied, VBM revealed no main effect of handedness on brain 
structure, even within the banks of the central sulcus in the vicinity of the hand area. 
This suggests that either VBM is insensitive to real but subtle macroscopic change 
(masked by interindividual variability in sulcal topography and difficulty in accurately 
classifying handedness leading to heterogeneous groups) or that functional
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lateralisation is not accompanied by macroscopic structural change. Since the spatial 
normalisation implicit in VBM is relatively low dimensional and does not aim to 
accurately match cortical sulci, it seems likely that VBM in its current state of 
evolution is missing subtle structural change in this region. Further studies with 
carefully selected homogeneous handedness groups and accurate cortical mapping 
techniques or tensor-based morphometry will be needed to help resolve this question.
VBM is then been applied to a number of disease groups (Chapters 5-9) to test 
the usefulness of this technique in diffusely distributed cortical and deep grey matter 
pathology (e.g. Alzheimer’s disease) and regionally specific lobar pathology (e.g. 
frontotemporal lobar degeneration of the semantic type)(Chapter 5). In these disease 
groups, VBM has been rigorously compared with the current best gold standard 
namely region of interest measurements performed by experts and also with post 
mortem data and PET studies of altered glucose metabolism. VBM confirms the most 
consistent previous imaging findings whilst expanding upon regionally specific effects 
in grey and white matter. In many regions, VBM is shown to be more sensitive than 
classical region of interest metrics (e.g. regional hippocampal volumes in Alzheimer’s 
disease)
VBM is then applied to patients with temporal lobe epilepsy with established 
mesial temporal sclerosis (Chapter 6). Here VBM confirms the results of independent 
ROI analyses of ipsilateral hippocampal volume loss and shows additional structural 
differences outside the affected hippocampus that correlate with clinical outcome after 
temporal lobe surgery. Patients with an unfavourable postoperative outcome show 
additional extra hippocampal structural changes in ipsilateral orbitofrontal cortex 
whereas patients with a favourable postoperative outcome show greater volume loss 
within the ipsilateral hippocampus within the resection site. The importance of this 
observation is that VBM detects clinically relevant structural changes that were missed 
on visual appraisal and classical morphometries.
Having demonstrated that VBM is a valid technique for characterising global 
and regional cortical and deep grey matter pathology in dementia, I examined a 
number of other diseases in which the structural correlates of known clinical and 
functional imaging features are less clear or previously unknown (migraine, 
schizophrenia and pure autonomic failure (PAF)). In schizophrenia (Chapter 8) and 
PAF (Chapter 9) VBM confirms the more consistent imaging findings in the literature 
whilst revealing new structural changes that match proven functional imaging deficits
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in biologically plausible locations. In this setting, VBM offers new insights into the 
underlying pathological mechanisms of disease. On the other hand, in migraine 
(Chapter 7), VBM detects no structural changes in areas previously thought to be 
affected functionally (e.g. brain stem activity changes in functional imaging studies). I 
conclude that VBM does not always find structural changes in patients with 
neurological disease. This is not surprising because the method informs about 
macroscopic and mesoscopic levels of structural change but cannot give information 
about microscopic changes. Also, functional abnormalities are not necessarily 
associated with structural change. Finally, VBM may be insensitive to very subtle but 
real macroscopic/mesoscopic structural changes either due to lack of power (an 
inadequate group size) or limitations of the technique. Phenotypically migraine is a 
heterogeneous condition so there may be no reason to expect a consistent anatomical 
change in a group of patients.
In order to test this possibility, VBM was tested in a specific homogeneous 
phenotype characterised by a known uniform genotype, namely a pedigree with 
familial ataxic migraine (Chapter 12). VBM again showed no brainstem structural 
changes, but clearly revealed cerebellar atrophy in those genotype positive family 
members with an ataxic phenotype, but not in genotype negative kindred. This result 
provides compelling evidence that there is no macroscopic structural change within the 
brainstem of migraine sufferers.
In light of major advances in molecular mapping and new insights provided by 
the human genome project, genotype-phenotype correlations are now practically 
possible. Since VBM has been shown to be sensitive to alterations of brain structure 
that anticipate the onset of clinical symptoms in a number of diseases, it follows that 
the structural phenotype may match the genotype better. Furthermore the versatile 
statistical framework on which VBM is based allows application of gene deletion 
mapping strategy revealing. For example, in Turner syndrome a small locus on the 
short arm of the X chromosome is responsible for abnormally formed amygdalae in 
affected females who show abnormal fear conditioning (chapter 10). The implication 
of significance is that the deleted locus normally contains a putative gene (or genes) 
that code for amygdala development. Following successful mapping of the X 
chromosome genotype-phenotype relationship, I have explored genotype-phenotype 
relationships in genotyped pre-symptomatic subjects at risk for Huntington’s disease 
(HD)(Chapter 11). In this case, use of VBM confirms structural alterations within the
252
caudate nucleus and other basal ganglia components in genotype positive subjects 
before the onset of HD symptoms. Furthermore the VBM-based study reveals new 
insights, including demonstration of asymmetric involvement of the caudate nucleus in 
genotype positive subjects that recapitulates the asymmetry of presentation of another 
basal ganglion degenerative disorder, Parkinson’s disease. There is also involvement 
of neocortex which has previously been overlooked in region of interest based studies. 
This study demonstrates that VBM is suitable for characterisation and monitoring of 
structural change within genetically at risk pre-symptomatic subjects in clinical trials 
of potential new therapies.
Strengths o f  the VBM technique
VBM is a fully automated technique that is therefore by definition reproducible 
and not subject to inter- or intra- rater variability. It is practical in the sense that the 
software is freely available, methodological assistance is available on the SPM help 
line; it can be performed on most standard computers and is relatively time efficient (in 
comparison with operator dependent techniques). It can therefore be applied to large 
data sets. One of the greatest strengths of the technique is the ability to characterise 
brain structure in a holistic way. Each and every voxel in an image is tested so that 
hypotheses can be examined in a spatially unconstrained manner. Brain function can 
be accurately localised by mapping brain structure into a standardised anatomical 
framework, and comparisons can be made with complementary information, from 
cytoarchitectonics and receptor distributions, to provide a more complete appraisal of 
the implementation of neural mechanisms.
The image pre-processing steps in VBM allow brains of different size, shape 
and orientation to be registered into a standard space so that appropriate cross sectional 
and longitudinal comparisons are feasible. The versatile statistical components of SPM 
incorporate voxel-wise estimates of variance and allow structure to be correlated with 
effects of interest (such as disease severity scores) whilst accommodating confounding 
factors (such as age and sex and global volumes). An additional advantage is that the 
triad of computational neuroanatomy techniques are complementary. VBM informs 
about voxel-wise differences in grey (or white matter) volume and concentration.
DBM informs about global shape differences. TBM informs about regionally specific 
shape differences with high precision. The optimised method of VBM (incorporating 
the modulation step and thus information from the deformation fields) is a hybrid
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between VBM and TBM. When high dimensional deformation warps can be 
practically utilised for large data sets, currently it is too computer intensive, then TBM 
will be a particularly interesting tool.
Weaknesses o f  the VBM technique
Many of the strengths of the technique also have down sides. VBM comprises a 
series of fully automated operations. None of these is perfect.
Spatial normalisation.
The spatial normalisation step uses relatively low dimensional warps to match 
global brain characteristics such as size and shape but does not aim to accurately match 
each and every gyrus. Since the human brain is characteristically variable, both 
between individuals and between brain regions in the same individual, it follows that 
individual gyri and sulci are not precisely matched. VBM aims to detect regionally 
specific differences in brain structure that remain after spatial normalisation, using a 
smoothing kernel to accommodate the imperfect gyral matching. The spatial 
localisation of VBM is thus limited to the chosen smoothing kernel which for most 
VBM applications is 10-12mm. Thus any local maximum relates not to the specific 
voxel coordinates but to the surrounding region defined by the smoothing kernel. In 
practical terms this means that a maximum in the amygdala may allow inferences 
about structural change within the amygdala and adjacent portion of entorhinal cortex 
and/or hippocampus. Smoothing kernels also render the data more normally distributed 
for the parametric statistical tests. Since group comparisons are, and have been show to 
be, robust to violations of normality even without smoothing kernels, there is the 
temptation to do away with smoothing kernels and enhance spatial localisation of 
inferences. It is important to resist this temptation since the spatial normalisation in 
VBM produces imperfect gyral matching. Once high deformation warps can be shown 
to produce accurate and reproducible gyral and sulcal matching, then VBM (with the 
modulation step) and TBM will be used without smoothing to inform about local 
differences with high-resolution spatial localisation.
Diseased brains provide a challenge for spatial normalisation. The linear and 
non-linear registration algorithms aim to map each brain to the template. If the patient 
brain differs substantially from the template brain there is potential for over fitting of 
the data. For this reason customised disease, age and sex specific templates are
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usefully created and regularisation is adjusted. The VBM study of Alzheimer’s disease 
and semantic dementia shows that spatial normalisation is accurate even for severely 
atrophic brains (diffuse and regional) when using customised grey and white matter 
templates. Brain scans with focal complex lesions such as tumours and haemorrhagic 
infarcts may not be reliably normalised and different additional strategies are needed in 
these cases (see Indications and cautions below). A number of systematic differences 
between patients and controls can potentially affect registration, such as systematic 
differences in grey and white matter intensity or motion artefact. These produce 
systematic differences in registration accuracy between groups. Such differences in 
spatial normalisation accuracy have not been formally studied, but it is important to 
note that these will not produce bias or false positives per se. Any differences detected 
by VBM will reflect systematic differences in anatomy between the groups, but 
caution about local inferences will need to be observed.
Segmentation
The segmentation step partitions the brain into grey and white matter, CSF and 
other compartments based upon an a priori knowledge of the spatial and signal 
distribution of voxels. Segmentation is not perfect and therefore some voxels will be 
misclassified. The optimised VBM methods automatically removes non brain voxels, 
so misclassification in normal brains is minimal. When the composition and resultant 
brain tissue signal is altered, as in disease processes or at the extremes of age, then 
classification of voxels becomes less precise, as can be shown around the hippocampus 
of patients with Alzheimer’s disease and semantic dementia (Chapter 5). Similarly in 
disease processes with multiple focal lesions in variable locations, such as multiple 
sclerosis or small vessel ischaemia, a template (even one customised to the disease 
group) will not be appropriate for a group of patients and thus segmentation will be 
unreliable.
Indications and cautions
VBM was originally designed to characterise brain structural changes between 
groups of subjects. For group studies the VBM statistical framework is robust to 
violations of normality (and thus false positives). Some researchers have been using 
VBM to detect structural changes within single subjects against a group of controls. 
Strictly speaking, such study designs are unbalanced and may be vulnerable to false
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positives. In these designs large smoothing kernels (12mm) are essential (Salmond et 
al. 2002). This concern should however be balanced with common radiological 
practice where an individual scan is reported based upon a radiologist’s personal 
perception of what constitutes a normal range. This method is equally unbalanced, 
which explains why visual inspection of a single scan (for example MR of an elderly 
subject to exclude atrophy) is often unreliable. VBM will probably prove more reliable 
than simple visual appraisal for the assessment of atrophy in single subjects compared 
to a large local age matched control group and customised templates (see Clinical 
applications below).
VBM is an automated method with a number of pre processing steps. Potential 
processing errors may enter at each stage and impact on the interpretation of the 
statistical output. For this reason, images should be evaluated after each processing 
step for potential errors of normalisation and segmentation. Though an automated 
technique, VBM is sufficiently complex that it should be preferably used by operators 
who understand the method and have a good working knowledge of MR and 
neuroanatomy.
As noted above, spatial normalisation aims to map MRI scans into standard 
stereotaxic space. For normal scans and those with distributed pathology, the spatial 
normalisation provides accurate global matching. Where there is marked focal 
pathology with complex signal changes, for example a large complex tumour or an 
infarct, there will be problems as spatial normalisation attempts to match the abnormal 
region to a corresponding normal region on the template. This will generally result in 
over fitting of the data and marked local distortions may occur. For these reasons, a 
different strategy is needed such as masking out the lesion zone manually or semi 
automatically using customised software such as MRIcro
(http://www.psychology.Nottingham.ac.uk/staff/crl/mricro.html). This software allows 
spatial normalised in situations such as those described without introducing artefacts 
from complex focal lesions. In general, VBM should thus be avoided or used with 
caution (with careful attention to each preprocessing step) in subject groups with 
complex focal lesions.
Clinical implications
This thesis demonstrates that VBM is a reproducible, sensitive and practical
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tool for the characterisation of brain morphology. The results are biologically plausible 
and valid in the sense that they confirm the most consistent findings from 
histopathological and classical morphometric studies and correspond to functional 
imaging studies.
VBM is becoming an established tool in the research domain in cross sectional 
studies of healthy and diseased populations. VBM is increasingly being used to 
examine the structural brain correlates of diseases with known functional deficits but 
previously occult or unclear morphological alterations. I have not yet formally 
evaluated VBM in longitudinal studies, but preliminary data show that this is a robust 
tool for evaluation of cerebral changes over 1-2 year time scales (within the time 
window of a MRI scanner). It is likely that VBM and similar whole brain techniques 
will be used as surrogate markers for disease progression in clinical trials of disease 
modifying agents
The role for VBM in clinical neuroradiology has yet to be established. Potential 
areas where the technique could be an asset to a neuroradiology department include 
assisting in diagnosis and clinical follow up of single cases. In certain instances 
diagnosis of pathology may be difficult owing to a wide overlap with normality. A 
typical example is the differentiation of atrophy from normal involution in elderly 
subjects on a single brain scan. Typical radiological appraisal depends upon the 
experience of the neuroradiologist and is likely to yield false positive or false negative 
diagnoses as well as intra-rater variability. A simple VBM analysis comparing the 
single subject scan to a group of local age and sex matched subjects from a local 
database will provide objective evidence of whether the scan in question is 
significantly different from the local norm. A second possibility would be to use core 
components of the VBM framework to co-register a single subject’s scans to a local 
age and sex-matched template and to assess and interpret a deformation image.
These strategies may also prove useful for pattern recognition in groups of 
diseases with clinical and imaging overlap. For example, atypical Parkinsonian 
syndromes such as multiple system atrophy (MSA), progressive supranuclear palsy 
(PSP) and idiopathic Parkinson’s disease may be difficult to differentiate. By creating 
disease specific templates, it may be possible to sub classify patients more accurately. 
A VBM study is currently in progress to examine this role.
In order to assist practicality in a busy neuroradiology department, these image 
analysis algorithms implicit in VBM could potentially be incorporated into the MR
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scanner software so that the results are made available at the time of reporting. The 
most obvious advantage of using such post-processing methods is their suitability for 
longitudinal evaluation of cases since the scans are in a standard anatomical 
framework. Furthermore longitudinal evaluation of a single patient will prevent subtle 
dynamic changes from being masked by interindividual variation. In this particular 
scenario, VBM is not intended to replace an experienced neuroradiologist, but rather to 
be a useful tool at his/her disposal and discretion.
Final conclusions
I have shown voxel-based morphometry to be a practical, reproducible and 
sensitive tool for the characterisation of human brain structure in cross sectional or 
longitudinal studies. The validity and biological plausibility of VBM detected results 
have been assessed in the context of the best currently available methods, and in this 
sense VBM replicates the most consistent and established reported results while 
offering new regionally specific detail, which in most cases corresponds with 
functional imaging data. By employing the same anatomical and statistical framework, 
direct correlations of structure and function are possible. With further improvements in 
computational power, more accurate mapping of cortical gyri and sulci will facilitate 
the detection of more subtle structural differences in brain morphology in health and 
disease. Importantly VBM is a fully automated reproducible whole brain technique 
that avoids the subjectivity of classical ROI morphometries and can be practically 
applied to large study groups. The software is freely available and so the technique can 
now be applied practically not only within research units, but also within the clinical 
domain. I therefore conclude that VBM is indeed a useful tool for characterising and 
mapping brain structure in health and disease.
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